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Abstract 
 
Members of the recently discovered family of short non-coding RNAs, termed microRNAs 
(miRNAs), regulate the expression of most genes encoded by the human genome by 
repressing translation of messenger RNAs to proteins. MiRNAs are stably expressed 
throughout the body and can be detected robustly and reproducibly by RT-qPCR in body fluids 
such as blood and urine. Alterations in circulating miRNA profiles have been associated with 
cancers of the brain, breast and liver, and miRNAs hold great promise as biomarkers of 
numerous other diseases. However, current methods for miRNA biomarker detection rely on 
laborious, expensive and expert techniques, and involve invasive biopsy acquisition. The 
research contained within this thesis focusses on the development of a non-invasive, 
inexpensive and rapid electrochemical analytical test to quantify miRNA in human urine 
samples. 
Therefore we describe how glassy carbon and disposable screen printed carbon electrodes 
(SPCEs), were modified through electropolymerisation of a naphthalene sulfonic acid 
derivative.  DNA complementary to a target miRNA was attached and the sensor analysed via 
electrochemical methods using a ferri/ferrocyanide electrolyte. After hybridising with a 
miRNA target, this analysis was repeated and compared to the original DNA-only analysis to 
give a corresponding change. This was performed using buffered solutions and shown to be 
sensitive to 20 fM and selective against sequences with a single mismatch; urine analysis was 
also performed. The method was then adapted for use with screen printed electrodes, using 
a new chlorination solvent system, to a lowest detected concentration of 10 fM. The ink 
materials used for the production of the SPCEs were optimised and a new design developed 
to allow for multiple analyses on one sensor. A small number of diabetic kidney nephropathy 
(DKN) patient and healthy control urine samples were then analysed for biomarkers we have 
recently identified, comparing their relative expression levels. 
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Chapter 1: Introduction 
 
1.1: MicroRNAs 
1.1.1: MicroRNA History 
MicroRNAs are a class of small (19-23 nt), single stranded and non-coding RNA molecules that 
were first discovered by Lee et al.1 in the Caenorhabditis elegans species of roundworm. This 
group first isolated the microRNA species Lin-4 and found it to have antisense 
complementarity to the messenger RNA (mRNA) Lin-14, which encodes the embryonic 
protein of the same name. The binding of several Lin-4 miRNAs to the 3’ untranslated region 
(UTR) of Lin-14 results in a downregulation of the downstream Lin-14 protein, which in turn 
changes the developmental timing of the roundworm larvae.1,2 Despite this, when first 
isolated it was assumed that, due to their size and relative instability, they were most likely 
specific only to the simpler roundworm organisms. However when the developmental timing 
miRNA species, let-7, was found to be conserved across various other species, interest into 
their biological importance exploded.3,4 This particular family of miRNA is also believed to be 
the first human microRNA discovered, and is now known to play a key role in the development 
of certain cancers.5,6  
Since then the number of publications on miRNAs and their biological significance has grown 
exponentially, with many new miRNA species being discovered each year. In fact, at the time 
of writing there are currently 28645 entries in the miRNA database (miRbase) with over 2000 
of these being human, targeting more than 30% of the human genome.7–9 Owing to their 
small size, miRNAs are able to hybridise with target mRNAs with perfect or minor imperfect 
complementarity, also their relatively short sequences compared to these mRNAs results in 
any one microRNA sequence being found either in a close or perfect match in a number of 
mRNA families. The high potential for a particular miRNA sequence to occur multiple times 
throughout mRNA species often result in one miRNA having multiple mRNA targets, also 
meaning that each miRNA species can have a variety of downstream phenotypic effects on 
the gene expression and protein production.7 Although in healthy biological processes there 
will be a driving bias towards the biogenesis of sequences required to maintain phenotypic 
status quo. 
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1.1.2 MicroRNA Biogenesis. 
MiRNAs are biosynthesised according to sequence information given in the miRNA gene via a 
multiple step biogenesis pathway. Initially they are transcribed according to the sequence of 
their antisense DNA, found in the miRNA gene, by the enzyme RNA polymerase II.10 This 
produces the hairpin structured primary miRNA termed “pri-miRNA” which is approximately 
1000-3000 nucleotides (nt) in length. This pri-miRNA is then converted into smaller stem loop 
strands of approximately 70-100 nt length using the Drosha RNase III enzyme and the complex 
subunit Di George syndrome critical region gene 8 (DGCR8), a double stranded RNA-binding 
protein also known as Pasha in Drosophila melanogaster and Caenorhabtis elegans.7,11–13 This 
newly formed pre-miRNA (precursor miRNA) is transported out of the nucleus, to the 
cytoplasm of the cell, via the karyopherin (transport protein) Exportin-5.11,14 Once inside the 
cytoplasm the pre-miRNA undergoes further cleavage and processing via dicer proteins, 
RNase III enzymes and an RNA binding protein to form a double-stranded (ds) miRNA duplex 
miRNA:miRNA*. This duplex contains two single stranded (ss) miRNA molecules, the guide 
strand miRNA and the passenger strand miRNA*.11 Finally this duplex is denatured to reveal 
the guide strand, which is incorporated into an RNA-induced silencing complex (RISC), while 
the passenger strand is often degraded and the nucleotides recycled.  
The RISC complex is then able to bind, perfectly or imperfectly, to the 3’-untranslated region 
(3’-UTR) of its target mRNA, which in turn results in downstream regulation of gene 
expression through mRNA degradation or by inhibiting the translation of said mRNA. This final 
complexation mechanism is what gives miRNA their profound effect on protein and gene 
regulation.1,7,11,12,14,15 Figure 1.1 shows a general summarised overview of this biogenesis 
pathway as adapted from reference 10. 
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Figure 1.1 A summarised overview of miRNA biogenesis. 
1.1.3 Biological role of miRNA 
As mentioned, miRNAs have a detrimental effect on mRNA translation and act, therefore, as 
post-transcriptional regulators of gene expression. Upon incorporation into the RISC complex, 
including argonaute (AGO2) protein a Mg2+ dependant endonuclease,11,16,17 the miRNA 
sequence behaves as an antisense sequence in order to bind to the 3’-UTR of its mRNA target. 
This it does either perfectly, allowing the endonuclease and AGO2 proteins to cleave the 
mRNA, or imperfectly leading to inhibition of translation and/or further degradation of the 
mRNA strand.18   
Controlling the expression of genes is essential for a number of cellular processes, not just 
the larval developmental timing mentioned earlier. MiRNAs have also been found to be 
important in cell proliferation and death, apoptosis, cell differentiation and even fat 
metabolism.19–22 Combined studies have also suggested that they are important in removing 
persistent mRNA that have fulfilled their purpose in the cell but whose continued presence 
could be potentially harmful. MiRNA induced degradation removes such strands faster than 
their own intrinsic decay mechanisms, such as enzymatic hydrolysis and degradation by 
exoribonucleases e.g. Xrn1.22–24 
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The relatively short length of miRNAs, compared to mRNAs, results in a high potential for 
complementarity with a number of different mRNA species sequences, thus one species of 
microRNA could possibly have multiple mRNA targets. For example miR-21 targets over 30 
gene targets for apoptosis alone, including B-cell chronic lymphocytic leukaemia/lymphoma 
2 (BCL2)25 and transforming growth factor - beta receptor II (TGFBR2),26 as well as having at 
least one target in each stage of the development of cancer cells as described by Hanahan et 
al.27,28 and shown in Figure 1.2 adapted from reference 24. This miRNA species has been 
shown to be oncogenic by having an inhibitory effect on cellular apoptosis, and is therefore 
often highly abundant in cancerous cells.29,30  
However another species, miR-16, which among many other things is also associated with 
various forms of cancer, actually displays tumour suppression activity.31,32 It does this in a 
number of ways, primarily through targeting the genes responsible for vascular endothelial 
growth factor (VEGF) and basic fibroblast growth factor (bFGF) proteins and repressing their 
expression,33,34 as a result, in multiplying cancerous cells, this miRNA species often displays a 
much lower expression. These two brief examples show that microRNA not only have multiple 
mRNA gene targets, but they can also have an inhibitory effect on a cells growth processes or 
an activation effect depending on its target. 
Of course, it is important to note that miRNA also have the potential to block mRNA 
expression in other areas of physiology, including those that are common to all cells. Because 
of this it has been suggested that there are certain genes that have been pre-programmed to 
avoid miRNA regulation, termed “antitargets”, and have sequences that are under selective 
pressure to resist miRNA binding, often via shortened 3’UTR’s with fewer potential miRNA 
binding sites.35,36 These mRNA can be found intact in cells where miRNAs are also expressed.37 
The target mRNA however tend to be localised to specific cells and used in developmental 
processes.  
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Figure 1.2 The gene targets for miR-21 that form the hallmarks of cancer. Those in blue are apoptosis specific, those in red 
are involved in glucose flux and oxidative phosphorylation. The green targets show those that are also targeted by miR-16 
showing how multiple miRNAs can also target the same genes.27,38–43 
1.1.4 MiRNAs as biomarkers. 
As mentioned previously, the influx of research into the biological roles of miRNAs has shown 
that they have the potential to target many cellular processes. However as these processes 
are overstimulated or impeded in diseased states, as is the case in cancers,44 trauma45 and 
acute kidney injury (AKI),46 interest grew into whether or not the microRNAs that target the 
genes involved in these processes would also change in expression. This would allow 
microRNA levels to be related back to a specific disease, and therefore give them significant 
biomarker potential. 
In late 2002, Calin et al. were one of the first groups to formally identify microRNA expression 
as a biomarker for B cell chronic lymphocytic leukaemia (B-CLL).47 They successfully managed 
to show that the genes for both miR-16 and miR-15 are located at chromosome 13q14, and 
that when this chromosomal region is deleted in B-CLL patients, the miRNAs expression is 
either down regulated or absent completely in at least 68% of cases. This finding confirmed 
the potential of miRNAs as biomarkers, and even more excitingly, as biomarkers for otherwise 
deadly diseases such as cancers. Since then, research into the field of miRNA discovery, as 
well as their use as therapeutics48 and as biomarkers, has grown exponentially with new 
miRNAs and methods to quantify them being published every week.  
 7 
 
MiRNA have been shown to be prevalent not only in cell lysates49 and tissue samples50, but 
also in blood51, serum52, faeces53, saliva54 and urine11,55. This last source is of particular 
interest, and as such forms the basis of the research in later chapters, due to its easy 
collection, relatively easy handling and high availability in clinical settings. Due to the 
presence of multiple RNase enzymes in biological extracts and excreta these miRNAs need to 
be protected to prevent their hydrolysis and allow them to be found in sufficient quantity for 
detection. Conveniently organisms actually supply this protection themselves, during natural 
cellular processes, in the form of AGO proteins and extracellular vesicles.56  
By binding to an AGO protein the miRNAs are prevented from entering the active site of the 
RNase enzymes, therefore slowing their rate of degradation enough to allow them to be 
detected and analysed. In fact, Beltrami et al.57 have shown that association with AGO 
proteins can stabilise the miRNAs in such a way that a miR-16 sample was still detectable in 
urine medium, at more than 50% of its starting expression, after being left at room 
temperature for 24 hours, compared to a miR-39 control which dropped to less than 10% 
expression after only 1 hour. This stabilisation was even effective enough to protect the miR-
16 from complete degradation via additional RNase A treatment for 15 minutes whereas the 
miR-39 spike was completely hydrolysed in less than 1 minute. Once removed from these 
AGO proteins, however, the miRNAs once again become susceptible to rapid degradation by 
the RNase enzymes in the biological matrix. This effect was also shown in the work performed 
by Beltrami et al. through their use of proteinase K to degrade the associated proteins, 
resulting in a significant drop in relative expression after 30 minutes incubation, vs. a sample 
that remained untreated. 
Although the miR-16 species investigated in the work performed by Beltrami is predominantly 
protein associated, some miRNA species are maintained within extra-cellular vesicles. These 
include miRNAs found in saliva and serum particularly, but also to a lesser extent in urine.57,58 
Being encased by vesicles also helps to protect the RNA from enzymatic degradation and, for 
the purposes of miRNA detection and analyses, the vesicles have to be broken apart to release 
the miRNA into bulk aqueous solution. This has been done in a number of ways but the most 
common of these are either with chemical lysing agents57,59,60 or by mechanical breakdown 
using a sonicator.60 These stabilisation effects are vital in allowing the endogenous 
 8 
 
microRNAs, present in patient urine samples, to survive long enough to be effectively 
extracted, isolated and quantified for the purposes of biomarker analysis. 
As eluded to earlier, the relative expression levels of microRNA have been shown to relate 
directly to a number of disease states. This, along with the fact that they are sufficiently 
protected from degradation in various biological fluids, makes them ideal for use in biomarker 
diagnostics. Throughout the work presented in later chapters there are two microRNA species 
of interest, miRNAs 21 and 16, whose expression levels have been associated with the onset 
of cardiac disease61 and B-CLL47 respectively as well as both being linked to various 
cancers.32,62 However they have been chosen specifically due to our interest in urinary 
biomarkers for kidney diseases.  
Work performed by Wang et al.63 has shown that an increase in miR-21 expression is observed 
in urine of fibrotic kidney patients, and Mukhadi et al. report that miR-16 is down regulated 
in patients with acute kidney injury (AKI).64 These observations are important, not only as 
useful biomarkers in nephrotic diseases, but also because it shows an important feature of 
microRNAs as biomarkers. This being that microRNA expression can be either up regulated or 
down regulated in disease states, therefore any change in relative expression should be 
explored as an important observation. It is important to note however that, owing to one 
microRNA being related to multiple diseases, the expression of multiple microRNA species 
should be investigated simultaneously in order to increase the reliability of any diagnosis 
made from their analysis.  
Another important microRNA of note that is used in later chapters is C. elegans miR-39, this 
is used not only as a house-keeping miRNA in RT-qPCR but also as a control target sequence 
in electrochemical urine analyses. This target has no known human orthologue and can 
therefore be used to distinguish between a true miRNA analysis and any interference. 
Seeing that the levels of microRNA are directly linked to a number of diseases throughout the 
body, it may also be possible to analyse other sequences, and assist with the diagnosis of 
patients with a variety of different illnesses through the analysis of these miRNAs’ expression 
levels. For instance, miRNAs 21 and 16 have already been discussed as targets in kidney 
disease, heart disease, B-CLL and cancers;32,62 however there are a vast number of other 
miRNA species which have a direct role in a number of ailments and may potentially be used 
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as an indicator for a wide array of disorders from the aforementioned cancers and auto 
immune diseases,65 right through to genetic disorders,66 malaria67 and arthritis.68 Figure 1.3 
shows how miRNA expression can be linked to diseases throughout the body, giving a visual 
indication of how important a microRNA biosensor could be to the medical community. 
 
Figure 1.3 A pictorial representation of how microRNA expression may act as an important biomarker for diseases 
throughout the body. The corresponding dysregulation is indicated by the arrow, ↑ being an up-regulation and ↓ being a 
down regulation, the ability to detect these dysregulations would demonstrate the potential diagnostic application of a new 
quantification technique.11,69–83 
1.1.5 MiRNAs in Kidney disease and Nephropathy 
Of interest to the research performed in the Institute of Nephrology at Cardiff University is 
the role microRNAs play in kidney diseases, nephropathy and acute kidney injury. In particular 
a number of researchers are doing work dedicated to determining which microRNA species 
expression levels can be related to a particular disease state. With these results indicating the 
subsequent need for fast and accurate quantification of these miRNAs.  
Brain disorders: 
ischemia (miR-10a, 
miR-223 ↑),76 
Alzheimer’s (miR-29-a, 
miR-29-b-1 ↓),77 
Parkinson’s (miR-133b 
↓),78 schizophrenia 
(miR-181b ↑)79  
Bone/blood 
diseases: leukaemia 
(miR-16 ↓)43  
Thyroid: papillary 
thyroid carcinoma 
(PTC, miR-221 ↑),69 
follicular thyroid 
carcinoma (FTC, miR-
197, miR-346 ↑)70 
Breast 
cancer 
(miR-16 
↓)29 
Liver disorders: 
chronic hepatitis 
B (miR-27a-3p 
↑),73 liver 
cirrhosis (miR-1 
↑),74 alcohol 
induced liver 
disease (miR-155 
↑)75 
Bowel 
disorders: 
Crohn’s 
disease (miR-
106↑, miR-
19b↓)72 
Kidney related conditions: 
diabetic kidney nephropathy 
(DN, miR-21, miR-29 ↑),11, 66 
AKI (miR-26b-5p, miR-146a-
5p ↓)67 acute post-
transplantation rejection 
(hsa-miR-324-3p ↓, hsa-miR-
125a ↑) 68 
Muscle/cartilage 
problems: 
rheumatoid 
arthritis (miR-
146a ↑)65 
Diabetes and 
its 
consequences: 
limb ischemia 
(miR-503 ↑)71  
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According to kidney research UK,84 and reports and newsletters from the Renal Association 
UK renal registry, chronic kidney disease costs the national health service (NHS) around 
£1.45bn each year in England alone, and by the end of December 2012, ≈55,000 people were 
receiving renal replacement therapy (RRT). Of these 27,621 were given a kidney transplant, 
22,331 were receiving haemodialysis at hospital, 3,792 were on peritoneal dialysis and 1,080 
were on haemodialysis at home;85 and the latest report shows that these numbers are rising 
rapidly.86 Despite this, currently around 3,700 people die each year while on dialysis and 250 
die waiting for a transplant.84 It is also mentioned that the majority of renal failure incidents 
occur as a result of diabetes complications and with 3,590,501 people having been registered 
as diagnosed in the 2016 quality and outcomes framework. With the inclusion of undiagnosed 
cases, an approximate 4.5 million people are living with diabetes according to Diabetes UK,87 
setting the stage for kidney problems to become an even bigger strain on the NHS and its 
patients.  
Having a way to quickly and painlessly predict the onset, or presence of, kidney disease or 
diabetes could therefore help to lower the number of new kidney patients requiring RRT, thus 
decreasing the financial impact on the NHS, but also giving potential sufferers an ‘early 
warning’ allowing them to receive the most appropriate treatment in a timely manner 
improving their prognosis and their quality of life. 
To this end, research mentioned earlier, performed by members of the Cardiff Institute of 
Nephrology, has shown that the levels of microRNA in urine has the potential to predict 
chronic kidney disease (CKD) and injury,55 and for those already on peritoneal dialysis (PD) 
their ‘cloudy’ PD fluid can also be analysed for the expression of a second miRNA species to 
gain information on the presence and/or extent of peritonitis.88 It is also worth mentioning 
that in some cases the expression of select microRNA species analysed can be specific to a 
particular stage of a disease or a particular infectious bacteria,89 giving specific details of, and 
not just being indicative of, the disease present. Thus if it were possible to quickly, cheaply 
and accurately analyse a patient’s urine sample/PD fluid for microRNA quantification, a 
personalised care approach may become possible. An approach resulting not only in better 
prognoses for the patients, but also lowering the use of broad spectrum antibiotics (which is 
becoming a significant problem due to resistant bacteria e.g. MRSA),90 and reducing the 
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number of kidney transplants or dialysis treatments required. All of this potentially saving the 
NHS money that may usually have been spent on more ineffective treatments.  
As a result of these benefits the work performed throughout this project focussed on the 
development of a new method of microRNA detection and then applying it to the analysis of 
isolated solutions of synthetic miRNAs, before moving on to the analysis of clinical urine 
samples. Currently the extraction, isolation and quantitative analysis of microRNA involves 
the use of time consuming, laborious, expensive and often specialist techniques. In particular 
these include blotting techniques,91 electrophoresis,92 fluorescence tagging93 and, the current 
‘gold-standard’ technique for nucleic acid quantification, RT-qPCR.57 Each of which will be 
described in detail, with some examples of research groups who implement them and how, 
in subsequent sections. However, these techniques all suffer from significant drawbacks, 
limiting their widespread application in medical devices and diagnostics.  
First and foremost these techniques are expensive and most currently require some form of 
expertise, such as adequate knowledge of how to handle lysing agents, nucleotide primers 
and organic solvents for RNA extraction. A knowledge of the technique being necessary 
particularly for any times where the extraction does not occur as standard. Alternatively 
specialist equipment may also be required, such as PCR machines, automated thermocyclers 
and/or spectrophotometers. Also with the need for specialist equipment comes an increased 
time demand. An RT-qPCR with extraction for example can take 2-3 days, but also the need 
for a point of care diagnostician to send samples to a central laboratory, where the equipment 
is maintained, also results in a time expense. This obviously also increases the likelihood of 
contamination and/or handling errors, but also increases the time between assessment and 
diagnosis, possibly causing a disease to spread or become more severe. Finally, an often 
overlooked issue is that at present the majority of these analyses are performed with blood, 
serum or tissue samples, requiring uncomfortable or even painful invasive procedures and 
increasing the chance of secondary infection.  
The research presented in this project therefore focuses on electrochemical analytical 
methods for the detection of microRNA from urine samples. Electrochemical methods, 
requiring relatively cheap equipment, being simple to perform (blood glucose sensors are 
already utilising a similar technique),94 and giving results within seconds, are the obvious 
choice of analysis for adapting microRNA quantification techniques into point of care 
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diagnostics. Furthermore, the ability to use readily available urine as the analyte removes any 
need for invasive sample collection procedures, improving the assessment experience for 
both patients and diagnosticians. Any new diagnostic biosensor that can be developed based 
on these techniques, with an eye towards future commercialisation and practical application 
as a one-time use ‘dip stick’, will therefore not only be important for clinical nephropathy, but 
also in the wider medical community as well. 
The majority of the sensor examples discussed later will describe themselves as biosensors, 
as is the case in our own research, however it should be noted that this may not be strictly 
the correct definition of the technology described. A biosensor would tend to indicate a probe 
that is able to be used and then regenerated completely over multiple cycles, however most 
of the examples described throughout are either single use after modification (as in Northern 
blotting and fluorescence based) or are moderately reproducible for 2 or 3 iterations. A better 
description of these technologies would be to call them dosimeters. These describe a single 
use test where once the result has been obtained the probe either needs to be fully recycled 
before it can be reused (recoverable dosimeter) or is disposed of completely. The disposable 
screen printed electrodes described in chapters 3 and 4 are examples of a dosimeter. Another 
common example are radiation dosimeters for determining radiation exposure levels in 
medical professionals.95  
 
Scheme 1.1 A schematic of the process by which microRNA can be used as a diagnostic biomarker. 
1.2: Current microRNA detection methods. 
1.2.1: Base pairing theory, hybridisation and antisense probes. 
There are a number of analytical techniques currently used in the analysis of microRNAs, each 
of which will be discussed briefly in the following section, however they are generally all based 
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around the same nucleotide pairing and antisense phenomenon. Therefore it is fitting to give 
a short overview into the structure of DNA and RNA nucleotides and importantly how they 
can come together to form duplexes and hybrids that are sequence specific, thus giving the 
analysis techniques their specificity. 
DNA and RNA chains are made up of nucleotide monomers, which in turn contain a ribose 
(RNA) or a deoxyribose (DNA) sugar, a phosphate linker forming the backbone and a 
nitrogenous base. These bases are either purine in nature as is the case for adenine (A) and 
guanine (G), or pyrimidine based as with thymine (T :- DNA only), cytosine (C) and uracil (U :- 
RNA only).96 It is then the order that these bases are found in the DNA or RNA strand that 
define its sequence and thus the organism’s phenotypical properties, which are established 
downstream by the presence and regulation of both genes, and the proteins that are being 
coded for by the organisms messenger RNA (mRNA). The sequence of these proteins being, 
in turn, determined according to its cellular DNA.96,97  
Of particular importance for the purposes of antisense based nucleotide detection, be it DNA, 
RNA or miRNA based, are the bonds that form between two corresponding nucleobases in a 
duplex. So called Watson-Crick base pairs, they are formed by hydrogen bonding between 
two nucleotides from opposing purine/pyrimidine families that share the same number of 
hydrogen bond donation/acceptor sites, i.e. between cytosine and guanine, and between 
Adenine and thymine/uracil.96,98 These pairs, consisting of 3 hydrogen bonds for cytosine and 
guanine and 2 for adenine with thymine/uracil, allow a single strand of nucleotides to act in 
molecular recognition of its sequence complement, thus allowing for the specific detection of 
one sequence in a solution of many. The generalised structures of these bases and their 
Watson-Crick base pairings are shown in Figure 1.4. 
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Figure 1.4 The different DNA and RNA bases shown with their Watson Crick base pairings and a generalised structure of 
both RNA and DNA. The difference in the ribose sugar for DNA and RNA is indicated with ‡ and the bases are placed 
according to their purine/pyrimidine family. 
An important structural feature to note here is that RNA contains an extra OH group at the 
C2 position. This extra group has a structural effect of causing the ribose sugar to adopt the 
N-type confirmation (resulting in A type duplexes) which will be described further when 
discussing LNA analogues. However another important effect of this extra OH group is the 
resulting decreased stability of RNA towards hydrolysis, this extra OH group allows the 
base/enzyme catalysed attack of the neighbouring phospho-ester resulting in the cleavage of 
the ester bridge and separating the strand into two pieces.99 This is the predominant reason 
for using DNA probe strands over RNA in many antisense based sensors and is also responsible 
for the rapid degradation of miRNA in particular, in the presence of RNases. 
However, these are only the natural nucleotides, there have since been many synthetic 
analogues developed in order to increase the binding affinity towards a natural nucleotide 
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target sequence, resulting in greater sensitivities of the detection method and often 
enhancing the specificity. Before delving further into the specific techniques used for miRNA 
detection, using some examples of research groups that have used them and how, it is 
worthwhile to describe these unnatural analogues in order to further understand the theory 
behind them and why certain groups throughout the field implement them in their own 
biosensor technology. 
1.2.2: Peptide Nucleic acid 
The first of these unnatural analogues to be briefly discussed are peptide nucleic acids (PNAs), 
which contain the same nucleobases, however the sugar and phosphate backbone has been 
replaced by a series of amide linkages, making them similar in structure to a peptide, albeit 
with an ethyl spacer in the backbone between each base which would not be present in 
peptides. In PNA the nucleobase is bound to the amino moiety “N-terminus” via an amide 
linkage, generally with a bridging methylene (Figure 1.5).100  
Since their initial invention, by Nielsen et al. in 1991,101 the synthesis and resulting properties, 
particularly their binding affinities with naturally occurring DNA and RNA sequences, have 
been highly researched and modified. Generally these PNA molecules are synthesised using 
Fmoc based solid phase synthesis (SPPS),102 however as the number of modifications that are 
possible with PNA have been researched some have been produced using DNA synthesisers 
which can fully automate the SPPS technique, while others have even been developed using 
solution based methods.103,104 In most cases the most important features of PNAs are their 
resistance to enzymatic degradation due to the structure and shape not being recognised by 
an organism’s hydrolytic enzymes such as nucleases and proteases,105 and their increased 
binding affinity with DNA and RNA targets. The latter of which is predominantly due to its lack 
of charged phosphate groups in its backbone reducing the electrostatic repulsion that would 
normally be present in a DNA/DNA, RNA/RNA or DNA/RNA hybrid.106 The extent to which this 
holds true is still being investigated, with recent research showing that negatively charged 
groups can be added to PNA without resulting in significant detrimental reductions in 
hybridisation efficiency.107  
The enhanced physiological resistance and increased DNA/RNA hybridisation efficiency give 
PNAs great potential in antisense based nucleotide detection, and it is these property that 
most research groups are attempting to influence with the most recent structural 
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modifications. For example, Akisawa et al. have developed a PNA sequence containing a vinyl 
cross linking group on the purine bases, which they found further enhanced the binding 
affinity of the PNA towards thymine of DNA and uracil of RNA (Figure 1.5A). They further 
found that this property could inhibit the Drosher processing of pre-miRNA and thus regulate 
the production of miR-122, a microRNA determined to play a role in the life cycle of hepatitis 
C, thus showing the displaying the potential importance of microRNA targets, and of PNA 
antisense, in therapeutics.108  
Alternatively the high affinity binding of PNA to DNA and RNA targets can also be used to 
investigate cellular processes by using synthetic PNA designed for hybridisation and RNA 
inhibition studies in place of the DNA/RNA alternatives. Ellipilli et al. have shown, in a couple 
of their own publications, that fluorination is possible at various different positions of the PNA 
to increase cellular uptake albeit with some hybrid destabilisation (Figure 1.5B).104,109 Also 
Kiviniemi et al. have shown that when 19F is used, once uptaken the investigation of PNA 
hybridisation with DNA/RNA targets through 19F NMR techniques is possible as well as the 
standard fluorescence microscopy techniques.110 With this in mind however, there have been 
cases where hybridisation efficiency is susceptible to great reductions upon modifications to 
some positions on the sequence, therefore careful design of the PNA is required.111  
 
Figure 1.5 The general structure of a PNA monomer, where B indicates the nucleobase A, G, C, T or U. Along with some 
modified examples from Akisawai et al. (A) and Ellipilli et al. (B).104,108 
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It should be noted however that with certain PNA sequences, and also owing to the uncharged 
nature of the PNA backbone, solubility issues have been encountered. Therefore further PNA 
modifications may be required in order to increase their solubility in aqueous buffered media, 
for example the inclusion of positively charged lysine residues.112 
1.2.3: Locked Nucleic acid analogues 
Another interesting class of synthetic oligonucleotide analogues, also used by various 
research groups mentioned later for the sensitive and selective detection of DNA and RNA 
targets, are the so called locked nucleic acids (LNAs). Similar to PNA these nucleotides also 
have greater hybridisation efficiency to DNA and RNA targets than a naturally occurring 
nucleotide strand, unlike PNA however, they still retain a pentose sugar (albeit a modified 
form) and the phosphate of the natural oligomer and thus the increased affinity is not due to 
a lack of electrostatic repulsion. Instead the ribose sugar contains a bridging chain between 
the 2’C and the 4’C, the first of which, synthesised by Singh et al. in 1998,113 and then shortly 
after by Koshkin et al.,114 comprised of an oxymethylene link. These researchers were the first 
to develop a synthetic oligonucleotide of this type using thymine and guanine as the 
nucleobases, and found that the introduction of this bridge resulted in a conformational lock 
of each LNA monomer that favoured DNA and RNA binding; a phenomenon that was 
attributed to the LNA monomer introduction causing the growing oligonucleotide to adopt 
the RNA like N conformer (see Figure 1.6).114 This conformational lock resulted in each case 
in either an equal or greater binding efficiency, measured by change in melting temperature, 
of the LNA/DNA or LNA/RNA target compared to the corresponding DNA based hybrids with 
a particular increase in affinity with RNA targets being reported with the addition of each LNA 
monomer. For DNA based antisense strands this locking of N conformation is not present, 
therefore the ribose sugar is free to switch between the N conformer (A type with a phospho-
ester separation of distance of 5.9Å) and the S conformer (B type with a phosphor-ester 
separation of 7.0Å),115 this gives the DNA sugar more flexibility which, upon hybridisation, 
results in a larger entropic penalty than for RNA hybrids.116 This lowers the free energy of 
DNA/DNA hybridisation meaning that they become harder to form and are less stable than 
RNA/DNA, RNA/RNA and all LNA based hybrids where at least one strand is locked in the N 
conformation.117 
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Since this initial data showed the potential of LNA in antisense based biomarker detection 
and therapeutics, a great deal of further research into their biological behaviour and their 
synthetic scope for more active analogues has been performed by a number of groups. For 
example, Ørom et al. successfully showed that the use of LNA as an antisense strand was able 
to inhibit miRNA activity, thus allowing for the investigation of miRNA specific activity in a cell 
but also potentially in the therapeutic deactivation of said miRNAs.118 Indeed Nedaeinia et al. 
have recently shown that the transfection of anti-miR-21 LNA into a colorectal cancer cell line 
LS147T, which displays increased expression levels of miR-21 in colorectal cancer patients, 
results in a decreased expression of miR-21 after 72 h exposure resulting in the cells growth 
being inhibited and the induction of apoptosis,119 thus displaying the potential for LNAs in 
miRNA therapeutics.  
However, LNAs can also be employed in the detection of oligonucleotides for the purposes of 
biomarker analysis. An example of this is implemented by Dean et al. where the 3D invasion 
of breast cancer cells is analysed through fluorescence microscopy techniques using a dsLNA 
sequence containing a fluorophore and quencher. In the dual stranded form, the fluorophore 
and quencher of the LNA are in close proximity and so no fluorescence occurs, however in the 
presence of the target mRNA the quencher is displaced and fluorescence is observed. This 
allowed the group to determine a relationship between the gene Notch-1 and the protein 
dll4, in particular they found that the presence of a Notch-1 ligand decreased the expression 
of dll4 mRNA and thus Notch-1 acts as a tumour suppressor, this was not able to be as 
confidently concluded via previous methods.120 Other applications in electrochemical based 
biosensors will be discussed later.  
Similar to PNA, many synthetic routes are available towards LNA and a wide range of synthetic 
analogues have been sought in order to improve the biophysical characteristics of the LNA, 
and to decrease the potential for hepatotoxicity (liver toxicity) which unmodified LNA 
displays.121 Most groups target the nature of the oxymethylene bridge, either by adding a 
methyl group to increase the potency of the antisense properties while decreasing liver 
toxicity,122 extending the bridge via an amino moiety to increase RNA and duplex DNA 
selectivity,123 or, by substituting the oxygen based bridge for a nitrogen based bridge in order 
to allow side chains to be projected into the minor groove of duplexes.124 Alternatively the 
bases themselves can be modified via the addition of triazole or alkynyl groups such as those 
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shown using the uracil base by Kumar et al. to increase the affinity towards DNA and RNA 
targets.125 The general structure of LNA compared to DNA and RNA, along with some of the 
next generation LNAs described are given in Figure 1.6. 
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Figure 1.6 The general structure of LNA compared to DNA and RNA, including a depiction of the locked N-type 
conformation.114 Also shown are some second generation LNAs by A) Seth et al. B) Abdur Rahman et al. C) Hrdlicka et al. D + 
E) Kumar et al.122–125 
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Both PNA and LNA hybrids with DNA and/or RNA are more susceptible to destabilisation due 
to mismatches, this in turn means that both PNA and LNA display greater specificity towards 
the target nucleotide sequence than a natural DNA or RNA oligomer, thus giving them great 
potential in aptamer based recognition and detection applications.126 One final thing to note 
however, about both PNA and LNA, is that despite both systems possessing great resistance 
to proteases and nucleases and having increased hybridisation efficiencies both have 
potential downfalls in biosensor applications, in addition to those mentioned. For PNA the 
lack of phosphate backbone results in them being generally more hydrophobic and thus 
harder to dissolve in aqueous solvents, and more susceptible to non-specific hydrophobic 
adsorption.127 Whereas for LNA the heightened binding efficiency does result in unwanted 
self-assembled structures such as hairpins and LNA/LNA duplexes, particularly in long 
sequences with multiple self-complementary sections, which in turn can be difficult to 
remove.128 Thus careful consideration of these potential problems needs to be taken when 
deciding whether or not to apply them to the research of interest. 
1.2.3: Reverse transcription-quantitative polymerase chain reaction (RT-qPCR) 
Currently RT-qPCR is considered the ‘gold standard’ in detection and analysis of miRNA as well 
as being used for determining the expression of other longer RNA strands.129,130 The inherent 
advantages of this method being that multiple samples can be analysed at one time, up to 
384 samples in some cases, the ultra-sensitivity of the technique due to the amplification 
processes involved,131 and the ability to use the amplified samples to perform sequencing.132 
As many investigations into miRNAs and their targets require the screening of hundreds if not 
thousands of different sequences it is clear why RT-qPCR provides a firm basis for expression 
level analysis and potential biomarker identification. Many research groups employ a variety 
of techniques based on the fundamental amplification processes involved in RT-qPCR in order 
to analyse known, and unknown miRNA sequences in a wide variety of different matrices. 
Some examples of these will be discussed in the following section along with a general 
overview of how RT-qPCR works. 
RT-qPCR analysis of miRNA from biological matrices generally requires a 3 step process, 
extraction/isolation, transcription into c-DNA and then amplification of the DNA via PCR. The 
extraction procedure can be performed on a number of different matrices, from cell cultures 
and tissue extracts,126,133 through to blood,134 and even through to non-invasively collected 
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urine samples.55,57 The isolation of miRNA from biological matrices is generally performed first 
using a commercial kit with a phenol/chloroform based extraction via a lysis reagent, i.e. 
guanadinium thiocyanate such as in Qiazol®,57 or Trizol,135 and a column based filtration via 
centrifugation. However, depending on the kit and the particular biological sample, a 
phenol/chloroform extraction is not always necessary.134 This isolation procedure is required 
to remove any proteins, fats, and other non-nucleic acid macromolecules, while breaking 
down any extracellular vesicles and purifying the RNA from DNA (if a DNAse is used) and any 
potential RT-qPCR inhibitors. Once isolated, the miRNA samples are often stored at −80 °C to 
prevent degradation prior to any further analysis.  
The miRNA once isolated can then be analysed by RT-qPCR. For the RT step the miRNA is 
mixed with a series of buffers containing: RNase inhibitors to prevent degradation of the 
sample, deoxynucleotide triphosphate monomers (dNTP) of each of the bases to build the 
complementary cDNA, reverse transcriptase enzyme to act as the polymerase for the growing 
cDNA, and a short primer specific to the sequence of interest to act as the starting point for 
cDNA growth and to increase the melting temperature of the cDNA.136,137 This primer is often 
stem-looped as this has been found to increase the stability of the growing RNA/DNA 
heteroduplex (due to base pi stacking) and also enhances the efficiency of the efficiency of 
the RT process over a linear counterpart.136 The reverse transcription process can then be 
completed manually, by annealing and heating to the reaction temperature for a set time 
period, followed by denaturation of the enzymes by heating to 80-90 °C and then cooling to 
4 °C for short term storage. Alternatively the same procedure can be set into a pre-
programmable thermocycler.  
Finally the qPCR analysis is performed, generally using TaqManTM analysis for miRNA derived 
expression or through SYBR green for less specific and lower quantitation of other gene 
expressions. During this step the miRNA (or other analyte) is mixed with the TaqManTM 
universal master mix and a primer specific to the miRNA target, at which time the mixture 
undergoes a number of heating and cooling cycles causing the TaqMan probe to attach to the 
cDNA target along with the primer. As the nucleotides in the master mix begin to bind to the 
denatured cDNA, in order to replicate, the DNA polymerase will cause the annealed TaqMan 
probe to be cleaved from the cDNA causing a fluorescent dye to be separated from a 
quencher. Only annealed TaqMan probes are affected and the higher the concentration of 
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miRNA in the initial sample, the more cDNA will be produced at RT and analysed at PCR, and 
thus fewer cycles of this probe annealing and subsequent enzymatic cleavage will be required 
to generate a fluorescent signal. In short, a smaller number of cycles indicates a higher 
concentration of the target sequence. This process is shown diagrammatically in Scheme 1.2. 
 
Scheme 1.2 A schematic to show the stages of TaqManTM based RT-qPCR for miRNA from urine. 
The benefit of using RT-qPCR for miRNA analysis is that, due to the amplification of the miRNA 
during the RT step, to form many more copies of cDNA, only a very small amount of target is 
required. In fact, when testing 1 and 2 step RT-qPCR techniques Tiechen Li found that 1 step 
RT-qPCR could detect samples as low as 1 pg/µL. This is particularly important as it allows the 
different biological matrices mentioned previously to be analysed with high reliability despite 
the very low miRNA concentration compared to total RNA content. It does however have 
drawbacks which limits its application in large scale diagnostic applications, the first of which 
being the timescale and costs related to running the analyses. The specialist chemical kits 
required to run an RT-qPCR experiment, along with the specialist laboratory based personnel 
and highly expensive qPCR analyser needed all result in potentially high costs per sample. Also 
the matrices used often require chemical extraction and filtration techniques which increases 
the likelihood of human error and potential imprecise absolute quantification data obtained. 
1.2.4: Fluorescence and chemiluminescence 
Another important method often employed for miRNA detection revolves around some form 
of luminescence, be this via fluorescence, a molecular dye that can naturally fluoresce after 
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absorption of light of a particular wavelength, or chemiluminescence, where a chemical 
reaction generates an emission of light. These techniques are often used for in situ analysis 
of miRNA expression in cellular in vitro studies and in some cases even in vivo studies are 
possible.93,138 The advantage of an excitation induced light based detection method is that 
they generally require relatively cheap (compared to RT-qPCR) and simple to use equipment 
such as a fluorescence or UV-vis spectrometer, or in some cases only a microscope is required, 
and very little sample purification, if any, is required.139 Also as mentioned previously in situ 
analysis can be performed on cell cultures and tissues, allowing for the direct imaging of the 
localisation of miRNA in a biological system, not only allowing the quantitative analysis of 
miRNA expression, but also helping towards the elucidation of where these miRNA are 
affecting biological or disease pathways.  
The exact methodology utilised to obtain a luminescent signal varies widely between different 
research groups, with some using inorganic nanoparticles, some using organic dye tags and 
most recently molecular beacons. One such example of using an organic dye tag is that of the 
work performed by the Wang research group of Agilent Technologies.140 In their research they 
use a T4 RNA ligase to attach a cytidine with attached cyanine dye to the 3’ end of the total 
RNA population, with the exception of the hairpin pre-miRNA which were not labelled. Then 
in order to make their microarray specific only to the target miRNA they used 
complementarity based DNA micro-arrays with multiple sequence targets and introduced a 
hairpin loop in order to prevent the hybridisation of longer RNA strands. The fluorescence 
signal obtained was then proportional to the concentration of miRNA target with a sensitivity 
calculated to be below 0.2 aM. This work proved that fluorescence based labelling techniques 
can allow for detection of multiple RNAs in micro-array technology, with great sensitivity. 
Despite this, the researchers do report that they had some discrepancies in the hybridisation 
yields for certain sequences, namely miR-126, 384 and 296, which resulted in data outliers 
and were cases where the response did not show the strong signal vs. concentration 
correlation seen with their other miRNA targets. They also mention how the hybridisation 
efficiencies are on average only around 30% with higher efficiencies only being available at 
the expense of specificity. Also direct labelling of the total RNA beforehand is a specialist 
technique that will require a laboratory based technician and an extra analytical step to 
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ensure the dye tag has been sufficiently attached to the entire RNA population. This method 
is shown schematically in Figure 1.7.  
 
Figure 1.7 An example of the strategy employed in fluorescence based miRNA detection via miRNA labelling by the Wang 
group at Agilent.140 
Neely et al. adopted a similar approach of using a label based fluorophore, however this group 
used labelled DNA and LNA chimeric probes to bind to the miRNA target.141 The DNA probe 
and the LNA probe had different coloured fluorophores allowing them to use red and green 
laser technology to have double coincident events. Any unhybridised labelled probes were 
then reacted with a DNA probe containing a quencher to minimise false positives. This 
method did not require the miRNA to be labelled, but the use of currently expensive laser 
technology and the lowered limit of detection of 100 fM does limit its adaption into 
commercial use.  
Alternatively the use of inorganic, metal based, nanoclusters as the source of excitation based 
fluorescence has recently gained in popularity. For example Wang et al. have designed a 
method that incorporates copper nanoclusters as the fluorophore, copper chosen in order to 
avoid the solubility issues of previously used silver nanoclusters.142 Their approach uses a long 
template strand of DNA with an AXAXB repeat unit, where the A section is complementary to 
the microRNA, the X section is an endonuclease recognition site and the B section is a scaffold 
for the fluorescent copper nanoclusters. In their methodology the microRNA binds to the 
initial A section beginning the amplification cycle, at which point dNTPs are added with DNA 
polymerase to extend the chain after which the first section is nicked by the nuclease. After 
completion of the second dsDNA the final B section starts to be copied and the second dsDNA 
section is nicked. Finally when complete the B section copy strand acts as a reporter which 
binds to a complementary DNA strand and this duplex acts as the template for the fluorescent 
dsDNA-Cu nanocluster via reduction of the Cu2+ in the presence of ascorbic acid. Although 
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highly complex this method overcomes the expense and solubility issues of silver based 
nanoclusters, however the sensitivity is lacking at only 1 pM and the selectivity is only tested 
via mismatches between the miR-200 family, thus the long repeat units could result in 
undesired target hybridisation with 1 or 2 mismatches. Once again this methodology is shown 
schematically in Figure 1.8.  
 
Figure 1.8 An example of the main strategies employed in fluorescence based miRNA detection via metallic nanoparticles by 
Wang et al.142 
More recently Zhao et al. have used gold based quantum dot fluorescence for their microRNA 
sensing, both in vitro and in vivo.143 Their method instead used fluorescent quantum dots 
(CdSe/ZnS), a combination of quantum dot labelled DNA and a partially complementary DNA 
hair-pin structure, which in turn become quenched when attached to a gold nanoparticle. 
These were then able to be inserted into cells both in vitro and in vivo whereupon the binding 
of the miRNA target disrupted the hair pin structure and regenerated the fluorescence. This 
particular technique is again interesting as it allows the visualisation of microRNA both 
quantitatively for the purposes of expression calculations, but also shows where the 
localisation of this microRNA occurs, which they used to indicate the presence of miR-21 in 
mouse tumours. The method is also shown to be specific down to 1 mismatch. However a 
mild lack of sensitivity towards miR targets dissolved in buffer, only being sensitive down to 
1 pM, and the long incubation times of 4 hours for most experiments limits the application of 
their methodology at the point of care environment. 
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Finally the use of molecular beacons, that being a labelled oligonucleotide that forms a hair 
pin structure where the fluorescent label is quenched by either a quencher or a surface until 
the target sequence binds, is becoming more popular in the fluorescent detection of miRNAs. 
A good example of how this can be done in a relatively simple manner is given by Li et al. using 
a DNA hair pin with a section complementary to let-7a and a group of 5 bases at the 3’ and 5’ 
ends that were complementary to each other to form the hair pin stem (see Figure 1.9).144  
 
Figure 1.9 An example of the strategy employed in fluorescence based miRNA detection via a moleculars beacon by Li et 
al.144 
To the 5’ end they added a fluorescein and to the 3’ end they added the quencher BHQ1 (Black 
Hole Quencher®), resulting in a hairpin sequence that gave no fluorescence. However when 
the target miRNA is added the stem-loop opens and the fluorescence signal is once again 
obtained. A duplex specific nuclease (DSN) selectively degrades the new DNA/RNA hybrid 
section, fully separating the fluorophore from the quencher and leaving the miRNA intact to 
bind to another hairpin. Thus resulting in rolling circle amplification (RCA), i.e. the produced 
miRNA can bind to the molecular beacon repeatedly resulting in increased response per 
miRNA strand, and an increased fluorescent signal, allowing for a limit of detection down to 
3.8 pM and a selectivity down to 1 mismatch. Unfortunately however, many more researchers 
have achieved greater sensitivity as has been, 142,143 and will be, discussed in future sections. 
The timescale of the reaction, requiring 2 hours reaction time, also limits the 
commercialisation of this technique. However its simplicity does make it of interest.  
Prior to this, Tu et al. had used a combination of this molecular beacon technology and gold 
nanoparticles for their method.145 In their research they used a hairpin probe DNA strand 
labelled with fluorescein isothiocyanate via a thiourea linkage at its 5’ terminus, which was 
attached to a gold nanoparticle via an Au-S bond through a thiol on the 3’ terminus. Once 
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attached to the gold the proximity of the fluorophore to the gold surface results in its 
quenching, then, when the target microRNA binds, as with the previous example the stem 
loop opens and the fluorescence is once again observed. This led to a limit of detection, using 
the miRNA extracted from cell lysates, of 20 fM and 10 fM for synthetic miR-122, while also 
being selective to a 34% fluorescence loss with 1 mismatch. There are of course many more 
example methods of utilising fluorescence for the purposes of miRNA detection,93,146 however 
for a brief overview only a few examples have been given. 
Alternatively chemiluminescence, i.e. a chemical reaction that results in emission of light, 
could also be use in place of fluorescence. This often involves the reaction of luciferin to 
oxyluciferin using a luciferase enzyme and ATP (adenosine triphosphate), which generates a 
light response in a process also called bioluminescence. This luminescence can then be 
measured using a spectrophotometer at wavelengths from 230 to 280 nm.147 An early 
example of this technique was employed by Ma et al. who attached an LNA probe sequence 
to a cover slip which can in turn hybridise with a target miRNA that is complementary, at 
which point UTP (uridine triphosphate monomer) and a polymerase add a poly U tail to the 
miRNA.148 This in turn releases lots of inorganic phosphate (PPi) which can be converted into 
ATP with adenosine phosphosulfate (APS) and ATP sufurylase which act as the feedstock to 
convert luciferin into oxyluciferin via luciferase. The technique is shown schematically in 
Figure 1.10A. This gave a limit of detection of 50 fM which is greater than most of the 
fluorescence based methods mentioned previously. However this procedure does require a 
number of chemical steps prior to analysis, including several enzymatic processes which may 
become expensive and thus not be suitable at the point of care environment. Another 
potential issue of the research by Ma et al. is that only testing of a complete non-
complementary strand of miRNA is reported, and thus the selectivity for only one or two 
mismatches may not be ideal.  
One final example that also utilises bioluminescence was proposed by Xu et al. in 2017 and 
uses the miRNA target itself as the source of ATP for the luciferin to oxyluciferin reaction.147 
In general terms a 3’-phosphorothioate modified DNA probe is mixed with the miRNA target 
and an exonuclease III enzyme added to digest the RNA but not affecting the modified DNA 
strand. The resulting AMP (adenosine monophosphate) monomer is then enzymatically 
converted to ATP as the feedstock for the luciferin reaction, which results in the regeneration 
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of the AMP, setting up a cyclic reaction system. Interestingly this approach was specific even 
to 1 mismatch and had a calculated limit of detection of 7.6 fM. Finally, the technique was 
able to be applied to cancer cells and lung cancer tissue extracts by using DNA probes 
modified with a biotin label and attaching them to streptavidin labelled magnetic beads, the 
miRNA can then be pulled from the sample and removed from the interferent endogenous 
ATP, ADP and AMP in the samples before being treated with exonuclease III and analysed as 
in Figure 1.10B. This work is highly useful for commercialisation as it is highly sensitive and 
can be performed easily using premade buffers, however it remains to be seen how well this 
would perform when directly applied to biological matrices such as blood and urine, hence if 
extraction of miRNA is required then it may not be applicable for point of care analysis. These 
bioluminescent variants and the luciferin to oxyluciferin reaction are shown in Figure 1.10. 
 
Figure 1.10 Examples of how luciferin bioluminescence can be used for miRNA detection. A) A route by Ma et al. (APS - 
adenosine phosphosulfate).148 B) A route by Xu et al. (AK :- adenylate kinase, PK :- pyruvate kinase, PEP :- 
phospho(enol)pyruvic acid monosodium salt hydrate, dCTP :- deoxycytidine triphosphate).147 
1.2.5: Northern blotting 
Before the use of TaqManTM based probes for miRNA detection northern blotting was 
considered the “gold standard” for miRNA quantification, and is still used for the detection of 
new and multiple species of miRNA where possible.139 As such, a description of how northern 
blotting works and some examples of where the method has been applied in the literature is 
required before continuing. Due to their small size (19-23 nt) the general procedure for 
miRNA blotting analysis differs slightly from the norm.149,150 In short, the miRNA is denatured, 
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generally using formamide, and separated using high percentage denaturing polyacrylamide 
gel, or urea-polyacrylamide gel, electrophoresis, however due to the use of this gel a transfer 
to positively charged nylon is required. Once transferred the target miRNA is hybridised with 
a 32P-radiolabelled DNA or RNA probe and detected by autoradiography or phosphorimaging 
(see Scheme 1.3). The issue with this form of analysis being that it is relatively insensitive (1 
nM),148 requires large amounts of sample (2-10 µg),151 requires careful handling of 
radiolabelled materials, some with a short shelf life (32P has a ½ life of 2 weeks) and is time 
and labour intensive.139,148,150–152  
 
Scheme 1.3 The generalised steps for RNA based northern blotting. 
Owing to the potential drawbacks, recent research into miRNA detection via blotting 
techniques has focussed on overcoming some of these disadvantages, particularly the 
lowered sensitivity compared to other methods. The first such example, employed by Válóczi 
et al.,153 uses LNA based hybridisation probes in place of DNA in order to increase the 
efficiency of the hybridisation process thus resulting in greater sensitivity and selectivity. The 
researchers claim that the increase in sensitivity is approximately 10 fold and it can be seen 
from their data that, even at 2.5 µg quantities of total RNA sample, miRNAs 171 and 319 can 
be seen after 6 hours exposure. Várallyay et al. have since improved on this, again using LNA 
based probes, and have a complete hybridisation to detection time of 4 hours again,91 
however this timescale, and the relative difficulty in performing the specialist analysis still 
makes this technique unfeasible for point of care use.  
Pall et al. instead chose to look at improving the binding of the DNA/RNA probe to nylon as a 
way of increasing sensitivity.154 In their work they hypothesised that, as UV is used to attach 
the DNA/RNA probe to the nylon prior to hybridisation, and that as this attachment occurs 
through thymine/uracil bases, this is resulting in the loss or reduced availability of this base 
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for the hybridisation event, with small molecules such as miRNA this is having a more 
pronounced effect. Thus they suggested that using a 1-ethyl-3-(3-dimethylaminopropyl) 
carbodiimide cross linker to attach the RNA (used in their example) to the nylon prior to 
irradiation, through a 5’ terminal phosphate, prevents this potential loss of hybridisation 
efficiency. This results in the RNA binding to the nylon at least as efficiently if not more so, 
leading to improved detection of miRNA over the standard irradiation procedure. Once again 
however, this procedure takes far too long (multiple hours) for its application in diagnostic 
points of care.  
Taking these adaptations, and substituting the 32P radiolabel for a digoxigenin label with 
chemiluminescent detection, Kim et al. were able to greatly improve the sensitivity of their 
northern blotting technique and also greatly shorten the exposure time required.155 The use 
of this new label, and combined LNA and carbodiimide cross linker modifications, resulted in 
an improved sensitivity to 0.05 fmol and a 1400 fold shortening of the length of time the blot 
membrane is exposed to the phosphorimager screen (30 s vs. 12 hours). The use of 
digoxigenin is also much safer than the use of radiolabels.156 However the technique is still 
rather laborious and requires 3 µg of total RNA to perform which is high compared to 
fluorescence and electrochemical based techniques.  
Finally, and very recently, Choi et al. have discovered that there is a lot of bias involved with 
the detection of small and miRNAs by northern blotting techniques.157 That is to say that 
standard miRNA northern blotting techniques have no difficulty detecting oligonucleotides 
around 24 nt long (e.g. miR-52) at 10 fmol quantities but are barely able to detect a truncated 
miR-52 sequence of 16 nt even at 50 fmol quantities. As some miRNA sequences can be as 
low as 15 nt, this bias needs to be removed. Hence they modified the method to use shorter 
(15 nt) probes and a lower hybridisation temperature in order to detect the shorter sequences 
as well as the longer ones. They found that even a 15 nt DNA oligonucleotide was able to 
detect complementary sequences in species containing 14 to 23 nt, thus showing that the 
smaller probes could be used for detection of species longer than itself. 
Despite the sensitivity being greatly improved with new linking techniques, LNA based probes 
and the avoidance of potentially dangerous radiolabels being possible, northern blotting 
techniques still suffer from long preparation times and specialist labour being required thus 
limiting its use in the point of care environment. 
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1.2.6: Electrochemical based techniques 
All of the previous techniques used for the detection and quantification of miRNA in biological 
matrices have suffered from some severe drawbacks that limit their application in the target 
point of care diagnostic environment. Be it a lack of sensitivity (northern blotting), a long 
timescale and large cost requirement (RT-qPCR) or a high level of technical knowledge and a 
laboratory based analytical requirement (fluorescence). Electrochemical based methods 
however have been developed that can achieve sensitivities towards nucleotide targets as 
low as attomolar (10−18 M) and have relatively short analysis timescales, from 30 – 90 
minutes.158 This, along with the ability of miRNA to be analysed in non-invasive urine 
samples,55,57 makes electrochemical based detection a very attractive means of analysing 
miRNA expression for the purposes of future commercial application in point of care based 
diagnostics. The fundamentals of electrochemical analyses, including a brief description of 
each electrochemical measurement used throughout this project (CV, coulometry, EIS, DPV) 
will be described in the next section along with examples from the literature of research 
groups who have used this particular technique. 
1.3: Electrochemistry fundamentals 
1.3.1: Redox chemistry and general electrochemical set-up 
Electrochemistry is an analytical technique that has bridged the gap between biology, 
chemistry and electronics since its accidental discovery by Galvani in 1791.159,160  
In general, it uses an electrical potential input (voltage) that can be varied with time to induce 
a current that is detected. In general, in order for this to take place the analyte must allow for 
the movement of electrons from one element to another via a redox based coupling. This is 
not necessarily the case for electrochemical impedance spectroscopy (EIS) which can have a 
capacitive current.161 In short, for certain redox active (often metal based) molecules when a 
voltage is applied in the positive/forward direction the molecule in solution will be oxidised, 
and when a voltage is applied in a negative direction the compound will be reduced. Both of 
these events generate a current, with the cathodic current resulting from the reduction of the 
analyte and an anodic current resulting from its oxidation.162,163 This is depicted in Scheme 
1.4. 
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Scheme 1.4 A diagrammatic representation of how application of a potential at an electrode surface results in a redox 
reaction, the basis for electrochemistry. 
The potential at which these events occur is known as the redox potential and varies with 
each compound and referenced generally to either a normal hydrogen electrode (NHE 0 V, by 
definition), a saturated calomel electrode (0.241 V vs. NHE) or a silver/silver chloride 
electrode (0.2224 V vs. NHE).164 These reference electrodes are used in analytical 
electrochemistry to monitor and maintain a known and constant potential to the system so 
that the working electrode potential is at the correct voltage, however they themselves can 
vary slightly from the norm depending on temperature and filling solution. The half equations 
for these references are given below, along with an example of how the Nernst equation 
shows how they are concentration and temperature dependant (Equations 1-4).164,165 
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(1) E = E°− (
RT
nF
) lnQ 
(2) Hg2Cl2 + 2e- ↔ 2Hg + 2Cl-     E° = 0.241 V 
(3) AgCl + e- ↔ Ag + Cl-                        E° = 0.2224 V 
(4) 2H+ + 2e- ↔ H2                         E° = 0.00 V  
Equations 1-4. Nernst equation (1) and half equations for SCE (2), Silver/Silver chloride electrode (3) and NHE (4). E = 
potential, E° = standard potential, R = gas constant 8.314 JK-1mol-1, T = temperature (K), n = number of electrons, F = 
Faraday constant 96485 Cmol-1, Q = reaction quotient / concentration dependence (aox/ared). 
These half equations describe the reactions at the reference electrode of a standard three 
electrode system, where the other two electrodes are a working electrode and an 
auxiliary/counter electrode. The reference electrodes supply a constant known potential as 
their internal redox chemistry occurs, thus giving the potentiostat a reference potential in 
order to generate its own applied potential.  
The second electrode in the 3 electrode system (or can be combined with the reference in a 
2 electrode system) is the auxiliary or counter electrode. This tends to be a coil, mesh or wire 
of an inert material such as gold, platinum or carbon, and is used to balance the redox reaction 
occurring at the working electrode. That is to say that it acts to close the circuit, when the 
working electrode is anodic, the counter electrode is cathodic allowing a current to flow 
between the two. The electrode does not take part in the electrochemical reaction being 
analysed, but will balance the potential applied to the working electrode and can, if a glass 
frit is used, prevent by-products from the cell (such as oxygen bubbles or salts), from 
interfering with the analytical measurements.166 Also, by having a surface area larger than 
that of the working electrode it prevents the kinetics of the electron transfer at the counter 
electrode from being a rate limiting step, and thus affecting the analytics of the reaction at 
the working electrode. The larger counter electrode area thereby ensures that the currents 
and potentials that occur at the working electrode are not limited by the currents at the 
counter.167  
Finally the third electrode is the working electrode, these can be made in different sizes from 
a range of reasonably chemically inert materials and can be either stationary (non-moving) or 
rotating disk. These materials are discussed in more detail in the next chapter. However, for 
the purposes of a three electrode cell the working electrode is where the electrochemical 
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reaction of interest takes place, it is the electrode where the current generated by the redox 
active analyte is measured. To be measurable the analyte also has to be redox active, and 
thus has its own set of half equations relating to the reaction taking place. For the research 
performed throughout this project the analyte in question is a mixture of ferri and 
ferrocyanide, K4[Fe(CN)6]/K3[Fe(CN)6], in a solution of KCl as an electrically conductive 
electrolyte allowing the flow of electrons through the electrochemical circuit. The equation 
for this reaction is also given below (Equation 5).  
(5) [Fe(CN)6]3- + e- → [Fe(CN)6]4- 
The remaining sections will describe the various electrochemical techniques that can be 
employed in the quantification of nucleotide targets including miRNA, including how they are 
performed, the data that is generated and examples from recent literature of research groups 
that have employed them. 
1.3.2: Cyclic voltammetry (CV) 
The first of the electrochemical methods to be discussed is the voltammetric technique cyclic 
voltammetry. In this technique the potential is swept from a low voltage to a higher voltage, 
at which point the direction of sweep is reversed and the voltages are swept from the higher 
point to the origin. This is one cycle of the voltammogram and can be repeated for a number 
of cycles and at varying speeds (mV/s) depending on the measurement requirements. As the 
potential is swept in the positive direction, electrons are drawn from the analyte solution 
causing the oxidation of the analyte and thus increasing the concentration of the oxidised 
molecule at the surface in relation to the Nernst equation. This causes a change in the current, 
giving a peak maximum at the point where all of the analyte is oxidised around the surface of 
the electrode at the maximum rate of conversion, resulting in depletion of the reduced form 
of the analyte at the surface. Over time a bilayer is formed of the oxidised analyte at the 
electrode surface, and as the thickness of the bilayer increases the concentration gradient of 
this oxidised species decreases and thereby the rate of diffusion is slowed so that the current 
begins to fall. This lowering of current is due to the rate of analyte movement to the electrode 
surface being diffusion controlled, according to Fick’s law, and thus becoming slower as the 
bilayer thickens. When the potential is reversed this reaction occurs in reverse, the bilayer 
becoming reduced and again results in another peak this time with a negative current. This is 
true for a one electron transfer system that is fully reversible.  
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Due to Fick’s law affecting the rate of diffusion to the surface according to the formation of 
the analyte bilayer, the scan rate of the experiment will also affect the amplitude of the 
current. A faster scan rate will cause the current to be measured faster than the bilayer can 
build up, and thus the current peak will be of greater magnitude, a slower scan rate however, 
gives the bilayer a longer time to form before the peak current is measured and thus gives a 
lower peak amplitude.163 Fick’s second law for diffusion and the resulting Randles-Sevcik 
equation for how this relates to the maximum current at 25 °C is given below (equation 6 and 
7) and example cyclic voltammograms for a 1 electron reversible system, a 2 electron system 
and a non-reversible system are given in Figure 1.11.163,168 
(6) 
∂c
∂t
= D (
∂2c
∂x2
) 
(7) imax = 2.69 × 10
5 × n
3
2 × A × D
1
2 × c0 ×ν
1
2 
Fick’s second law for diffusion (6) and the Randles-Sevcik equation (7). Where c0 = concentration (M), t = time, A = electrode 
surface area (cm2) D = diffusion coefficient (cm2s-1), x = distance from electrode(cm), jmax = max current (A), n = number of 
electrons and ν = sweep rate (Vs-1) 
 
Figure 1.11 Left a diagrammatic example of a 1 electron reversible redox reaction including peak cathodic and anodic 
currents (Ipc/Ipa) and peak potentials (Epc/Epa). Top right, a one electron irreversible oxidation of analyte with the effect of 
increasing scan rate. Bottom right, 2 electron reversible redox reaction. 
Due to its simplicity to perform and analyse, many research groups have employed CVs in 
assisting with the detection and quantification of miRNA, as such it has also been 
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implemented in different areas of our own research and why it is important to discuss some 
of the work performed by these research groups here. Often cyclic voltammetry is not used 
as a direct quantitative measurement, but is instead used to determine how well the 
electrode modification procedure is occurring and what potential to use for quantification 
using other voltammetric or amperometric techniques. One group that does however, at least 
for initial feasibility studies, is Gao and Yu.169 In their research they labelled a Let-7b miRNA 
target with a ruthenium phenanthroline-dione complex (Ru(PD)2Cl2) which is redox active. 
They then modified an indium tin oxide (ITO) electrode with an alkoxysilane and then with a 
Let-7b complementary DNA capture probe. The hybridisation of this probe with the labelled 
miRNA target brought the redox active ruthenium complex into close proximity with the 
electrode surface and thus, when a voltage is applied, an electrochemical response was 
generated. The procedure is summarised diagrammatically in Figure 1.12.  
 
Figure 1.12 An example of how CV is used by Gao and Yu in the preparation of their biosensor. Peaks 1-3 have been labelled 
with 1 being 50 nM target, 2 being 10 nM target and 3 being 10 nM of non-complementary RNA. The CV peak current is 
proportional to target concentration.169 
The researchers were therefore able to perform feasibility studies using CV and found that 
when hybridised with 10 nM and 50 nM of the target a set of oxidation and reduction peaks 
are obtained, the amplitude of which is directly proportional to the concentration of the 
target. They also performed the same procedure with a non-complementary miR-92 which 
resulted in no observable peaks. These findings demonstrated that the response being 
obtained was through target hybridisation and not through non-specific binding. Through this 
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they were able to use Ru(PD)2Cl+ as the redox indicator to give an initial limit of detection of 
2 nM.  
As mentioned before other groups have used CV based analysis more for feasibility studies, 
or for performing and characterising their electrode modifications. For example Wang et al. 
use CV to electrochemically deposit a substituted naphthalene sulfonic acid onto their 
electrode and then use a separate set of CVs to check each step in their modification,170 a 
technique that has been adapted in later chapters of this thesis.  
Alternatively Gao et al. have used CV measurements to optimise their choice of redox 
reporter, to give the highest signal to noise ratio and potentially a negligible Rct value (a 
measure of impedance discussed later), using a variety of different redox active analytes to 
determine which is best to use in their future calibration impedance plots.171 These reports 
show how CV can be employed universally throughout electrochemical analysis for a variety 
of purposes, and surprisingly, only infrequently in the direct determination of analyte 
concentrations themselves. 
Cyclic voltammetry can, and has, also been used for a number of applications other than just 
nucleotide quantification. It has also been successfully applied to investigation of reaction 
kinetics,172 food and drink analysis including the determination of polyphenols and sulfur 
dioxide in wine,173 and determining the oxidation and reduction potentials of organic 
compounds for use in electrochemical synthetic methodologies.174 
1.3.3: Chronocoulometry / amperometric analysis 
Unlike CV, chronocoulometry and amperometric analyses are based around using a fixed 
potential and measuring the change in current or charge over time. In amperometric and 
coulometric based techniques a voltage where there is no electrolysis is initially applied, and 
then switched after a certain timepoint to a potential that results in a net oxidation or 
reduction, i.e. from a reduction potential to an oxidative one or vice versa, at which point a 
change in the current (and thus charge) occurs. This causes a build-up of the redox product 
(oxidised or reduced depending on potential used) over time, initially there is a redox spike 
which continues to generate this current/charge at a slower and slower rate until the 
potential is removed at the analysis completion time. The relationship between the analyte 
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concentration and the current or charge is given by the Cottrell equation (Equations 8 and 9), 
which also takes the diffusion rate (flux) into account over time.163,166,175,176 
(8) i =
nFAc√D
√πt
 
(9) Q =
2nFAc√Dt
√π
 
The Cottrell equation for current from analyte concentration (8) and the integrated form for charge dependence (9). Where 
n = number of electrons transferred, F = Faraday’s constant (96485 Cmol-1), A = surface area of electrode (cm2), c = analyte 
concentration (M), D = diffusion coefficient (cm2s-1), t = time (s). 
This shows that the concentration of the analyte at the electrode surface is therefore 
proportional to the charge/current generated, and thus a higher current indicates more of 
the electroactive species being able to reach the surface at the time of the potential being 
applied. For amperometric based analysis the current is measured and for coulometric 
analysis this current is integrated with respect to the analysis time to give the charge, in both 
cases time is the second variable. As with voltammetric analyses these techniques can have 
multiple switching steps, for example in chronocoulometry it is possible to switch from an 
oxidative potential to a reductive potential after set periods of time. This gives what is known 
as double step chronocoulometry. Double step chronocoulometry is used analytically as a 
method to give a defined charge peak for each analyte concentration over time, however it 
also is used for characterisation of the electrode charge during adsorption of species.166 Figure 
1.13 shows the example outputs for single and double step amperometry and equivalent 
chronocoulometry. 
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Figure 1.13 Example outputs from amperometric (top) and chronocoulometric (bottom) analyses, the left hand plots have 
an initial potential which is then switched to another in one step, the right hand is double step, starting at one potential, 
switching to a second for a time and then finally to a third (or back to the first). The time where the potential is changed is 
marked. 
Many groups have used amperometric based analysis for the quantification of nucleotide 
targets including miRNA. Two researchers from one particular group, Zhou et al. have utilised 
this analytical technique in a number of their reports, one of which uses a gold electrode, 
modified with gold nanoparticles which increases the electron transfer ability (determined 
using electrochemical impedance spectroscopy, EIS, using a ferri/ferrocyanide redox couple), 
to attach a thiol tagged hairpin DNA sequence, containing a section complementary to miR-
21, via a strong Au-S bond. Once this hairpin modified electrode had been prepared, they 
then set about producing a reporter cluster by attaching a series of DNA aptamer strands and 
a DNA capture strand to free gold nanoparticles. Hybridisation of the miR-21 target to the 
probe opens the hairpin structure of the electrode bound DNA, leaving a section 
complementary to the capture strand of the cluster, which also hybridises to the probe. 
Finally a hemin solution was added to the probe causing an electrochemically active hemin-G 
quadruplex complex to form between the folded DNA aptamer strands and the hemin, after 
which amperometric based analyses were performed.177 This method gave a limit of detection 
of 3.96 pM, which was high compared to other miRNA detection methods mentioned 
previously and some of their own previous works.  A diagram of the system adapted from the 
research is given in Figure 1.14. 
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Figure 1.14 Gold nanocluster and hemin-G-quadruplex based miRNA biosensor development as described by Zhou et al.177 
Before they published this work they had produced a system that uses the same gold 
nanoparticle/DNA cluster, this time however using a streptavidin and horse radish peroxidase 
(HRP) combination as a reporter, firstly with 3 reporters per miRNA target and then a simpler 
method for 1 reporter per target for limits of detection of 6 fM and 60 fM respectively.178,179 
As a final modification they attempted to maintain the sensitivity and specificity of their 
sensor by employing a hairpin DNA probe containing occasional bases produced using LNA, 
and a biotin label for attaching streptavidin-HRP complex directly, rather than as part of a 
cluster, thus simplifying the modification procedure. This option did achieve an increase in 
sensitivity over the hemin-G based method mentioned earlier, at a limit of detection of 400 
fM, however it did not reach the same sensitivity as their earlier works. In each case however 
the sensitivity analysis was performed using amperometric techniques.180 
As for coulometric analysis, Yao et al. have employed a RCA based technique for detection of 
microRNA using a gold electrode chip fabricated on a polystyrene substrate, having chosen 
chronocoulometry as their analytical technique due to its ability to allow for absolute 
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quantification of biomolecules at the electrode surface.181 In their work, a thiolated DNA 
probe is attached to a gold electrode, after which the target miR-143 and a second DNA strand 
is added, the miRNA hybridising with sections of both and then a phi29 DNA polymerase joins 
the DNA strands together along with an additional added padlock probe. Over time (4 hours) 
this is repeated, generating a RCA cycle, during which a cationic ruthenium(III) hexamine 
complex is added which becomes electrostatically trapped to the negatively charged 
phosphate groups and acts as the redox reporter. The more DNA probes that have been 
added during the amplification cycle, the greater the coulometric response and the better 
sensitivity can be achieved.  
Figure 1.15 shows their procedure diagrammatically. Using this method the group achieved a 
sensitivity down to 100 fM which is comparable to the works done by Yin and Zhou,179,180 but 
also allowing them to determine the exact surface coverage of the DNA probes and the 
resulting percentage of probes hybridised, using the Cottrell equation mentioned earlier. 
These examples show how amperometry and coulometry can be readily used in the 
quantification of miRNA targets and are often employed to do so, they also help to show some 
of the advantages of coulometry and amperometry over other methods, such as allowing the 
simple absolute quantification and surface coverage of biomolecules at the electrode surface. 
 
Figure 1.15 The procedure employed by Yao et al. for the detection of miRNA using chronocoulometric analysis.181 The 
example graph is not to scale and is for illustration purposes only. 
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Along with miRNA detection, coulometry is also used in common electrochemistry for 
measurement of the electrode active surface area, diffusion coefficients and kinetics of 
electron transfer reactions.175,176 
1.3.4: Electrochemical impedance spectroscopy (EIS) 
The final electrochemical technique used throughout the remainder of this thesis, and thus 
discussed here, is electrochemical impedance spectroscopy (EIS). In the simplest terms EIS is 
an electrochemical technique that uses alternating current (AC). In EIS the applied potential 
is fluctuating which results in an alternating current possessing both a phase and an amplitude 
which are measured as the frequency of the potential is swept. Combining these elements 
results in a measure of the impedance of the cell, which is composed of contributions from 
the electrode, the electrode/solution interface, the analyte solution and diffusion of the bulk. 
Impedance can be thought of as a similar phenomenon to resistance, however it takes both 
resistance and capacitance into account and is dependent upon frequency. The potential 
applied is oscillating in a sinusoidal manner over time which generates a corresponding 
current that is also sinusoidal in nature (AC), however the voltage lags behind the current 
resulting in a phase shift (θ) of π/2 for capacitors. Taking both of these points into account 
and remembering that from Ohms law resistance (R) is equal to potential divided by current, 
it is possible to calculate impedance by substituting these frequency dependant terms for 
current and potential into the equation for Ohms law.182 These are shown (Equations 10-12) 
along with the sinusoidal current and potential for a capacitor in Figure 1.16. It should be 
noted that there is no shift for a resistor and for an inductance the voltage is the leading 
waveform. 
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Figure 1.16 The sinusoidal waveforms of a.c potential showing the phase shift and the equations for frequency dependant 
potential (E) of a capacitor (10), current (i) (11) and impedance (Z) (12). E/i (t) is the potential/current at time t, E/im is the 
maximum potential/current amplitude and f is the frequency in hertz. 
Taking the equations from Figure 1.16 and noting that, although for a capacitor alone the 
phase shift is π/2, for any real complex circuit it can adopt any value and this can depend on 
the frequency. Thus the true impedance value can be split into two further values, Z’ which is 
also known as Zreal and Z’’ which is Zimaginary, the two values described mathematically by the 
following Equation 13: 
(13) Z(f) = Z′ sin(2πft) − Z′′cos (2πft) 
Z = total impedance (Ohms = Ω), Z’ = impedance real (Ω), Z’’ = impedance imaginary (Ω), t = time (s) and f = frequency (Hz). 
Typically, during EIS experiments the impedance data is plotted in the form of a Nyquist plot, 
these are plots of Z’ (Zreal) vs. –Z’’(Zimaginary), and the resulting vector between the origin and 
the point in question represents the total impedance with the angle between the vector and 
the x axis being the phase angle. For single electrolytic capacitors, or for an electrical circuit 
with a capacitor and resistor in series (i.e. attached to each other directly) this is a linear plot 
with no change in Z’. However for an electrochemical circuit there is often an electrical bilayer 
that forms as the electrochemical reaction takes place, this in turn acts as a capacitor in 
parallel to the resistor. Thus at high frequencies the current is able to pass freely through the 
capacitor with ease, however at lower frequencies the current passes preferentially through 
the resistor. Owing to the relationship between Z’ and resistance and –Z’’ and capacitance 
this variation with frequencies results in a semi-circular Nyquist plot. These mathematical 
relationships are shown below in Equation 14: 
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(14) Z′ = R  − Z′′ =
1
2πCd
 
Z’ = impedance real (Ω), R = resistance (Ω), Z’’ = impedance imaginary (Ω) and Cd = differential capacitance. 
Finally, for a standard 3 electrode circuit undergoing an electrolytic reaction the impedance 
behaviour for the cell often follows behaviour similar to a Randles circuit. In this circuit there 
is a resistor in series with a capacitor (Cdl), which arises from the double layer at the interface, 
which is in turn in parallel with a second resistor (Rct). This generates a semi-circular Nyquist 
plot at lower frequencies as mentioned previously, with the resistor in series shifting the x-
axis by the value of its resistance. At higher frequencies the current can pass freely through 
the capacitor, however in this system there is a new Warburg constituent describing the 
frequency dependence of diffusion of the bulk analyte to the surface on the impedance. 
Therefore at high frequencies the resistance is low and the solution resistance is the only 
contribution, and the reaction can be thought of as non-electrolytic with the double layer 
providing the path of negligible resistance.  
As the frequency decreases however this is no longer true and electrolysis starts to take place, 
therefore the current starts becoming impeded due to the charge transfer resistance (Rct) and 
the double layer capacitance (Cdl) giving the characteristic semi-circle. Then at low frequencies 
the bilayer no longer has an effect on the resistance and there is a large rise in the impedance 
at the end of the semi-circle which is modelled by Warburg impedance. This final impedance 
increase is due to concentration changes as a result of the a.c. current which is diffusion 
determined and gets increasingly difficult to reverse as frequency is lowered due to the 
diffusion distance increasing at lower frequencies.163,166,183 The different impedance plots 
mentioned above along with the equivalent circuits used to simulate and model the data for 
analysis are given in Figure 1.17 
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Figure 1.17 The various forms of Nyquist impedance diagrams that can arise depending on the properties of the 
electrochemical cell. The general diagram for an electrolytic reaction is given at the bottom showing how the impedances 
are dependent on the electrolyte solution and the diffusion to the bilayer surface. Also given are the model circuits used to 
fit the data. 
Due to its high sensitivity and ability to show the exact nature of the impedance response, be 
it due to the electrode/solution interface or via the diffusion of the bulk analyte, electrical 
impedance spectroscopy is the analysis technique of choice for a great deal of published 
methodologies. One particular group that has used a combination of voltammetric techniques 
and electrical impedance to detect miRNA at ultra-low concentrations is that of Labib et al. In 
one example of their work they have managed to detect a miRNA target to concentrations as 
low as 5 aM.184 For reference a diagrammatic summary is given in Figure 1.18. 
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Figure 1.18 The electrode modification procedure for miRNA analysis by Labib et al. Also shown are the effect of each stage 
on the square wave voltammetric response (left) and impedance spectra (right). 
This is a particularly interesting example, not only because it shows incredibly good sensitivity, 
but more importantly because it has the ability to switch miRNA targets once one has been 
analysed. Their initial stage is similar to many other examples, a 3’-thiolated RNA probe 
strand, this time with a second modification in the form of a 5’-phosphate, is attached to a 
gold nanoparticle modified screen printed carbon electrode. This is then used to hybridise 
with the target and square wave voltammetry and electrical impedance spectroscopy 
analyses used to determine the sensitivity at this stage which is given as 0.4 fM.  
In the second mode of the three mode technique, a p19 caliper protein is used which causes 
a ‘signal off’ response in the voltammetry (and thus a larger impedance) at higher 
concentrations of target miRNA, so called as the voltammetric current response is lower 
(impedance response larger) than that obtained for the DNA modified electrode alone due to 
shielding from the protein. This ‘signal off’ response then allows for greater sensitivity than 
the hybridisation step alone, hence by using concentrations from 10 aM to 10 fM they 
determined a limit of detection of 5 aM, thus increasing the sensitivity over the first mode.  
Finally, in the third mode, a pre-hybridised combination of a second miRNA target and its 
complementary RNA probe (this time not thiolated) is added which causes the p19 protein to 
be displaced leaving behind just the original miRNA target and its probe. This displacement is 
again concentration dependant which indicates the potential for detection of two different 
 48 
 
miRNAs via a single sensor, however the authors mention that the surface cannot be fully 
regenerated in this way and thus the limit of detection is worse at this stage at 50 pM.  
This work is particularly important for this third stage however, being particularly useful if it 
could be optimised to reduce the hybridisation times required (1 hour at every hybridisation 
stage) and increase the sensitivity at the second target stage. Unfortunately they also appear 
to only perform the impedance measurements once as they do not give any error bars for its 
data analysis.  
 
Figure 1.19 The preparation of a gold screen printed electrode biosensor for miRNA detection described by Cardoso et al.185 
A second interesting example from Cardoso et al., summarised in Figure 1.19, should also be 
mentioned.185 This research is an example of how simple electrochemical miRNA detection 
has the potential to be. In their example, a synthetic thiolated RNA probe is attached to a gold 
screen printed electrode via an Au-S bond, and any unreacted surface blocked through 
binding with mercaptosuccinic acid (MSA). This RNA modified sensor is then hybridised with 
varying concentrations of the miRNA target and a combination of voltammetry and EIS 
experiments are performed to determine the sensitivity. Which, despite the simplistic nature 
of the technique is quoted as being as low as 5.7 aM in real human serum samples (1 aM is 
potentially reachable in buffer), and subsequently also shows the ability to detect miR-155 in 
extracts from a breast cancer cell line. They also demonstrate some ability to regenerate the 
sensor surface, after the hybridisation measurement, by using heat treatment to denature 
the RNA duplex. The regenerated surface is then available for use in another hybridisation 
event and measurement.  
Despite these promising results and the great sensitivity achieved, the simplicity of the 
technique may be its downfall, as there is nothing which allows it to be patent protected and 
thus is not ideal for commercialisation and use in point of care diagnostics. They also only 
show responses obtained from the sample analysis using their sensor corroborated by serial 
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dilution analysis, they do not compare their values to concentrations determined by PCR or 
for a healthy vs. diseased comparison. It does however pose an interesting starting point 
towards very simple electrochemical miRNA detection. 
1.4: Surface chemistry analysis techniques 
1.4.1: Attenuated total reflectance - Fourier transform infra-red spectroscopy (ATR-FTIR) 
The first surface analysis technique to be discussed, and potentially most straight forward, is 
infra-red spectroscopy. Infra-red spectroscopy uses light in the infra-red region (generated a 
red hot filament) to cause the bonds in a molecule to vibrate, absorbing and releasing energy 
as they do so and thus allowing for the identification of that bond. For measurement of an 
infra-red spectrum by attenuated total reflectance (ATR), the sample, in this case an electrode 
surface, is loaded onto a crystal, usually of germanium, zinc selenide, silicon, KRS-5 (eutectic 
mix of thallium bromide and thallium iodide) or diamond.186 After which an IR beam, which 
has been generated internally by a heat element, is collimated (each ray made parallel) passed 
through a beam splitter in the interferometer which passes half of the beam to and from a 
fixed mirror and the other half to a moving mirror, which changes the path length of the light 
compared to that of the fixed mirror. The beams are then recombined via the interferometer, 
with the difference in path lengths creating constructive and destructive interference i.e an 
interferogram. The combined beams are then and passed through the crystal holding the 
sample. Upon hitting the crystal the beam is reflected, creating an evanescent wave which 
extends into the sample causing vibrations within the sample as it is absorbed at specific 
wavelengths. The beam is passed to the detector which detects the intensity of the absorbed 
wavelengths, with the wavelengths absorbed showing no response in the interferogram. 
Finally this is analysed by the computer which performs a Fourier transform (FT) to convert 
the interferogram into an infrared spectrum of wavenumber (1/wavelength λ) vs. 
transmission of that light through the sample. This is shown in Scheme 1.5.187  
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Scheme 1.5 A schematic of how ATR-FTIR takes place inside the spectrometer, including the relationship between energy 
and wavenumber (frequency) and a diagrammatic example of an IR spectrum. Adapted from reference 181.187 
The wavelength (and thus wavenumber) of light that is absorbed by the sample depends on 
the functional groups present. Upon absorbing the infrared radiation, in the form of the 
evanescent wave, the functional groups on the molecule consisting of differently atoms of 
different mass will begin stretching and contracting (vibrations) and/or bending, often these 
atoms are visualised simply as balls on a spring, however this is not strictly true. The energy 
needed for this to occur depends on the mass of the atoms and the ‘rigidity’ of the bond as 
determined by the bond strength. Stronger bonds such as C=O carbonyls require higher 
wavenumbers (≈1700 cm-1) than weaker bonds such as C-O single bonds (≈1100 cm-1).188 As 
long as this vibration also fulfils the selection rule of resulting in a change in dipole moment 
it will be excited by the IR photon, then as long as there is enough sample and the wavelength 
absorbed is within range it may be detected by an IR spectrometer.189 Each functional group 
is found at a particular wavenumber of absorption and thus allows for the identification of 
functional groups present on the surface/sample. These relationships are shown below for 
diatomic molecules in the Hooke’s law Equation (15) and the reduced mass Equation (16).189 
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(15) ν̅̅̅ =
1
2πc
√
k
μ

(16) μ =
m1m2
m1 + m2

Top equation (15) is Hooke’s law for a diatomic molecule, relating the frequency (wavenumber) of a vibration to the force 
constant and mass of atoms, with the reduced mass equation also shown in the bottom equation (16). ν̅̅̅ = frequency 
(wavenumbers), c = speed of light (2.998 × 108 ms-1), k = force constant (variable describing bond stiffness/strength), μ = 
reduced mass and m = atomic mass.  
1.4.2: Atomic force microscopy (AFM) 
An imaging method often employed for the study of surfaces is atomic force microscopy 
(AFM).190 AFM, uses direct physical contact with the atoms on the surface in order to 
determine its topography. A silicon based tip (usually Si, SiO2 or Si3N4) attached to a micro 
cantilever that acts as a microscopic spring is able to oscillate if an alternating voltage is 
applied to a piezoelectric crystal, often in the cantilever holder and/or the sample holder. This 
is known as tapping mode AFM, alternatively the tip does not have to oscillate as is the case 
for contact mode AFM. In either mode the tip is then passed along the surface to come into 
contact with the atoms on the surface. Two imaging modes are then available, if contact mode 
is used, the tip is passed over the surface of the sample and a feedback loop is used to monitor 
the deflection of the cantilever, if this falls below or rises above a set value the sample is 
moved up or down respectively, by applying a different voltage to the piezoelectric crystal, to 
return to the set value, with the voltage applied being related back to the height of the 
surface. 
However if tapping mode is used the AFM tip oscillates at a set amplitude and is intermittently 
brought in and out of contact with the surface, the whole time being monitored by a feedback 
loop, if the sample has a bump the tip has less room to oscillate and the amplitude decreases 
and vice versa for a depression in the surface, the feedback loop then changes the sample/tip 
separation distance to restore the amplitude to the set value. This movement is detected via 
a laser and a position based detector which generates a topographical map of the surface, 
sensitive up to a maximum depth of 10-20 µm and a maximum lateral resolution of 1 nm.191 
This is shown diagrammatically with an example from our work in Figure 1.20. 163,192 
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Figure 1.20 A diagram showing how the AFM technique works including sample output from our own research shown in 
Chapter 2.192 
AFM also has other advantages in that it does not require vacuum unlike the similar technique 
scanning electron microscopy (SEM),193 and can also be used where there is negligible change 
in topography, such as imaging the frictional properties of a material (sometimes known as 
lateral force microscopy LFM).194 In this case the output from the position detector (a 
photodiode) is used to generate the height Z and the piezo scanner voltages supply the X and 
Y information. It can also be used for other purposes as well as it is possible to perform atomic 
manipulations on the surface using the tip, such as moving one atom from one location to 
another, bringing two atoms into close contact with each other for the purposes of catalysis, 
or for stimulation of individual cells.195–197 
1.4.3: Laser ablation - inductively coupled plasma mass spectrometry (LA-ICPMS) 
A final imaging technique employed in this research is laser ablation-inductively coupled 
plasma mass spectrometry, first invented in 1985.198 As with the ATR-FTIR this technique is 
used to identify the chemical species present on the surface, rather than directly imaging the 
topography as in AFM. However unlike ATR-FTIR this technique is able to directly quantify the 
elemental composition of the surface, down to values as low as parts per trillion (ppt),199 
rather than identifying the functional groups present. Standard ICPMS techniques require a 
liquid sample or one that has been dissolved in a solvent, often requiring concentrated acids 
and microwave radiation, this poses problems when the sample is unstable or particularly 
insoluble. 
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This problem is overcome using LA-ICPMS however as a solid sample can be loaded directly 
into the instrument, at which point a UV laser is focussed onto the sample in raster (parallel 
scan) lines of 10-100 of µm width which results in aerosolisation of all constituents in the path 
of the laser. The aerosol is then passed through to the plasma torch of the ICPMS using a 
carrier gas of helium or argon, the sample is held at this torch for up to a millisecond at 6000 
K where the aerosol constituents become vaporised, atomised and finally ionised. Finally the 
atomised sample is passed to the MS under ultra-high vacuum where ion optics separate the 
positively charged ions from the neutral and negatively charged ions, the positive ions are 
then passed through a quadrupole mass analyser which separates them according to m/z 
value. The detector then receives a signal for each ion passed to it, giving a quantitative 
output of ion current, in reference to a calibrated standard, and thus the amount of each 
element present in the original sample.200,201 This process is summarised in Scheme 1.6. 
 
 
Scheme 1.6 A simplified schematic showing how laser ablation - inductively coupled plasmon mass spectrometry (LA-ICPMS) 
is performed. 
The data obtained through LA-ICPMS can also be used to create visual maps indicating the 
localisation of the elements throughout the sample, and, with more specialist forms of mass 
spectrometer, the concentration of each element or isotope can also be used to determine 
the age of the sample. This gives it great use throughout other areas of science, particularly 
in biology and archaeology where tissues such as hair, leaves, teeth and even brain tissues 
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have been analysed,202–205 allowing for monitoring of pharmaceuticals or biological processes; 
and in archaeology it is used to analyse historical items to determine their chemical 
composition to better understand our ancestors.206,207 
1.5: Research aims and impact 
At the start of this chapter the importance of different miRNA expression levels throughout 
medicine was discussed, particularly its direct correlation with diabetes disease and resulting 
kidney nephropathy. The prevalence of both diabetes and kidney disease throughout western 
populations was also discussed, with the inherent problems to the health services and the 
detrimental effect on the patient’s lifestyle being described, thus emphasising the need for 
faster and less specialised miRNA detection for implementation in point of care diagnostics. 
Therefore it is the aim of the research described throughout the rest of this thesis to describe 
a method of modifying a set of carbon based electrodes for use in quantifying miRNA in a 
urine matrix. The direction of travel is towards a commercially available biosensor that can be 
used in the point of care environment by non-scientist end users for the diagnosis of the early 
stages of kidney disease, hopefully resulting in the patient being diagnosed before requiring 
dialysis or transplants. 
We will start by modifying a commercially available and industry standard stationary glassy 
carbon electrode (GCE) chemically with a naphthalene sulfonic acid in order to generate a 
surface of sulfonic acid functionalities, before further modifying these to sulfonyl chlorides to 
allow the attachment of DNA probe strands. This will then allow us to electrochemically 
detect and quantify a miRNA with a sequence complementary to this DNA probe strand. Doing 
this with varying miRNA target concentration will allow for the determination of the 
sensitivity of the biosensor. This method was chosen to begin with as it requires only 3 steps 
to go from a clean carbon surface to a DNA based sensor, meaning that it should be relatively 
quick to produce the sensor each time it is required which is one of our target parameters. 
The relatively simple DNA/miRNA hybridation based procedure will also keep the analysis 
simple and requires very few additional chemicals which is also preferred if the technique is 
to be adapted for point of care use. Different miRNA sequences and sample matrices can then 
be used to determine the selectivity of the biosensor and its application in the detection of 
urinary miRNAs.  
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Should this prove successful then we will be looking to develop the methodology for 
adaptation onto disposable screen printed electrodes. Using disposable screen printed 
electrodes will allow us to produce multiple sensors at any one time and will move us closer 
to our overall aim of developing a commercially viable biosensor. Finally, we will be looking 
towards producing disposable electrodes of our own design for the detection of multiple 
miRNA species on one biosensor as this will be required for a diagnostic test. Should we will 
be looking to test our sensor on patient urine samples in order to determine whether or not 
a significant difference can be detected between a healthy individual and a patient with 
diabetic kidney nephropathy. By combining all of these objectives together we will be one 
step closer to the development of a biosensor that shows viability for use in a clinical point of 
care environment. 
Thus the aims of the project were as follows: 
1. Develop an electrode modification procedure that could be applied to an industry 
standard carbon electrode for detection of miRNAs in solution, and quantification by 
electrochemical analysis. 
2. Develop the methodology described following aim 1 for implementation on a screen 
printed carbon electrode as a disposable biosensor. 
3. Design a screen printed carbon electrode that could perform simultaneous repeated 
detection of a single miRNA target to obtain repeatable data on a single electrode. The 
potential for future adaptation towards multiple microRNA detection on one 
electrode was discussed. 
4. Detect existing urinary miRNA biomarkers in healthy control and diabetic kidney 
nephropathy patients, showing the difference in expression levels and discriminating 
between them. 
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Chapter 2: Glassy Carbon Electrode 
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Chapter 2: Glassy Carbon Electrode Results 
 
2.1: Glassy carbon and other electrode materials 
The electrochemical data described in this chapter were generated using a modified 
commercially-available glassy carbon electrode (GCE). Commercially available multi-use 
electrodes, of which a GCE is an example, are manufactured in a variety of shapes, sizes and 
materials. The standard stationary electrodes made with a PCTFE tube of 7.5 cm length and 6 
mm overall diameter, with an embedded 1.6-3 mm working area disk of an inert material such 
as gold, platinum, silver, nickel, pyrolytic carbon paste or glassy carbon, and in some cases 
palladium. Alternatively rotating disk electrodes, in which the electrode is mounted in an 
automated rotator prior to submersion in the analyte, are also available and are often used 
to determine redox reaction mechanisms.208 A final class known as microelectrodes, in which 
a wire of inert gold, platinum or carbon fibre of ≈10 µm diameter, can also be produced to 
enable faster scan rates and lower capacitance.209  
While each of these electrodes has its own specific use, the work described here focuses on 
the use of the standard tubular stationary electrode with a 3 mm glassy carbon surface. To 
develop electrochemical miRNA detection, glassy carbon was preferred to better gold or 
platinum alternatives on the basis of its lower price. Cost is an essential consideration for 
diagnostic testing, and work in later chapters describes the use of disposable screen-printed 
electrodes, also based on carbon materials, following the proof-of-principle glassy carbon 
electrode analysis described in this chapter. 
The use of noble metal electrodes is common to a wide range of products used extensively in 
academic and industrial research laboratories. This popularity is due to their extreme 
chemical inertness, high anodic range and the ease by which they can be obtained in pure 
form from ore.210 The use of gold electrodes in the study of biological molecules such as 
proteins and nucleic acids is particularly popular due to the simplicity of immobilising these 
types of molecules onto the electrode surface. Gold surfaces have a highly exploitable affinity 
to thiols and disulfides that allows them to bind to these groups via a strong Au-S link, either 
through the removal of the thiol hydrogen, or cleavage of the S-S bond in a disulphide. DNA 
sequences may readily be purchased with thiol modifications at their 3’ or 5’ ends, allowing 
very simple surface monolayer generation.211,212 Gold is thus a good electrode material for 
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DNA based analysis, but is limited to anodic potentials as positive potentials have the 
potential to oxidise its surface, starting at 1.36 V.213 It should be mentioned, however, that 
reductive potentials can also be problematic for thiol-bound gold surfaces, as reduction can 
cause the desorption of thiolates from the surface. These are able to be re-adsorbed through 
oxidative potentials, particularly where cyclic voltammetry is used, but the extent of re-
adsorption depends heavily on the alkyl thiol used.214 By contrast, platinum may be used in 
these ranges, and while the same bonding to thiols is not possible, it is still a highly modifiable 
material,215,216 and shows stable electrochemical behaviour. However, the presence of any 
water or acid in the analyte can result in a reduction reaction and hydrogen evolution even at 
previously useable negative potentials.217 Both of these materials are also expensive in 
comparison with carbon. 
Consequently, carbon-based electrodes have also been developed, with three main types of 
glassy, pyrolytic and carbon paste. These are markedly cheaper per unit mass than either 
platinum and gold, and, owing to their inertness to both chemical attack and 
oxidation/reduction reactions, are useable across a much larger potential window (-0.8 V to 
2.2 V compared to ≈-0.2 V to 1.8 V and -0.5 V to 1.9 V for platinum and gold respectively)218 
Also, due to the brittleness of carbon to mechanical strain, it is straightforward to polish and 
chemically clean the electrode before each new modification or experiment, leaving a fresh 
carbon surface for a good signal to noise ratio. 
Glassy carbon is the most expensive of the above three types, but the surface chemistry of 
glassy carbon has been investigated extensively, and activation and modification of these 
electrodes is a highly researched area.219 This type of carbon also has a high amount of surface 
order which allows for better electrochemical responses in comparison with carbon paste 
electrodes, while still retaining small defects as possible nucleation zones for an increased 
chemical modification potential than the highly orientated pyrolytic graphite.220,221 
Interestingly, the exact structure of glassy carbon remains a highly disputed topic. It has 
previously been assumed that the structure is similar to that of graphite,222 or even a polymer 
of carbyne chains due to its electrochemical behaviour.223 However this would not account 
for its extreme resistance to even strongly acidic solutions, thus recent work done by P. J. 
Harris suggests that it has a much more fullerene-like structure.224 
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The advantages mentioned above, the extreme inertness to chemical attack, high potential 
for modification, suitability with biological systems and relative cheapness compared to noble 
metal based electrodes suggest that glassy carbon is highly suitable for our investigation. Also, 
as mentioned previously, the aim of this project is to develop a biosensor that can be applied 
to a series of screen printed carbon electrodes for potential future commercial application. 
These electrodes are based more on a polymer based carbon ink, thus having a carbon 
electrode allows for better comparison between the disposable electrode and the research 
standard than the use of a noble metal based electrode. Nevertheless carbon paste, despite 
being closer in nature to the disposable electrodes than glassy carbon, is not ideally suited to 
proof-of-principle testing due to inherent surface malformations of the disordered electrode 
material. Therefore all of the results performed in this chapter were generated using the 
relatively high order, and well researched glassy carbon electrode material. 
2.2: Modification procedure  
In order to detect mature microRNAs (miRNAs) in solution, the GCE first needed to be 
modified to allow the addition of a DNA probe strand complementary to the target miRNA 
sequence, for Watson-Crick base pairing. Unlike gold surfaces, which are able to form strong 
sulfur-gold linkages to thiol groups on 3’ or 5’ modified DNA strands in order to immobilise 
them,225,226 glassy carbon surfaces require functionalising before a probe oligonucleotide can 
be deposited. A number of ways have been reported for doing this.170,227,228 Due to its 
simplicity, a similar version of the modification procedure described by Wang et al. was used 
for the production of our sensor. An overview of the procedure and the theory of how this 
effects the electrochemical response is described below. 
Firstly, the surface of the electrode must be refreshed to ensure no crossover or 
contamination from previous experiments. To achieve this with a GCE, an alumina polish was 
used at consecutively smaller grades, the largest as an abrasive to remove any compounds 
attached at the surface, and the smaller to smooth the surface to an even ‘mirror-like’ finish. 
It is important that this is done evenly over the entire the surface, therefore a ‘figure 8’ motion 
was employed to ensure that the abrasion was reproducible after each experiment.229 Finally, 
the polished electrode was sonicated in acetone, ethanol and deionised water to remove any 
residual alumina. 
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The cleanliness of the electrode was then tested by performing cyclic voltammetry 
measurements using a mixture of ferri and ferrocyanide in KCl. For a ‘factory fresh’ and 
machine cleaned electrode the peak separation should be close to 59 mV.230 The polishing 
technique and an example of a clean voltammogram are shown in Figure 2.1, the best and 
most robust separation achieved was 101 mV, and this was carried forward. The absolute 
peak separation was likely also to be dependent on the precise surface of the glassy carbon, 
as well as the exact conditions of the cell e.g. concentration, supporting electrolyte, scan rate 
et cetera.231 
 
Figure 2.1 A diagram of the polishing technique and an example of a 'clean' cyclic voltammetry obtained. The black spots 
are points of possible slight pressure increase due to direction changes with the arrows indicating polish direction. CV 
performed using 5 mM K3[Fe(CN)6]/K4[Fe(CN)6] in 0.1 M KCl electrolyte at room temperature. 
The electrode preparation procedure was followed by electrode modification. Firstly, the GCE 
surface was modified by electrochemical deposition of the naphthalenesulfonic acid 
derivative 4-amino-3-hydroxy-1-napthalenesulfonic acid (ANSA) via multiple cyclic 
voltammetry cycles. Despite an absence of detail from Wang et al. it is believed that under 
voltammetric deposition the ANSA amino group is oxidised, allowing it to bind to the carbon 
surface of the electrode, and that subsequent polymerisation results in the formation of an 
ANSA monolayer across the GE surface. An investigation into the compound’s chemically 
induced oxidative polymerisation revealed a possible monomer bonding pathway, the details 
of which will be briefly described. 
Doğan et al. have shown, through the use of the chemical oxidant NaOCl, that under oxidative 
stress the naphthalene aryl systems become joined through the amino functionality at 
position 4 and the naphthalene carbon 9, possibly through a radical pathway. This is made 
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possible due to the availability of the ring system to delocalise the unpaired electronic spin 
density.232 It is believed that the same process is occurring on the glassy carbon surface at the 
oxidation potential during electrochemical deposition, with the polymer forming a covalent 
film along the surface. The proposed polymerisation pathway is shown schematically in 
Scheme 2.1, adapted from published data.232  
 
Scheme 2.1 A schematic showing a potential pathway of how 4-amino-3-hydroxy-1-naphthalenesulfonic acid (ANSA) is 
polymerised via oxidative stress and resonance of the unpaired spin through the aryl napthalene.232 
The cyclic voltammogram obtained during the electrochemical deposition procedure was 
used as an indicator of sulfonic acid deposition (Figure 2.2). Over multiple cycles it was seen 
that the oxidation peak at ≈0.32 V became progressively less intense, and the other minor 
peaks flattened out. After 4-5 cycles the intense oxidation peak reached a steady state current 
response, and the remainder of the cycles were uniform in peak intensity, indicating that the 
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maximum surface coverage of ANSA had been obtained. A total of 8 cycles were therefore 
performed in order to ensure that the maximum coverage was obtained each time the 
electrode was modified, allowing for the greatest reproducibility between experiments. An 
example of the voltammogram obtained during the deposition, indicating the gradual decline 
in peak intensity, is shown in Figure 2.2. The deposition was visually apparent as the 
development of a red hue in the solution around the electrode surface during voltage 
application. 
 
Figure 2.2 An example of the cyclic voltammograms obtained during deposition of ANSA onto the GCE. A clear lowering of 
peak intensity can be seen at the oxidation peak of 332mV over increasing cycles. Performed in 10 mM ANSA in 25 mM pH 
7.0 PBS. The deposition is also shown schematically (top). 
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Following ANSA deposition, a cyclic voltammogram performed in ferricyanide solution 
showed that the surface was hindered from electron transfer due to the vastly decreased 
current response for oxidation and reduction. This was as predicted for a fully coated surface. 
Having confirmed that the deposition procedure was successful, the sulfonic acid 
functionality on the electrode was chemically modified to a sulfonyl chloride, to activate it 
towards nucleophilic attack from the amine tagged probe DNA sequence. The probe 
sequence could then be covalently linked to the ANSA surface for miRNA hybridisation. 
Therefore the electrode was then submerged in a solution of PCl5 in acetone to substitute the 
hydroxyl of the sulfonic acid with a chloride, thereby generating the required sulfonyl chloride 
(see Scheme 2.2). 
 
 
Scheme 2.2 A summarised  mechanism for sulfonyl chloride formation from PCl5 and ANSA, the true mechanism likely not 
being concerted. Adapted from the mechanism for acyl chloride formation.233 
Again the electrode modification was tested to ensure successful adaptation of the sulfonic 
acid to the sulfonyl chloride by cyclic voltammetry in ferricyanide solution. These showed that 
the oxidation and reduction peaks increased in current response, most likely due to the 
reduced negative charge across the surface of the newly modified 4-amino-3-hydroxy-1-
napthalenesulfonyl chloride (ANSCl). This charge reduction resulted from the absence of 
acidic hydroxyl groups to deprotonate in solution and form negatively charged sulfonate, 
which in turn would repel the ferricyanide electrochemical analyte from the surface.  
With the surface chemistry of the electrode suitably modified, a C6 amino tagged DNA probe 
complementary to the target miRNA sequence was covalently attached via sulfonamide bond 
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formation. Placement of a droplet of the amine tagged DNA, dissolved in aqueous buffer, on 
the ANSCl modified electrode led to reaction between the amine functionality and the 
sulfonyl chloride via a nucleophilic substitution, resulting in the formation of the 4-amino-3-
hydroxy-1-napthalenesulfonyl amide-DNA probe (ANSAm-DNA) as shown in Scheme 2.3. 
 
Scheme 2.3 Proposed summarised mechanism  for the attachment of a C6 amine tagged DNA sequence via sulfonamide 
coupling, again certain steps are likely not concerted. The DNA is shown pictorially by the red helix. 
Once prepared, the electrochemical response of the ANSAm-DNA probe was analysed in 
ferricyanide solution. This showed that a modest decrease in current response compared to 
the ANSCl response, which was expected due to the increased negative charge of the DNA 
phosphate backbone and the size-related increase in surface coverage. 
Finally, to ensure that the probe functioned as a detection tool for miRNA, the ANSAm-DNA 
probe was submersed in a solution of the target miRNA sequence in buffer and heated for 30 
minutes to allow hybridisation between the DNA probe and the target miRNA. As predicted, 
and shown later with further data, this again resulted in decreased current response due to 
the further increased negative charge and surface coverage. This modification procedure is 
summarised diagrammatically in Figure 2.3. Examples of the changes in cyclic voltammetry 
and Nyquist impedance responses for each stage of the modification procedure are also 
shown. 
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Figure 2.3 A summarised schematic of the procedure for modifying a glassy carbon electrode for miRNA detection, DNA is 
displayed red and the miRNA in blue. Also shown are example cyclic voltammograms and impedance data for each 
modification step, performed using 5 mM K3[Fe(CN)6]/K4[Fe(CN)6] in 0.1 M KCl electrolyte at room temperature. 
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2.3 Sensitivity and Selectivity Results 
The above data describe testing the GCE modification procedure and confirming that it 
resulted in a measurable change at each stage and displayed a difference before and after 
probe DNA:target microRNA hybridisation. Probe sensitivity was then analysed across a range 
of miRNA concentrations compared to a buffered “blank” sample. 
DNA sequences complementary to mature miR-21 and miR-16 were selected for use as 
probes, since these miRNAs are highly abundant and widely expressed throughout human 
tissues. The sequences of the mature miRNA species and their DNA complements are given 
in Table 2.1. 
Table 2.1 DNA and RNA sequences used for initial sensitivity testing, shown in 5’-3’ orientation. 
Species Name Species Sequence 
Anti-miR-21 (DNA) 5’NH2-C6-TCA ACA TCA GTC TGA 
TAA GCT A 
miR-21 (RNA) UAG CUU AUC AGA CUG AUG UUG A 
Anti-miR-16 (DNA) 5’NH2-C6-CGC CAA TAT TTA CGT 
GCT GCT A 
miR-16 (RNA) UAG CAG CAC GUA AAU AUU GGC G 
 
For sensitivity experiments, the probe was initially produced by modifying the electrode 
surface and applying the desired antisense strand, as described above, at which point an 
initial set of electrochemical measurements was performed for baseline comparison. The 
chronocoulometric and EIS responses provided the most defined and analysable data, and 
the most reproducible analytical data, and were therefore deemed to be the most informative 
electrochemical measurements. Cyclic voltammetry was also performed, however, as the 
data obtained from the voltammograms did not give a clear relationship with miRNA 
concentration, this chapter will focus on the coulometric and impedance responses for the 
production of sensitivity plots. It should also be noted that double step coulometry was 
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performed, as the change in voltage provided easily interpretable peak minima for direct and 
consistent comparison between each concentration analysed. 
DNA bearing probes underwent chronocoulometry and EIS analysis to generate an initial 
origin DNA only response. After this, the probe was submerged in buffered miRNA solutions 
of varying concentrations to allow hybridisation of the attached DNA and the miRNA target. 
The resulting hybridised DNA/miRNA probe was then electrochemically analysed for a second 
time, and the response obtained at this point was compared with that of the origin response 
to give a change in either charge (Q) or charge transfer resistance (Ohms = Ω, R2) for 
coulometry and EIS respectively. Prior to obtaining the full data set for miR-21, the 
hybridisation event was performed using 10-10 M over defined periods (60, 40, 30 and 10 
mins) to determine the optimum hybridisation time. These results are shown in Appendix 1 
Figure A1.2 at the end of this thesis, 30 minutes hybridisation gave a response close to that 
after 60 minutes and so was selected for further experimental hybridisations. Once optimised 
the hybridisation after 30 minutes was repeated 3 times for each concentration, and the 
average change plotted against its corresponding concentration as a log10 scale. This resulted 
in a linear correlation with a regression coefficient of 0.98 for the coulometry data and 0.90 
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for the EIS data, as shown in Figures 2.4-2.5 and 2.6-2.7, respectively. The raw data is 
displayed in Appendix 1 Table A1.1 and A1.2 respectively. 
 
Figure 2.4 The chronocoulometric response obtained for different concentrations of miR-21. Performed using 5 mM 
K3[Fe(CN)6]/K4[Fe(CN)6] in 0.1 M KCl electrolyte at room temperature. 
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Figure 2.5. Change in coulometric response between the electrode modified with complementary DNA strand alone and 
following RNA incubation (Q) with log10 [miR-21] (M), performed in triplicate. The calculated limit of detection is 2 × 
10−14M (20 fM) and the Pearson regression coefficient is 98% 
 
Figure 2.6 The impedance response obtained for varying concentrations of miR-21. Performed using 5 mM 
K3[Fe(CN)6]/K4[Fe(CN)6] in 0.1 M KCl electrolyte at room temperature. 
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Figure 2.7 Change in charge transfer resistance (R2) between the electrode modified with complementary DNA strand 
alone and following RNA incubation (Q) with log10 [miR-21] (M), performed in triplicate. The Pearson regression coefficient 
is 90%. Fitted to the following equivalent circuit: 
 
 
The above data were used to calculate an extrapolated hypothetical sensitivity of 0.68 fM for 
coulometry, and of 2.14 fM for impedance. Analysis of buffered solutions in the absence of 
miRNA provided a measure of experimental noise. This was calculated by performing the 
blank experiment in triplicate and then adding triple the standard deviation to the average 
response obtained. The resulting change in response from these blank solutions gave a 
simulated worst case scenario of noise response and gives a limit of detection of 20 fM, the 
calculation for this is described in Appendix 1 Table A1.3 at the end of the thesis.  
The data collected for this sensitivity plot were obtained in triplicate by starting the electode 
preparation and modification procedures anew for each replicate, to measure the variability 
across the whole procedure, including the cleaning step. However, it was also possible to 
obtain replicates by using heat treatment to denature surface-bound DNA/miRNA hybrids, 
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regenerating the single DNA strands at the probe’s surface and recapitulating the initial 
electrochemical response magnitude. By performing this heat treatment repeatedly it was 
determined that 2 surface replenishments, i.e. 3 data points, could be obtained accurately 
before the response dropped significantly. This is also shown in Appendix 1 Figure A1.1 at the 
end of this thesis. 
The selectivity of the miR-21 probe characterised above was then investigated. Since mature 
miRNAs are typically 19-23 nucleotides in length, determination of probe selectivity between 
closely-related sequences is particularly important. This point is emphasised in miRNA 
families such as the let-7 miRNA family. Mature human let-7a and let-7b sequences differ by 
two nucleotides, with adenine residues at positions 17 and 19 of hsa-let-7a and corresponding 
guanines in hsa-let-7b; with hsa-let-7c differing only by the guanine residue at position 19.234 
Mindful of these potential sequence similarities, the following experiments were undertaken 
to investigate probe sensitivity. 
To this end, a series of synthetic miRNA targets were designed with central and/or peripheral 
sequence mismatches. Mature miR-16 was included as an example of a highly expressed 
human miRNA with comparatively little sequence identity, with 8 of 22 matching nucleotides. 
To maximise response from the mismatched sequences, the maximum concentration of 10 
nM used previously in the sensitivity testing was used. The miRNA sequences used for 
selectivity testing are shown in Table 2.2 and the coulometric (Q) and impedance charge 
transfer resistance (R2) responses for each sequence are shown in Figure 2.8. 
Table 2.2  Sequences of oligonucleotides used for selectivity testing of the miR-21 probe. Sequence mismatches are 
indicated in bold and underlined. 
MiRNA description Sequence 
miR-21 UAG CUU AUC AGA CUG AUG UUG A 
1 mismatch UAG CUU AUC GGA CUG AUG UUG A 
2 mismatches UAG CUU AUC GGA CUG AUG UUG C 
3 mismatches AAG CUU AUC GGA CUG AUG UUG C 
miR-16 UAG CAG CAC GUA AAU AUU GGC G 
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Figure 2.8 The response obtained for coulometry (top) and Nyquist impedance (bottom) experiments performed using 10-8 
M solutions of mismatched (mm) miRNA targets. Experiments were performed in triplicate and are shown against the 
response obtained for 10-8 M miR-21 for comparison. Performed using 5 mM K3[Fe(CN)6]/K4[Fe(CN)6] in 0.1 M KCl electrolyte 
at room temperature. 
The data shown in the above figure (raw data and % signal drop is also given in Appendix 1 
Table A1.4 and A1.5 respectively) demonstrates probe specificity, with significant 
differences between the miR-21 response and all other readouts. The smallest difference in 
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magnitude was observed with the single base mismatch sequence, which nevertheless 
resulted in a significant drop in response of almost 63% of the miR-21 signal, i.e. a response 
resembling detection of a concentration of between 10-12 and 10-13 M. The response then 
decreased with each increase in the number of mismatches. These data demonstrated 
probe selectivity, and further testing was then carried out as described below. 
As each nucleotide has slightly different electronic effects and sizes, they may show 
different response curves when analysed with the ferricyanide analyte. This is potentially 
complicating and time consuming if the biosensor for each target miRNA sequence required 
a separate calibration plot and would make their implementation difficult. A universal 
calibration plot would not only alleviate this problem, but also act as further proof that the 
responses obtained for the miR-21 target resulted from probe:miRNA interactions, and 
were not artefactual. To ensure that the general relationship between concentration and 
electrochemical response was independent of the miRNA target sequence, sensitivity 
testing was repeated using anti-miR-16 as the probe strand and miR-16 as the target. The 
results of this overlaid with the original sensitivity plots for the miR-21 coulometric (Q) and 
impedance charge transfer resistance (R2) are displayed in Figure 2.9. 
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Figure 2.9 Sensitivity testing for target miR-16 using its complementary DNA strand as probe. MiR-16 data are shown in 
orange and the corresponding coulometry (top) and Nyquist impedance data (bottom) miR-21 data in blue. Performed in 
triplicate using 5 mM K3[Fe(CN)6]/K4[Fe(CN)6] in 0.1 M KCl electrolyte at room temperature. 
Figure 2.9 (raw data Appendix 1 Table A1.6 and 1.7) shows that, despite some variance at 
higher miRNA concentrations (e.g. 1 nM and 10 nM), the responses obtained for both miR-16 
and miR-21 were comparable. With the exception of the 10-8 data, the coulometry points for 
both miR-16 fell within and miR-21 the error bars. 
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This indicates an overall concordance for the data for these two miRNA sequence with 
significantly different base compositions and suggests that this method is broadly applicable 
for miRNA detection. 
2.4 Synthetic urine experiments 
Before testing the probe for urinary miRNA detection, synthetic miRNA targets dissolved in a 
variety of urine-like matrices were tested. MiRNAs were dissolved in a solution containing 
urine’s principal constituents: salt (NaCl), protein and urea. To a 0.1 nM miR-21 aqueous 
solution NaCl was added to a concentration of 3 mg/mL and 10 mg/mL to simulate the lower 
and upper salt concentrations limits possible in patient urine samples. The choice of salt, and 
later protein, concentrations were chosen according to a report published by NASA on the 
constituents of human urine.235 
Once the miRNA had been dissolved in the buffer matrix, containing the desired 
concentration of salt, the probe was added and allowed to hybridise with the target miR-21 
as normal. The coulometry (Q) and impedance charge transfer resistance (R2) were then 
measured as before, comparing the response obtained from the probe alone to that after 
hybridisation with the target miRNA. This was repeated for both the 3 mg/mL and 10 mg/mL 
salt matrices containing the miRNA and the response plotted against that obtained from the 
synthetic miRNA in the buffer alone. The resulting comparative graphs are shown in Figure 
2.10. 
 
Figure 2.10 A comparative graph of coulometry (left), and charge transfer resistance (right), responses obtained for a 
solution 0.1 nM miR-21 in buffer and with different salt concentrations. Each experiment was performed in triplicate using 5 
mM K3[Fe(CN)6]/K4[Fe(CN)6] in 0.1 M KCl electrolyte at room temperature. 
 76 
 
These comparative graphs show that neither high nor low salt concentrations significantly 
affected miRNA electrochemical responses. In both cases the standard deviations of the 
responses (shown by the error bars) were within that of the response obtained with buffer 
alone, suggesting that the salt content in a urine sample would not have a significant effect 
on miRNA quantification.  
To test the effect of urea on miRNA electrochemical response, powdered urea was dissolved 
to a 9.3 g/L aqueous urea solution. This concentration was again chosen from the NASA report 
mentioned above. Target miR-21 was then diluted to a concentration of 10 pM in this urea 
solution and the resulting mixture was then used as the hybridisation solution. Coulometric 
responses using probe alone and miRNA were then compared (Figure 2.11). 
 
Figure 2.11 The coulometric response obtained following hybridisation with 10 pM miR-21dissolved in both buffer 
(performed in triplicate), and 9.3 g/L urea (performed once). Performed using 5 mM K3[Fe(CN)6]/K4[Fe(CN)6] in 0.1 M KCl 
electrolyte at room temperature. 
Although only performed once, these data show no significant effect on miR-21 coulometric 
response of 9.3 g/L urea (1 mL, 155 mM), suggesting urinary DNA/miRNA hybridisation is 
unlikely to be affected by urea. 
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The last urinary constituent tested was the readily available protein bovine serum albumin 
(BSA), which was used to mimic the effect of urinary proteins on probe responses. Urinary 
protein concentration is low in healthy individuals, but increases in kidney disease patients, 
where it can be monitored as albuminuria.236,237 
Proteins are potentially problematic since attachment of these macromolecules to the 
electrode surface is likely to inhibit the electrochemical analyte from reaching the glassy 
carbon surface. This would result in an observed surface resistance that is much higher than 
the resistance caused by the DNA/miRNA hybrid, thereby falsely inflating the miRNA 
concentration. 
To investigate the effect of urinary proteins on the electrochemical readout, 1 mg of BSA was 
added to a 1 mL solution of 0.1 nM miR-21 prior to probe hybridisation. The probe was 
analysed by EIS and the resulting Nyquist spectrum is shown in Figure 2.12. 
 
Figure 2.12 A Nyquist impedance plot showing increased resistance of a solution of 10-10 M miR-21 in the presence of 1 
mg/mL BSA. Performed using 5 mM K3[Fe(CN)6]/K4[Fe(CN)6] in 0.1 M KCl electrolyte at room temperature. 
Figure 2.12 shows that when BSA was added to the miRNA solution, the resulting impedance 
was markedly higher than that observed for the same miRNA concentration in buffer. This 
suggested that the protein was covering the electrode surface, resulting in an apparent 
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concentration that was vastly different to the true miRNA concentration. In a urine sample 
from a kidney disease patient, the protein concentration is likely to be significantly higher 
than in a healthy individual. Therefore analysis of a patient urine samples would be potentially 
problematic. 
In order to avoid this protein electrode “caking”, the electrode was submerged in 1 mg/mL 
buffered proteinase K solution for a further 30 minutes. Proteinase K is a non-specific serine 
protease used widely for protein digestion in biological samples.238 The resulting impedance 
response following proteinase K treatment is shown in Nyquist format in Figure 2.13. 
 
Figure 2.13 A Nyquist impedance plot showing the effect of probe incubation in proteinase K following BSA and 10-10M miR-
21 incubation. Performed using 5 mM K3[Fe(CN)6]/K4[Fe(CN)6] in 0.1 M KCl electrolyte at room temperature. 
The impedance plot data shown in Figure 2.13 show that proteinase K digestion resulted in a 
pronounced signal decrease to a level close to that obtained for miR-21 in buffer alone. This 
observation suggested that proteinase K could be used in analysis of human urine samples to 
prevent protein “caking” on the probe surface. 
2.5 Urine analysis 
Following the initial testing of synthetic urine matrices described above, analysis of urine 
samples was carried out. Ideally, urinary biosensor analysis should be quick, cheap and 
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straightforward at the point of care. To this end, it is important that the urine sample should 
require very little pre-treatment prior to analysis. 
To test the biosensor, firstly urine was used completely untreated, submerging the anti-miR-
21 DNA functionalised probe into a sample of urine for 30 minutes, with heating to promote 
hybridisation (Figure 2.14). 
 
Figure 2.14 Coulometry plot showing the response with anti-miR-21 DNA probe alone and with the untreated urine sample. 
Performed using 5 mM K3[Fe(CN)6]/K4[Fe(CN)6] in 0.1 M KCl electrolyte at room temperature. 
As shown in Figure 2.14, the change in charge between the DNA probe alone and the 
untreated urine response was greater than the 10 nM highest concentration used in the 
original sensitivity testing. This would indicate a urinary miR-21 concentration of over 10 nM 
which was not anticipated, therefore it was hypothesised that this result was due to 
adsorption of protein to the probe surface. To prevent this, a brief initial proteinase K 
incubation was used, following which the digest was spin-filtered to remove any undigested 
proteins (including remaining proteinase) and lipids. This procedure is summarised in Figure 
2.15 alongside an example of the data output with and without proteinase K digestion. 
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Figure 2.15 Urine pre-treatment procedure (top panel), and coulometry data showing how the use of proteinase K at 37 °C 
for 20 minutes affects the response following incubation in urine. Performed using 5 mM K3[Fe(CN)6]/K4[Fe(CN)6] in 0.1 M 
KCl electrolyte at room temperature. 
Figure 2.15 shows that the probe response obtained was greater than expected in untreated 
urine. However, following probe pre-treatment in proteinase K at 37 °C for 20 minutes, the 
resulting coulometric response was markedly increased. On the basis of the above data, 
future urine analyses used proteinase K treatment prior to probe/miRNA hybridisation. 
Five urine samples from healthy control subjects were obtained from the Wales Kidney 
Research Tissue Bank for miRNA detection analysis. For electrochemical analysis, urine 
samples were incubated with 10 µL of 20 mg/mL proteinase K and then filtered through a spin 
filter prior to probe insertion and hybridisation. Analyses were performed three times for 
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each urine sample to ensure data reproducibility. The miR-21 concentration of each sample 
was then determined from the coulometry data, and was compared to the calibration curve 
(Figure 2.5). The urine analysis results are shown in Figure 2.16. 
 
Figure 2.16 MiR-21 concentrations in 5 control subject urine samples calculated using coulometric analysis. As the 
concentration axis is negative, shorter bar means signify lower miR-21 concentrations. Performed in triplicate using 5 mM 
K3[Fe(CN)6]/K4[Fe(CN)6] in 0.1 M KCl electrolyte at room temperature. 
The data (Figure 2.16, raw data Appendix 1 Table A1.8) showed some variation between 
samples, with sample 1 having the lowest miR-21 concentration and sample 2 the greatest, 
and averaged around 10-10 M (0.1 nM). This variation was predicted on the basis of previous 
unpublished analyses by the host laboratory. 
Quantification of miRNAs using reverse transcription – quantitative polymerase chain 
reaction (RT-qPCR) was carried out by calculating relative expression in comparison with cel-
miR-39. Currently this represents the “gold-standard” for miRNA detection and analysis,239 
and so data obtained through this technique were therefore chosen as the best with which 
to compare our electrochemical data. 
Firstly, a calibration curve was generated using a serial dilution series of synthetic miR-21 
solutions as templates for RT-qPCR analysis, made up in biological grade water and therefore 
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not requiring an initial chemical extraction step. The resulting graph of threshold cycle (CT) 
versus concentration, from 10-8 M to 10-14 M miR-21, is shown below. The CT values in the 
linear region were then plotted against their respective initial miR-21 concentrations to 
generate a calibration curve. 
 
Figure 2. 17 The raw data amplification plot showing the number of cycles required for each buffered miR-21 concentration. 
Left to right 10-8, 10-9, 10-10, 10-11, 10-12, 10-13, 10-14 M. 
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Figure 2.18 Calibration plot of CT versus miR-21 concentration (-log10[miR-21]) obtained using the PCR amplification plot 
shown in Figure 2.17. 
The calibration curve (Figure 2.18 raw data Appendix 1 Table A1.9) had a Pearson regression 
coefficient of 99.9%. This showed that the RT-qPCR amplification procedure was highly 
reproducible, reflecting a linear relationship between CT and concentration. 
The calibration curve was then available to be used to convert CT values to miR-21 
concentrations, and therefore a quantitative comparison between the electrochemical 
measurements and the PCR analysis would be obtainable, thus proving whether or not the 
probe was functioning correctly.  
For urine sample analysis, miRNAs were extracted using the spin column-based miRNeasy kit 
from Qiagen. The resulting aqueous filtrate was used for subsequent RT and Taqman® qPCR 
analysis. The calibration plot equation was then used to convert the resulting CT values to 
concentrations, and then plotted graphically alongside the previously obtained 
electrochemical data for comparison, as shown in Figure 2.19. 
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Figure 2.19 Comparison of miR-21 concentrations for 5 urine samples calculated via electrochemistry and RT-qPCR. 
Electrochemical measurements performed in triplicate using 5 mM K3[Fe(CN)6]/K4[Fe(CN)6] in 0.1 M KCl electrolyte at room 
temperature. 
Figure 2.19 (PCR raw data Appendix 1 Table A1.10) shows that the miR-21 concentration 
values obtained using electrochemical detection were consistently greater than the 
corresponding RT-qPCR data. Qualitatively however, sample 1 had the lowest miR-21 
concentration and sample 2 the highest as was the case for the electrochemically measured 
concentrations. 
To evaluate the validity of these concentration differences, a series of control experiments 
were performed. The first of these used a 1 nM PNA sequence complementary to miR-21 to 
hybridise to urinary miR-21 and thereby block any urinary miR-21 signal detected by the 
probe following proteinase K treatment. As described above, since PNA does not have a 
negatively charged sugar phosphate backbone that is electrostatically repulsive to other 
phosphate backbones, it has a greater RNA binding efficiency than DNA. Probe:PNA binding 
would therefore be favoured, preventing hybrid denaturation and subsequent miR-21 
annealing to the DNA on the probe., decreasing the electrochemical response in comparison 
with PNA-free urine. Following data collection, exogenous synthetic miR-21 was added to a 
final concentration of 0.1 nM (Figure 2.20). 
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Figure 2.20 Coulometry analysis of urinary miR-21 detection using a complimentary miR-21 DNA probe in untreated urine, 
in urine containing 0.1 nM PNA complimentary to miR-21 PNA, and in PNA-treated urine following addition of 10-10 M 
synthetic miR-21. Performed using 5 mM K3[Fe(CN)6]/K4[Fe(CN)6] in 0.1 M KCl electrolyte at room temperature. 
As seen in Figure 2.20, the addition of PNA complementary to the target miR-21 produced a 
slight increase in the probe response. By contrast to the change observed in untreated urine, 
the magnitude was greatly reduced. This reduction was similar to that seen when the probe 
was suspended in a heated solution of water or buffer in the absence of miRNA. In the latter 
case, the slight drop in response intensity may have been the result of a marginal reduction 
in electrode surface electrochemical hindrance resulting from a small of number of the DNA 
strands of the probe being lost, possibly by very weak hydrolysis of the sulfonamide linkage, 
or small numbers of the DNA strands being hydrolysed. 
These data suggest that the PNA:target miR-21 hybridisation occurred and thus the miR-21 
was not detected in this experiment whereas it was in previous experiments. In the presence 
of 0.1 nM miR-21, a slight decrease in response was observed that was considerably reduced 
in comparison to untreated urine. This might indicate that some of the exogenous miR-21 
bound to the PNA, but that a small quantity remained to interact with the probe. However, 
degradation by urinary RNases cannot be excluded. 
A positive control was then carried out in which the urine sample and added PNA solution 
was prepared as before, but the sequence of the DNA probe strand was complementary to 
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miR-16. The proteinase K-treated urine sample was filtered, and spiked with miR-21 specific 
PNA, the miR-16 probe was incubated to induce hybridisation and the resulting coulometry 
response is shown in Figure 2.21. 
 
Figure 2.21 Coulometry analysis of urinary miR-16 detection using a complimentary miR-16 probe in urine in the presence 
and absence of 0.1 nM PNA. Performed using 5 mM K3[Fe(CN)6]/K4[Fe(CN)6] in 0.1 M KCl electrolyte at room temperature. 
Figure 2.21 shows that miR-16 detection was not affected by the presence of miR-21-specific 
PNA. These data suggest that the loss of response observed in Figure 2.20 was due to 
sequence-specifc PNA:miRNA hybridisation, and not a non-specific artefact. They also support 
the qualitative and quantitative miR-21 detection in Figures 2.16 and 2.19. 
A further control experiment used RNA digestion enzyme RNase A to digest all urinary RNAs, 
following which samples were treated with proteinase K as above prior to coulometry analysis 
with a miR-16-specific probe. Subsequently, exogenous 10 pM miR-16 was added and the 
coulometry analysis was repeated, as shown in Figure 2.22. 
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Figure 2.22 Coulometry analysis of urinary miR-16 detection using a complimentary miR-16 probe in RNase-treated urine, 
and in RNase-treated urine in the presence and absence of 10 pM PNA exogenous miR-16. Performed using 5 mM 
K3[Fe(CN)6]/K4[Fe(CN)6] in 0.1 M KCl electrolyte at room temperature. 
The data shown in Figure 2.22 again provided evidence of hybridisation between probe and 
urinary miRNA. These findings also suggest that the concentration differences observed in 
Figure 2.19 was not due to interferents or artefactual, and that electrochemical detection was 
more sensitive than RT-qPCR. 
The practical protocols from which the conflicting data seen in Figure 2.19 were generated 
have a number of differences. One key difference is the RNA purification procedure required 
prior to RT-qPCR that is not needed for electrochemical detection. To assess miRNA losses 
occurring via the extraction procedure, 10 nM, 100 pM, 1 pM and 10 fM solutions of synthetic 
miR-21 were made up in buffer and extracted using the standard miRNeasy kit protocol. RT-
qPCR was then used to detect miR-21 in these solutions before and after extraction. The 
calibration curve described above (Figure 2.18) was then used to determine miR-21 
concentrations. A plot of miR-21 concentration obtained before and after extraction is shown 
in Figure 2.23. 
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Figure 2.23 Comparison of miR-21 concentrations detected before (blue line) and after (orange line) miRNeasy kit 
extraction. 
Figure 2.23 (raw data Appendix 1 Table A1.11) shows that for each concentration, a lower 
concentration was detected via RT-qPCR following extraction. For a 10 nM solution there was 
an approximate 7000 × reduction in concentration, and the quantitative differences detected 
decreased with reduction in miR-21 concentration. These data suggest that losses during 
extraction contributed to the differences in concentration detected using RT-qPCR compared 
to electrochemistry. 
To assess the probe shelf life, artificial probe ageing was carried out by storing the probe for 
24 hours at a range of different temperatures: 4 °C, 25 °C, 30 °C, 40 °C and 50 °C. The extra 
data generated are presented at the end of the thesis (Appendix 1 Figures A1.3 and A1.4 and 
Table A1.12). 
These data are displayed graphically in the Arrhenius plot shown in Figure 2.24. Assuming first 
order kinetics, a theoretical storage times to 50% of the reference signal of 129.9 h (at 4 °C ), 
68.3 h (25 °C), 59.4 h (30 °C), 45.5 h (40 °C) and 35.4 h (50 °C) were calculated (Figure 2.24). 
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Figure 2.24 Arrhenius plot of ln k vs. 1/T (K) for a DNA modified electrode stored for 24 hours at 4 °C, 25 °C, 30 °C, 40 °C and 
50 °C. 
2.6 Summary of the results obtained. 
In this chapter a glassy carbon electrode-based probe was used to detect miRNAs in a variety 
of solutions ranging from a buffered miR-21 to more complicated mixtures of enzyme-treated 
urine with spiked in miRNAs and PNAs. 
The procedure used initially to modify the electrode ready for use as a probe was explained 
in detail effectively detected miR-21 by electrochemically. The modified electrode was then 
used to analyse buffered solutions of synthetic miR-21 over a range of concentrations from 
10 nM to 10 fM, and was found to have a sensitivity limit of 20 fM. The probe successfully 
discriminated mismatched sequences from mature miR-21 and miR-16, and probe flexibility 
was demonstrated by preparation of a miR-16 probe. Later tests in synthetic urine matrix 
showed no effect by salt and urea, but albumin proteins in the form of BSA were detrimental 
to the probe response via a blocking effect at the probe surface.  
The use of proteinase K was necessary to remove BSA protein and endogenous human 
proteins in urine samples. A number of urine samples were tested both electrochemically and 
using RT-qPCR, and showed a significant concentration difference between the two analytical 
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methods. Several control experiments were performed to show that the probe response 
resulted from miRNA:probe hybridisation. In addition, the extraction procedure used to 
prepare miRNA solutions for RT-qPCR analysis was shown to result in decreased detection of 
urinary miRNAs. Finally the storage lifetime of the probe to 50% of the reference result was 
determined at varying temperatures. 
The work presented builds upon work performed by Wang et al. on the detection of DNA 
sequences to a sensitivity of 72 fM.170 Our work was found to be only slightly more sensitive 
when applied to the detection of miR-21 giving a detection limit of 20 fM, however the 
significant advances are the application of our research to the detection of microRNA targets 
in real world urine samples and as well as indicating the specificity to 1, 2, 3 and full 
mismatches rather than the 3 and fully mismatched sequences explored by Wang.  
The next chapters explore this adaptation of the GCE protocol for use with screen printed 
electrodes for the detection of human miRNA. 
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Chapter 3: Screen Printed Electrode 
Prototypes
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Chapter 3: Screen printed electrode prototypes. 
 
3.1: Introduction to screen printed electrodes 
In the previous chapter a set of experiments were performed on a glassy carbon electrode, 
but, due to the need to constantly renew the electrode surface for each analysis, this is not 
suitable for high-throughput testing, nor for use at the point of care. Therefore it is the aim 
of this project to adapt the method for use in screen printed electrodes which can be 
produced and modified in bulk quantities and then disposed of after use. This is made possible 
through a collaboration with Gwent Electronic Materials® who have kindly supplied a 
selection of prototypes for testing and troubleshooting throughout the work presented 
herein. 
Unlike the glassy carbon electrode used previously, screen printed carbon electrodes are 
made using a carbon ‘ink’, typically consisting of graphite or graphene particles that are 
suspended in a volatile solvent and a polymer binding resin for ultra-thin dispersion onto a 
chemically resistant substrate.240–242 Although these are typical contents of the easily 
produced, easily modified and cheap screen printed electrodes of the type tested later, 
numerous other materials have also become popular in similar disposable electrodes. For 
example the advent of carbon nanotubes, within which reactive molecules may be 
embedded, has led to their use in screen printed electrodes manufacture.242 Gold has also 
been used for nucleotide analysis due to its ability to easily bind to thiol functional groups 
which are a common tag for DNA and RNA sequences.243 
The choice of ink materials is essentially limitless as the vast majority of inks, be they carbon, 
silver, platinum or any other base material, may be modified during formulation. For example 
nanoparticles of noble metals such as gold or platinum can be added to improve 
electrochemical outputs and for use as catalysts, but the costs associated with this make them 
unpopular.244 Other, less expensive, chemical additives have also been added for certain 
applications. Mixing the base carbon ink with manganese dioxide has been used for ascorbic 
acid and nitrite detection,245 bismuth oxide has been applied for lead and cadmium detection 
in water,246 Prussian blue has been added for pesticide detection,247 and even enzymes can 
be formulated into the ink for screen printable enzyme electrodes.248 
 93 
 
The choice of electrode base material, i.e. the conductive element/mixture used as the 
electrically active surface, is not the only property that needs to be explored for a particular 
application. The substrate material, i.e. the material that the electrode is printed onto, also 
has to be chosen according to the desired application. In the past the substrate materials that 
could be used were simple plastic or polymer based materials such as PTFE, Valox 
(polybutylene terephthalate), poly vinyl chloride (PVC) or alumina. These non-conductive and 
chemically inert substrates are all sheet based materials, designed to be fairly rigid and simple 
to print on. As the exact size of electrodes to be printed, and the shape and design of these 
electrodes, is defined by the design of the print mesh, it is feasible to generate anything from 
microelectrodes to complete electrode sheets depending on the application. Thus it is 
possible to generate electrochemical sensor arrays consisting of multiple active surfaces and 
indented ‘wells’ for microfluidic handling, this array of sensors can then be used for the 
analysis of multiple analytes at once rather than individual measurements.249 This particular 
application will be explored in later chapters in this work for detection of multiple RNA species 
in a urine sample. 
However, as the formulations for ink based electronics have become a lot more sophisticated, 
enhancing both their electrochemical behaviour and ability to maintain performance during 
mechanical stress, numerous other substrates have become available. One significant 
advance is the ability to print electrochemical cells onto flexible materials such as malleable 
plastics and textiles.250–252 This has ushered in a new world of ‘wearable electronics’ 
technology, finding application not only in devices such as smart watches and activity 
trackers, but also wearable medical devices for monitoring blood glucose in diabetes 
sufferers,253 or for use in monitoring infant temperature/glucose levels/vitals et cetera.254  
Despite many possible electrode construction options, the majority of commercial sensors 
follow a generic design. First the reference material and conductive ‘tracks’ are laid down, 
often as a silver/silver chloride material, with the exact choice again depending on the 
application. Next, the counter and working electrode surfaces are printed simultaneously, if 
they are using the same ink base, as the examples used throughout this project do, if not then 
each layer is printed consecutively. Finally, an electrical dielectric (insulator) ink is laid down, 
this ink is generally used to shield the electrode conductive trails from any chemical solvents, 
prevent any electrical noise and create a defined working area. However this material may 
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have additional functionality, such as changing colour in the presence of certain metals or 
compounds, if formulated appropriately. A general schematic of this procedure is shown for 
one of the designs in this project in Scheme 3.1. 
 
Scheme 3.1 The general screen printed electrode layering scheme that was used in this project. 
Therefore the purpose of the research described herein is to develop the previously used GCE 
modification procedure for use with screen printed electrodes. A variety of designs was 
available from Gwent Electronic Materials (GEM) that were prototyped to test their 
applicability, and adapt the GCE protocol for optimal performance with these disposable 
electrodes. New designs and materials will be discussed in the final chapter for optimisation 
of the biosensor for the detection of multiple miRNA targets in urine. 
3.2: Initial prototyping of the electrodes. 
To start the prototyping process a set of GEM’s most popular screen printed electrodes were 
tested, the only modification made to their design being the omission of the silver chloride 
reference and carbon auxiliary as the previously used external silver/silver chloride reference 
and platinum wire auxiliary were used. This was done for two reasons: firstly, the use of the 
three electrode design required a custom made connector, which was not deemed necessary 
during the prototyping stages; secondly, removal of these other sources of variability 
permitted direct focus on the reactivity of the working electrode. Thus the initial electrodes 
tested consisted of a silver/silver chloride track and connector, with a 2 mm diameter carbon 
working electrode and grey coloured standard dielectric coating. This design is displayed in 
Figure 3.1. 
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Figure 3.1 Initial prototyping design for the screen printed electrodes, supplied by Gwent Electronic Materials. 
Very importantly for high-throughput and point of care applications, screen printed electrode 
use is straightforward. Each card, as shown in the previous figure, contains a number of 
electrodes, in this case 4, which can be simply cut out with scissors or a scalpel and used 
individually. The bottom section and sides of the electrode can also be shortened, as they 
contain no carbon or silver/silver chloride trace, if the design is too long to fit the desired 
working vessel. Once cut out, the electrode is then connected to the potentiostat using a 
crocodile clip at the silver/silver chloride connection and used in the same manner as the 
glassy carbon electrode i.e. in a 3 electrode cell with silver/silver chloride reference and a 
platinum wire auxiliary. 
The first experiment performed using these electrodes was the standard deposition 
procedure using ANSA, to compare the electrochemical behaviour of the screen printed 
electrode (e.g. CV response curve) during this deposition to the GCE. Thus the screen printed 
carbon electrode (SPCE), the silver/silver chloride reference and the platinum auxiliary were 
submerged in a solution of ANSA and repeated cycles of cyclic voltammetry were performed 
to encourage deposition. The resulting cyclic voltammogram is given in Figure 3.2. 
 96 
 
 
Figure 3.2 An overlay of the cyclic voltammograms obtained after 4, 8, 12 and 16 cycles in ANSA. 
This plot shows a number of slight differences to the GCE while maintaining a similar shaped 
response voltammogram. The first difference is that the maximum current observed during 
the cycles is vastly reduced (almost 1/2 the GCE response for the later cycles), most probably 
due to the reduction in working electrode surface area from 3 mm to 2 mm. The second is 
that there is substantially more noise at the negative voltages, which may be an inherent issue 
with the materials used to produce the screen printed electrodes, as this was seen across the 
majority of electrodes used. However, the remainder of the cycle was reasonably well 
reproduced. Sixteen cycles were used in this experiment, but it can clearly be seen that after 
8 cycles the difference in current response becomes very small, and there is an increase in 
response after 16 cycles. This suggested that, like the GCE, 8 deposition cycles were sufficient 
for the SPCEs. 
At this point the screen printed electrodes were functioning as expected, and the chlorination 
step was then investigated. The GCE procedure was followed, then a 2 mL solution of acetone 
and PCl5 was produced and the ANSA deposited electrode was submerged in it. Chlorination 
time was allowed, as before, after which the electrodes were removed, rinsed and analysed 
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via electrochemical methods using a ferricyanide electrolyte. This was repeated 5 times, with 
similar results in each case. 
In most cases the dielectric layer became discoloured and dissociated, also in some cases the 
silver/ silver chloride connector became discoloured and peeled away in small areas. This may 
have resulted from acetone solubility of the polymers used to bind the inks to the substrate. 
Alternatively, the use of acetone may have removed some water from the hydrated polymers, 
causing them to lose their adhesive properties.   Figure 3.3 shows an example cyclic 
voltammogram carried out at this stage compared with an analogous GCE output. 
 
Figure 3.3 Comparative CV of the GCE following the chlorination step and the SPCE after chlorination under the same 
conditions. Performed using 5 mM K3[Fe(CN)6]/K4[Fe(CN)6] in 0.1 M KCl electrolyte at room temperature. 
The above data reflected the observed electrode damage following the chlorination 
procedure. The current response obtained from the SPCE was far higher than that observed 
for the GCE, with a peak of just over 0.3 mA compared to expected 0.08 mA, respectively. This 
difference in peak current might be due to the difference in electrode area, but as this 
electrode is smaller than the GCE a smaller peak current would be expected. The shape of the 
CV curve was also markedly different: it did not show the reversible oxidation and reduction 
peaks of the ferricyanide and tailed off in an unexpected way in the negative voltage range. 
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The chlorination procedure was therefore revised before continuing with the modification 
procedure.  
A number of different PCl5 solvents were tested for solubility to find one that both dissolved 
the reagent and left the electrode intact. As summarised in Table 3.1, the majority of solvents 
proved unsuccessful, either failing to show any dissolution of the PCl5, or showing clear and 
severe damage of the SPCE. Also, the carbon disulfide solvent was deemed too dangerous to 
test due to the potential to generate mildly toxic thiophosgene (CSCl2) in a side reaction.  
Table 3.1 Solvent PCl5 solubility and effect on the SPCE after 30 minutes. 
Solvent Electrode damaged? PCl5 solubility. 
Water/ethanol No Hydrolysis reaction 
Acetone Slow Yes 
Hexane No Slow 
Heptane  No  No 
Cyclohexane Yes Yes 
Tertiary-butyl-methyl-ether Yes Yes 
Diethylether Yes Yes 
Dichloromethane Yes Yes 
Chloroform Yes Yes 
Carbon disulphide Yes *Thiophosgene production 
Ethyl glycol dimethyl ether Slow Yes 
Benzene Yes Yes 
Toluene Yes Yes 
Cyclohexyl methyl ether Yes Yes 
 
The experimental observations listed in Table 3.1 show that the SPCE was highly susceptible 
to damage in most of the PCl5 solvents tested. However, when submerged in hexane the SPCE 
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showed no visible signs of damage, even overnight. While the dissolution of PCl5 was very 
slow in this solvent electrode damage was not observed, and hexane was therefore chosen. 
Solution of PCl5 in hexane was then tested to ensure that chlorination occurred as desired. 
The ANSA modified electrodes were submerged in the hexane/PCl5 for 1 hour, 2 hours and 4 
hours. Following this, they were analysed using ATR-IR by compressing the electrode surface 
against the ATR crystal and comparing the resulting spectra against that of an ANSA electrode 
subjected to the PCl5 in acetone procedure. The blank and ANSA electrodes were also imaged 
for a reference (Figure 3.4). 
 
Figure 3.4 Overlaid ATR-IR spectra showing the unmodified SPCE (black) the isolated ANSA compound (red) and the ANSA 
modified electrode (green). 
This initial IR spectrum shows how the SPCE appears when it is unmodified, and then how it 
changes following electrodeposition of the naphthalene sulfonic acid, the IR of the acid is also 
given for peak reference. From the spectrum, the most obvious change following the acid 
deposition was the presence of a new peak at 2360 cm−1. 
This peak usually indicates the presence of a nitrile (CN). However this would not be possible 
in the experimental system without being present in the ink, and was not observed in the 
unmodified electrode. 
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On the other hand, the ink did have a C=O stretch as indicated on the IR at around 1712 cm−1, 
and the 2360 cm−1 peak might be a stretch resulting from the amine of the sulfonic acid 
reacting with a functional group on the carbon surface. Either through an isocyanate (N=C=O, 
≈2270) or an isothiocyanate (N=C=S ≈2125), this would also be indicative of the mechanism 
by which the amino functionality binds to the carbon surface of the SPCE. However, as this 
peak is missing from some of the scans displayed in Figure 3.5, a more plausible explanation 
is that these peaks arise due to unresolved atmospheric CO2 that was not removed during the 
background measurements. This is further indicated by its clear double peak. Having 
measured the deposited spectrum, the chlorination procedure was tested at a number of 
time points to determine time of completion (Figure 3.5). 
 
Figure 3.5 IR spectra recorded after different chlorination conditions, the first by submerging the ANSA modified SPCE 
electrodes in acetone/PCl5 for 30 minutes (black) and the remainder by submerging in hexane/PCl5 for different time 
periods: 18 hours (red), 4 hours (green) 2 hours (blue) and 1 hour (orange). 
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The data shown in Figure 3.5 are not conclusive regarding the time required for the electrode 
to react in hexane/PCl5 and show only slight differences to acetone/PCl5 treatment. The most 
obvious indicator would be a change around 700 cm-1 indicating the presence of a Cl, but in 
all cases this section was not well resolved.  Notably, the peak at ≈2360 cm-1 appears in only 
3 of the 5 surfaces tested, providing further evidence of unresolved atmospheric CO2 not 
removed correctly during the background scans. 
A reaction time of 4 hours was selected, as this was the first time point at which all of the 
ground PCl5 had dissolved completely or the solution had become saturated. Importantly, 
subjecting the sensors to this chlorination mixture did not result in the same misshapen cyclic 
voltammetry plot recorded previously. An example voltammogram is given in Figure 3.6, and 
shows a GCE-like SPCE response following chlorination. 
 
Figure 3.6 Comparative CV showing that the SPCE displays expected electrochemical behaviour following PCl5 chlorination 
using hexane solvent (orange) compared to GCE chlorination with acetone solvent. Performed using 5 mM 
K3[Fe(CN)6]/K4[Fe(CN)6] in 0.1 M KCl electrolyte at room temperature. 
The above CV curve comparison (Figure 3.6) shows that the SPCE displayed the correct 
electrochemical redox behaviour following submersion in the hexane/PCl5 chlorination 
mixture. Clear oxidation and reduction peaks were observed with no tailing off seen 
previously. The GCE response following chlorination in acetone is shown in Figure 3.6 for 
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comparison of the CV curve shape, but it was noted that the SPCE response was much smaller 
than that obtained from the GCE. 
As mentioned previously this current response is likely due to the working areas of the SPCE 
(diameter of 2 mm) and GCE (diameter of 3 mm) differing. The area of a circle (A) is calculated 
using the equation A = π × radius2: a circle of 3 mm diameter has a total area of 9π mm2, and 
a 2 mm diameter circle has a 4π mm2 area. It is therefore conceivable that the current 
expected from a 2 mm diameter electrode would be below 0.5 × that for a 3 mm electrode. 
This assumption concurs with the observed data, the GCE giving a current of ≈80 µA and the 
SPCE a current of ≈35 µA. 
Following the successful SPCE chlorination procedure, the electrodes were modified with the 
amine tagged DNA sequence complementary to miR-21, as carried out previously. For the 
purposes of prototyping the DNA was applied in a 10 µL droplet in buffer and allowed to air 
dry overnight at room temperature. The surface was then analysed using cyclic voltammetry 
in ferricyanide to analyse SPCE integrity, and no modification to the DNA addition procedure 
was required. 
The final modification step to be tested was the submersion of the SPCEs into buffered miRNA 
solutions. Initially this was performed at 50 °C for 60 minutes to ensure that the predicted 
changes in response were observed. However, similar signal aberrations were observed to 
those seen following chlorination failures. Visually, it was apparent that the dielectric coating 
was peeling away from the Valox® backing, and bubbles were forming underneath the layer 
in the areas that were submerged for the hybridisation. Also, the silver connector pin showed 
discolouration, which was also unexpected since the only relatively volatile compound in the 
buffer was water. These observed changes were thought, at least in part, to explain the 
aberrant electrode response. 
For the next trial, the outermost dielectric layer was strengthened using a commercially 
available fast drying resin used most often for hardening and sealing nail varnish. Application 
was carried out using an applicator brush around the active working surface, with particular 
attention to the edges where the electrode had been cut out and possible entry points for 
moisture had been generated, and the resin was left to air dry completely at room 
temperature (see Figure 3.7). 
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Figure 3.7 An illustration of commercial resin application to strengthen the dielectric layer and prevent water ingress. 
Along with this modification, it was also deemed necessary to cover the silver connection pins 
with insulation tape in order to prevent any possible detrimental effect of buffer vapour, 
perhaps indicated by the discolouration noted above. The electrodes were then again 
submerged in buffered miRNA solution in a 1mL Eppendorf tube, and heated to 50 °C for 60 
minutes to determine their stability. The resultant cyclic voltammogram in Figure 3.8 shows 
improved oxidation and reduction profiles, indicating that the treated electrode was more 
durable. 
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Figure 3.8 Overlaid cyclic voltammogram showing data for one SPCE strengthened with resin (orange) and one un-
strengthened SPCE (blue) following incubation in buffered miRNA solution. Performed using 5 mM K3[Fe(CN)6]/K4[Fe(CN)6] 
in 0.1 M KCl electrolyte at room temperature. 
Figure 3.8 shows a misshapen voltammogram, similar to that obtained from chlorination in 
the acetone/PCl5 mixture, for the un-strengthened SPCE. Although oxidation and reduction 
peaks were obtained, there was a rapid ‘tailing off’ of the current in the lower voltages, and 
the peak currents were much higher than expected. However, when the resin and tape were 
applied, a redox curve of the more expected shape was observed, with no tailing effect, and 
the peak currents were within ranges observed at previous steps in the modification 
procedure. 
The SPCEs had therefore successfully survived each of the modification steps and displayed 
cyclic voltammograms similar to those obtained at each step of the GCE modification. It was 
then necessary to determine if SPCEs detected changes in electrochemical response similarly 
to the GCE. This would also provide data on the sensitivity of the SPCE, and how it compared 
to the previously obtained GCE sensitivity. Thus, the SPCEs were modified using the 
aforementioned changes to the original procedure, and then incubated in solutions of miR-
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21 of varying concentrations for 30 minutes at 50 °C. They were then analysed using cyclic 
voltammetry and chronocoulometry as before. 
However, the SPCEs were unsuitable for Nyquist electrical impedance spectroscopy analysis 
(shown Appendix 2 Figure A2.1 at the end of the thesis). By plotting the data as a Warburg 
plot however some analysis was possible by extrapolating the intercept of the linear section, 
this is also given in the Appendix (Appendix 2 Figures A2.2 and A2.3). The results of this first 
set of sensitivity tests are displayed in the plot in Figure 3.9 (raw data Appendix 2 Table A2.1). 
 
Figure 3.9 Coulometry change (Q) between the DNA modified SPCE and the DNA/RNA modified SPCE for different miR-21 
concentrations. Performed in triplicate using 5 mM K3[Fe(CN)6]/K4[Fe(CN)6] in 0.1 M KCl electrolyte at room temperature. 
Initial results using this adapted modification procedure seemed promising, a highly linear 
change in coulometric response was observed with the log10 of miR-21 concentration, as had 
been observed with the GCE. However, there were still major differences between these 
results and those obtained previously. Firstly, the SPCE sensitivity was much lower than that 
for the GCE, with an SPCE minimum observable concentration of 715 fM to the GCEs 
calculated limit of detection of 20 fM (and minimum extrapolated concentration of 6 fM). 
Also, the individual data points for 10-8, 10-9 and 10-11 M show high variability compared to 
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those obtained in analysis using the GCE. In addition, the failure rate of the SPCEs, although 
much improved using the modified procedure, was still significant. 
3.3: Using SPCEs with an increased working area diameter. 
To address the issue of reduced SPCE sensitivity, a new electrode design was required which 
incorporated a 3 mm active surface to improve the limit of detection. GEM supplied the set 
of SPCEs shown in Figure 3.10, with a 3 mm diameter active surface suitable for testing ink 
materials as above.  
 
  Figure 3.10 3 mm electrode design made available by Gwent Electronic Materials (GEM).  
These 3 mm SPCEs did have some additional differences to the 2 mm electrodes described 
above. The grey dielectric no longer surrounded the entirety of the surface, the connection 
was carbon and not silver/silver chloride, and they were markedly smaller in length.  
These electrodes maintained normal responses throughout the adapted modification 
procedure. The new SPCEs were then tested to determine the effect of surface size on the 
resulting signal obtained.  
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Figure 3.11 Cyclic voltammogram comparing current response from the GCE (orange), the 2 mm SPCE (grey) and the 3 mm 
SPCE (blue) following DNA addition. Performed using 5 mM K3[Fe(CN)6]/K4[Fe(CN)6] in 0.1 M KCl electrolyte at room 
temperature. 
The cyclic voltammogram in Figure 3.11 shows the current response compared to the GCE. 
The 3 mm diameter SPCE gave oxidation and reduction peaks much closer in magnitude to 
the GCE than the 2 mm electrode. Although there is still some difference, which could be 
down to a slightly different surface coverage or down to the properties of the ink over the 
GCE, the 3 mm diameter electrode does give a closer resemblance to the GCE than the 2 mm 
electrode. 
Following the above findings, the sensitivity of the 3 mm SPCEs was then tested. The 
electrodes were modified as previously and hybridised with different miR-21 concentrations.  
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Figure 3.12 A plot to show the change in coulometry response (Q) over a range of miR-21 concentrations. Performed in 
triplicate (except 10-14 M) using 5 mM K3[Fe(CN)6]/K4[Fe(CN)6] in 0.1 M KCl electrolyte at room temperature. 
The chronocoulometry data shown in Figure 3.12 (raw data Appendix 2 Table A2.2) suggest 
that SPCE sensitivity was related to working electrode diameter. Using the 2 mm SPCE gave a 
minimum extrapolated concentration of 715 fM, but the 3 mm electrode gave a minimum 
observable concentration of 1.8 fM. This was much closer to the GCE sensitivity (extrapolated 
as 6 fM, limit of detection of 20 fM), and the response magnitude of the 3mm SPCE was also 
more similar to the GCE than that obtained by the 2 mm electrode. 
However, despite showing an extrapolated sensitivity increase for the 3 mm SPCE, it should 
be noted that the error for some points with this prototype, namely 10-10 and 10-8 M was 
clearly higher than that for the GCE. In addition, the 10-14 M data proved difficult to obtain 
reproducibly due to electrode failures and obvious anomalies (charge changes in the lower 
concentrations that are orders of magnitude larger than those obtained at 10 nM). This data 
point is reported only for one trial, and the absolute sensitivity cannot be accurately 
ascertained. 
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3.4: Surface imaging and analysis techniques. 
Up to this point, the surface of each of the electrodes, from the GCE to each of the SPCE 
designs was analysed via electrochemical means, with one series of preliminary IR 
spectroscopy measurements. To further characterise the chemistry at the electrode surface, 
and to observe changes resulting from the modification and hybridisation, further analyses 
were carried out. 
In order to first reveal the chemical changes that occurring over the course of the modification 
procedure, a set of the 2 mm electrodes were produced, each being analysed after each 
individual step in the experimental procedure. Laser ablation-inductively coupled plasma 
mass spectrometry (LA-ICPMS) was then performed on each electrode to determine the 
concentration of each element on the surface. 
The key elements for each of the steps were chlorine, nitrogen, sulfur, phosphorus and 
carbon. These concentrations were also compared to a ‘blank’ sample, i.e. a fresh SPCE that 
was not modified, to determine approximate base values for each element at the electrode 
surface prior to modification. Exact values may vary slightly across each electrode, depending 
on variance at the time of printing. The values for the key elements are given in Table 3.2 and 
Figure 3.13 with the full data analyses are given in the Appendix (Appendix 2 Table A2.3). 
Table 3.2 Elemental concentrations at the surface of an SPCE at different stages of modification. Obtained via LA-ICPMS and 
averaged over 3 readings. ANSAm-DNA indicating the DNA attached via sulfonamide link to the ANSA modified surface. 
 Average atom concentration (ppb) 
C Cl S P N (ppm) 
Blank 228595 +/- 
11961 
6138 +/- 
248 
300 +/- 44 209 +/- 15 39526 +/- 
439  
SPCE-ANSA 255050 +/- 
3722 
5684 +/- 
65 
263 +/- 43 258 +/- 10 37864 +/- 
36 
SPCE-ANSCl 
(acetone/PCl5) 
57254 +/- 
201 
1025 +/- 
6 
Not 
observed 
113 +/- 5 7314 +/- 
129 
SPCE-ANSCl 
(hexane/PCl5) 
268197 +/- 
7361 
5580 +/- 
35 
282 +/- 27 4791 +/- 
58 
36443 +/- 
401 
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SPCE-ANSAm-DNA 4325352 +/- 
365964 
4902 +/- 
1246 
954 +/- 171 6064 +/- 
414 
1696514 
+/- 252657 
SPCE-ANSAm-
DNA/miRNA 
2017832 +/- 
582378 
1534 +/- 
544 
657 +/- 94  9831 +/- 
2792 
723689 +/- 
184944 
SPCE-ANSAm-
DNA/non-
complement 
2882532 +/- 
102513 
2732 +/- 
113 
341 +/- 46 283 +/- 9 73241 +/- 
682 
 
Figure 3.13 The ICP-MS data shown graphically, displaying the change in the key elements at each stage of SPCE modification. 
The blank data show that the predominant electrode surface element was carbon, as would 
be expected from a screen printed carbon electrode, with some chlorine, sulfur and 
phosphorus compounds from the ink or its binding polymers. When the naphthalene sulfonic 
acid was deposited (SPCE-ANSA) the carbon concentration increased by a considerable ppb, 
as expected. However, the chlorine and sulfur levels fell slightly, possibly due to a slightly 
different ink constituent or due to the new polymer surface decreasing the laser’s permeation 
depth.  
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Increased sulfur content would be predicted due to the new sulfur atom introduced for each 
sulfonic acid molecule, but this was not observed. It has already been mentioned that Cl may 
be difficult to measure as it does not readily form Cl+ ions, so has low Cl measurement 
sensitivity, and for atomised sulfur (32S+) there is potential spectral overlap on the mass 
spectrum with atomised oxygen (16O2+) if not standardised,255 which may explain the 
unexpected trend in sulfur concentration. 
Subsequent experiments added further clarity. The SPCE subjected to the acetone/PCl5 
chlorination conditions showed a dramatic decrease in the concentration of all key elements 
including carbon and nitrogen. This indicated that damage was occurring to the surface of the 
ink itself, particularly as its carbon content was reduced by ≈75% compared to the blank 
result. 
Valox, made from a PET-based polymer, was not expected to contain nitrogen, but the carbon 
ink ingredients were. Decreases in carbon and nitrogen contents therefore suggested surface 
damage was causing ink to leach from the substrate during chlorination, supporting the above 
electrochemical observations in which the current response did not match the predicted 
redox behaviour. 
By contrast, the hexane-based chlorination procedure did not result in decreased carbon 
concentration, which stayed around the same level as the SPCE-ANSA stage. The modest 
increase in this quantity was possibly due to slight differences in electrode inks, or residual 
hexane. The chlorine content varied little from the deposited electrode or the blank, perhaps 
for the above reasons of low sensitivity and difficulty producing Cl+, The increase in 
phosphorus content showed residual PCl5 was likely present in this sample, but the overall 
picture suggested that hexane chlorination did not cause the damage seen using 
acetone/PCl5. 
When DNA was added to the hexane chlorinated electrode to form the SPCE-ANSAm-DNA 
electrode surface, the carbon, nitrogen and phosphorus concentrations increased by a large 
amount, as expected. The chlorine concentration also appeared to drop slightly, as would be 
expected from the sulfonamide linkage reaction liberating some of the surface chlorine atoms 
as HCl. Then, when the electrode was submerged in a solution containing miRNA 
complementary to the attached DNA probe, there was a large increase in the phosphorus 
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content, indicating the presence of more phosphate backbones as expected from the 
additional RNA. This phosphate increase was not observed when a non-complementary 
sequence was used, in fact there is a substantial decrease in phosphorus and nitrogen, 
indicating that some of the original DNA probe strands were lost or degraded, perhaps due to 
the elevated hybridisation temperature. 
The above observations suggested that the electrode not only survived the modification 
procedures, but that the DNA has been attached as desired, and that the desired hybridisation 
event was taking place. The experimental observations therefore support the use of the 
modified SPCEs hybridisation protocol described above as a viable methodology for the 
detection of miRNAs in solution. 
Having used LA-ICPMS to analyse the surface chemistry, determine the electrodes survived 
the procedure and, at least chemically, functioned correctly, visualisation on a macroscale 
was then undertaken. This was especially necessary since some of the LA-ICPMS data were 
not predicted, for example the drop in nitrogen content on miRNA hybridisation, and the low 
sulfur content upon deposition of the sulfonic acid. Such analyses would also allow further 
scrutiny of the urinary miRNA detection procedure described in Chapter 2. 
To achieve this macroscale visualisation, atomic force microscopy (AFM) techniques were 
used. The disposable SPCEs were readily sheared to fit into the AFM instrument. The GCE 
would have had to be destroyed for this purpose, at prohibitive expense for multiple images. 
Therefore the SPCE electrodes alone were used. Since the overarching aim of the project was 
to develop a test using disposable SPCE based sensors, this was deemed sufficient. 
The first of AFM images are displayed in Figure 3.14 and show the surface of a blank 3mm 
diameter SPCE. 
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Figure 3.14 A TM (tapping mode)-AFM image and zooms of the 3 mm SPCE surface with no surface modifications, with a 
graphical indication of the triangular feature length (green line in image, left profile) and the average step height in the 
layers (purple line in image, right profile). 
The AFM images of the unmodified SPCE show that the carbon surface of the working 
electrode consists predominantly of triangular layers, each approximately 1.75 µm in length 
as indicated by the green line with a layer step height of approximately 50 nm. The surface 
roughness analysis also indicated a roughness of 0.43 µm and an average height standardised 
of 1.61 µm from the lowest point. This is an important observation, showing that while there 
are areas of order along the surface (the around 1.75 µm for each top triangular feature) it is 
not planar as might be expected from a GCE as there is roughly a 10 % change in height across 
the surface (ink quoted as 16 µm average printed thickness, an average of 1.61 µm height 
difference from the standardised low point is measured by AFM roughness analysis). The 
roughness across the surface could also account for some of the variability noticed earlier as 
slightly different active areas may occur between each individual electrode on one substrate 
and across the whole batch. This is likely to average out over the whole surface, and will be 
depend on exact production conditions. 
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The images from this “bare” surface provide a baseline reference point for images generated 
at different stages of the SPCE modification process. With respect to the ink itself, the 
triangular features indicate that the carbon is graphitic in nature, the trigonal planar geometry 
of graphite resulting in the triangular shape in bulk. A similar image of layered triangles has 
been reported for isolated graphite nanosheets by Shang et al,256 and also in a 3D AFM image 
of a screen printed carbon electrode shown by Wongkaew and Poosittisak.257 Interestingly, 
throughout all the images collected where these triangular graphite features are visible, there 
appears to be directional bias with the tip of the triangles pointing to the right. Were this bias 
due to the action of the squeegee during printing, the direction of bias would be expected to 
differ in different images, since the exact orientation in the AFM machine compared to the 
time of printing was not controlled. This same directional bias can be seen in the image by 
Wongkaew and Poosittisak, therefore it is possible that this is occurring due to the action of 
the AFM tip horizontal movement.  
Figure 3.15 shows an image obtained following deposition of the naphthalene sulfonic acid. 
 115 
 
 
Figure 3.15 A TM-AFM image and zooms of the 3mm SPCE surface following ANSA deposition. The length of the feature 
highlighted by the green line is also given graphically (left profile) and the step height by the purple line (right profile) 
These images show the same triangular features as the unmodified surface, as seen by both 
the visible shapes and the approximate 1 µm length of the highlighted example (the tip 
appears covered by another feature). However, the deposited ANSA had a profound effect. 
Rather than the sharp edges observed previously, the presence of ANSA caused the layers to 
become much less pronounced, and gave rise to a more uniformly smooth surface. This would 
be expected if a polymer was being generated, as hypothesised previously. 
Despite the triangular features losing their sharp edges, the roughness across the bulk surface 
increased slightly from 0.43 µm to 0.46 µm, there was also a slight increase in average height 
across the surface from 1.61 µm to 1.64 µm, possibly indicative of the polymer being 
deposited over the surface. The layered step heights were still apparent, with an approximate 
step of 70 nm, however they were not as defined in this case with the profile curve being 
smoother, and the individual steps appeared to merge in some cases (hence the steady drop 
at the right hand side), again suggesting the presence of a rounded coating rather than a flat 
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surface. The surface coverage of the naphthalene sulfonic acid might also explain the 
dramatic drop in electrochemical response obtained following the deposition procedure using 
the GCE, as seen in Chapter 2.  
The next images taken compared an SPCE surface following chlorination in hexane/PCl5 
(Figure 3.16) and one submerged in acetone/PCl5 (Figure 3.17). 
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Figure 3.16 An AFM image and zooms of the 3mm SPCE surface following chlorination in hexane/PCl5. The length of the 
triangular region was given according to the green line and the layer step height by the purple line (right hand profile). The 
white line in the lower image indicates the section used to analyse a rounded artefact (left profile). 
 
Figure 3. 17 An AFM image and zooms of the 3mm SPCE surface following chlorination in acetone/PCl5. The length of the 
round features and the step heights are given by the green line and the graphical profile. 
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In the lowest magnification image of the hexane/PCl5 chlorinated SPCE (top left), some areas 
of undefined space to the left might indicate that the surface damage, or more likely areas 
where the tip did not come into contact with the surface. However, the average height of the 
surface was 1.14 µm, and with a roughness of 0.38 µm, this indicated a slight reduction in the 
average height and a slightly smoother surface than previously observed. Also, the same 
rounded triangular shapes seen in Figure 3.15 were still observed, with a length of ≈1.2 µm 
as expected, but here the step in layers was much lower, being only 20 nm and much more 
rounded. This might indicate that the layered structure was being stripped during this 
treatment and leaving a smoother surface for the electrochemistry. This in turn could explain 
the drop in average peak height observed and, if there was a dramatic change in height at 
different areas of the surface, why the tip did not always make contact. In this image there 
are also a number of smaller circular features that can be found throughout. The size of these 
(≈45 nm) would not be observed for an atomic change from OH to Cl alone, and could signify 
a cluster of sulfonyl chlorides or, more worryingly, macroscopic interferents. They are 
dispersed throughout however, whereas interferent adsorbate compounds would be 
expected to adsorb at the edges of any surfaces rather than being dispersed across the whole 
system.  
The lowest magnification image (top left) obtained from an SPCE submerged in an 
acetone/PCl5 solution (Figure 3.17) shows more undefined area than the corresponding 
hexane/PCl5 image. This might be due to surface damage, but is most likely due to the tip not 
making correct contact with the surface in this area. When a section showing some visible 
features was measured at an increased magnification it was observed that, while the 
triangular backing structure was seen in places, many round features cover the surface. 
The average surface roughness was only 0.21 µm, much lower than observed previously, 
indicating ridges and valleys in the surface. The average height was almost halved at 0.52 µm, 
possibly as a result of many ink layers being stripped by the acetone/PCl5 solution. This would 
also explain the smoother surface, since the layers causing the previously observed increased 
roughness had been removed. 
The size of the round features was also significantly bigger than previously (between 50 and 
100 nm compared to the ≈45 nm of Figure 3.16), with the step heights between them hard to 
distinguish but ≈10-20 nm, as before. The increased size of these features, along with the 
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potential stripping of the electrode graphite layers suggests surface damage, the rounded 
features likely being artefacts and representing areas where the binding material or the ink 
itself was swollen due to attack from the acetone/PCl5. The hexane/PCl5 chlorinated 
electrodes showed the expected CV behaviour and fewer surface artefacts, the surface 
visually resembling more closely the SPCE-ANSA stage. It was thus concluded that the 
acetone/PCl5 procedure irreparably affected the electrode surface, and therefore, at least 
with the carbon ink used, could not be implemented satisfactorily in biosensor production. 
Figure 3.18 shows AFM images of an SPCE with DNA probe strands attached. The image was 
taken following biosensor modification by attachment of DNA strand complementary to miR-
21. This image was taken for the purposes of comparison with DNA/RNA hybrid scans with 
untreated and proteinase K treated urine samples.  
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Figure 3.18 An AFM image and zooms of the 3mm SPCE surface following addition of anti-miR-21 DNA. The graphical 
representation of the length of the round features is given by the green line in the image (left profile) with the step height 
indicated by the purple line in the image (right profile). 
 
Figure 3.19 An AFM image and zooms of the 3mm SPCE surface following hybridisation with miR-21 in buffer. The length of 
one of the rounded features is given as indicated by the green line in the image (left profile) with the step heights being 
given by the purple line in the image (right profile). 
Figure 3.18 shows that there was a substantial amount of surface coverage of some form of 
adsorbate following the application of the DNA droplet. It should be noted that the electrode 
in this instance was developed using the hexane/PCl5 treatment that showed only slight 
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artefact coverage following chlorination, and that the electrode was thoroughly rinsed with 
water multiple times before submitting for AFM analysis. 
Surface roughness analysis showed an average roughness of 0.41 µm and an average height 
across the surface of 1.63 µm, both of which were higher than that observed when 
chlorinated in hexane, indicating the deposition of objects roughly 590 nm in length. The 
rounded features themselves they were ≈40 nm in length, with a step height between each 
of ≈10-20 nm indicating their proximity and very limited layering. This suggested that the 
features seen here were likely areas where the DNA strands were localised as they were highly 
abundant, of similar size, and were dispersed along the surface, not just along the edges as 
would be expected for unwanted surface contamination. Ink blistering or swelling was not 
suspected since the maximum ink height increased on the hexane/PCl5, and the layer loss as 
seen with acetone was not observed. There were also sections where triangular graphite was 
still observed.  
Figure 3.19 shows an SPCE modified with DNA following hybridisation of miR-21 target in 
buffer. As with the DNA modified SPCE the surface of this electrode was covered with highly 
dispersed, rounded features. These features may show areas where DNA/RNA duplexes are 
forming, on account of their highly dispersed and regularly shaped nature. As seen in the 
lowest magnification image, these features aggregate only in certain areas, not as a general 
electrode coating or around the edges of any ridges/valleys in the surface. This would be 
predicted if there was an underlying polymer layer with DNA attachments, not just a layered 
graphite structure. Thus it is unlikely that they are caused by a general covering of the 
electrode by any unwanted macromolecules.  
By analysing the surface roughness it was determined that the roughness was 0.47 µm, 
meaning that the change in height across the surface had become more pronounced. The 
maximum height was displayed as 1.67 µm, both values being larger than those for DNA 
alone, and thus suggesting the attachment of a second molecule. The height difference was 
not expected, since length of the DNA/RNA hybrid was not expected to differ from the DNA 
probe. A possible explanation might be that the new hybrid lowered the degrees of freedom, 
increasing DNA rigidity about the sulfonamide bond. 
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The profile graph shows the round features to be roughly 90 nm in length, approximately 
double what the length of DNA alone, with a height of approximately 35 nm. This would again 
point to the formation of a duplex from the single chains that were present previously. This 
image, together with the electrochemical behaviour, suggest that RNA/DNA hybridisation 
event was taking place, and also acts as a reference for comparison with the urine based 
images to follow.  
Figure 3.20 displays AFM images taken after submersion of a DNA modified SPCE in an 
untreated urine sample. 
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Figure 3.20 An AFM image and zooms of the 3mm SPCE surface following hybridisation in untreated urine. The graphical 
surface profile of the rounded features highlighted by the green line is also given. 
 
Figure 3.21 An AFM image and zooms of the 3mm SPCE surface following hybridisation with urine treated with proteinase K 
and spin filtered. The length of one of the round features, highlighted by the green line, is also given graphically. 
Much like the previous images of both DNA and DNA/RNA hybrid electrodes, this untreated 
urine sample also resulted in many rounded features. However from the mid zoom image 
shown top right, and the high zoom image shown bottom right, it appears that these features 
were not as dispersed across the triangular surfaces as previously. Instead, most often they 
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aggregated predominantly at the corners and edges of the triangular surfaces of the 
carbon/graphite ink. Indicating that they were likely interferent artefacts as oppose to true 
DNA/RNA features. 
Surface roughness analysis indicated that the surface roughness was 0.40 µm with an average 
height of 1.05 µm. These values were much closer to those obtained when the hexane/PCl5 
chlorination procedure was performed (1.14 µm and 0.38 µm respectively) and much lower 
than those obtained for the DNA containing electrode (1.63 µm and 0.41 µm respectively), 
possibly suggesting that DNA was no longer attached to the surface. However, it seems more 
likely that the artefacts/proteins present in the urine were forming a second coating of the 
electrode in between the DNA strands. This would result in an increase in the standardised 
zero height value, making the surface appear uniformly thicker so that the change in height 
observed due to the DNA appeared smaller. 
The rounded features were much larger than those observed previously, ≈120 nm in length 
with a rounded height of ≈35 nm. It therefore appeared that many contaminating 
macromolecules coated the electrode surface, for example lipids and proteins, most likely 
what caused the large drop in current response seen in the GCE urine control tests. While the 
GCE would likely not be expected to have this triangular topology, there would still be surface 
defects to which these macromolecules could adsorb.  
The final AFM image in this, shown in Figure 3.21, shows an SPCE that had been immersed in 
a urine sample treated with proteinase K and spin filtered, as used in the optimised urine 
analysis tests performed using the GCE in Chapter 2.4. 
These images, when compared to those in Figure 3.20, allow several conclusions to be drawn. 
Average roughness was 0.37 µm, with an average height of 1.4 µm. This was lower than 
expected with a surface of DNA/RNA hybrids (0.47 µm and 1.67 µm with synthetic miR-21), 
possibly due to the lower miRNA concentration  in the urine sample coupled with minimal 
amounts of the layering effect, seen for the untreated urine sample from smaller proteins and 
lipids, increasing the baseline height slightly. When each image was viewed individually it was 
observed that in both the lowest magnification image (top left), and the next magnification 
(top right), there was increased coverage of round features compared with previous 
observations. In addition, these features aggregated around each other over large areas, as 
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seen for the DNA/miRNA hybrid images in Figure 3.19. The positioning of the features was 
also different in Figure 3.21. In Figure 3.20, the round features were found at the edges and 
corners of the triangular geometries, but in Figure 3.21 they appeared more frequently along 
the flat surfaces as opposed to the vertices and edges. 
As stated above this was thought to signify the RNA/DNA hybridisation event as uniform 
coverage rather than non-specific adsorption of macromolecules at crevices. The general 
appearance of these features also resembled those in Figure 3.19. Finally, the length of one 
of these features was measured via profiling to be approximately 80 nm, rather than the ≈120 
nm found without treatment of urine, and a height of approximately 40 nm. These lengths 
are again more consistent with those found for the DNA/RNA hybrid images in Figure 3.19.  
Taking all the imaging techniques into account, both the LA-ICPMS and the AFM, it appeared 
that the modified SPCE survived hexane/PCl5 treatment, bound DNA, and mediated RNA/DNA 
hybridisation as intended. From the AFM data it may also be posited that the urine treatment 
with proteinase K and spin filtration resulted in fewer contaminating macromolecule 
interferents found at the surface of the carbon ink. The data obtained following this treatment 
are thus more plausible than those showing much lower current response / greater resistance 
shown in the urine control experiments (Chapter 2.4). 
3.5: Chapter conclusions. 
Over the course of this chapter, prototyping and troubleshooting of two individual SPCE 
designs were explored. The modification procedure employed for the GCE was not 
appropriate for use with the SPCEs, as it resulted in loss of electrochemical response and 
visible surface damage. Also discussed were the various alterations required in the 
modification procedure, including an increased reaction time in the different chlorination 
solvent of hexane, and the use of a commercial nail hardening resin for protection against 
water ingress during the hybridisation event. These alterations allowed a sensitivity curve to 
be produced for the first 2 mm SPCE design that showed a greatly reduced sensitivity over 
that of the GCE. 
Thus a new design was trialled using a 3 mm diameter working electrode, the same as that of 
the GCE and therefore the data could be compared directly. Use of this design increased 
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sensor sensitivity and produced an overall minimum response much closer to the GCE while 
still having a large degree of variability. 
Finally, the surfaces of these electrodes were analysed using LA-ICPMS and imaged using AFM 
in order to visualise how the surface of the ink changed during the different modification 
steps. These data showed that the hexane solvent led to improved electrode survival 
compared to the acetone/PCl5 mixture. The effectiveness was also seen of proteinase K 
treatment and spin filtration treatment of urine samples to remove undesired 
macromolecules, resulting in the electrochemical analyses shown in Chapter 2.4. 
The final chapter will discuss the work performed during a 3 month placement at Gwent 
Electronic Materials®, and how trialling different carbon and silver inks and dielectrics might 
allow us to overcome the solvent difficulties seen here. A new electrode design to allow the 
simultaneous analysis of a number of different microRNA targets in a urine sample using an 
electrode array will also be discussed. This will also be used to determine if differences in 
urinary miRNA biomarker concentrations can be detected between the healthy individuals 
and diabetic kidney disease patients. 
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Chapter 4: Multi-electrode array prototyping 
 
4.1: Introduction to screen printing methodology 
In Chapter 3 were discussed the various layers that make up the screen printed electrodes 
used throughout this project, along with a very generic schematic of the order these layers 
are printed. During this project a 3 month industrial placement at Gwent Electronic Materials 
(GEM) was undertaken to further develop the design of the electrodes and the materials 
which they are made from. A brief discussion of exactly how the electrodes are printed, along 
with some of the tools and techniques used for precise printing, is discussed in this section. 
In order to screen print electrodes one needs three key items, starting with the inks that they 
will be printing with. These can be made from a number of materials, most mentioned in the 
previous chapter, but are often carbon/graphite, gold, silver or platinum based for the 
working electrode,258 carbon or silver for the counter electrode and silver/silver chloride for 
the reference. A final dielectric (insulating) ink,259 in the case of GEM commonly polymer or 
silicone based, is also often used in order to define the surface area and reduce the variability 
of said area between each electrode,260 and provide a protective layer for the conductive 
traces from solvents.  
Secondly a screen is needed to supply the template for each layer of the electrode, these can 
be custom designed to fit a specific purpose. Those used at GEM have an aluminium frame 
for stability with the mesh material consisting of polyester or stainless steel, the latter of 
which being used when high tension (and thus greater registration accuracy in printing 
intricate/highly designs) and non-electrostatic printing is required.261  
Finally a method of performing the screen printing is required, although this can be done by 
hand for very simple testing of the ink materials, often a screen printing machine is used to 
ensure consistent prints for precise electrode sensors. Again there are many examples of 
screen printing machines, some designed for large substrates and mass production, others 
for low throughput, some with laser guided print alignment others aligned by eye. The 
machine used to print the electrodes in this project is a DEK 1202, a picture of this and the 
tools used are shown in Figure 4.1. 
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Figure 4.1 The DEK 1202 screen printing machine used to print the electrodes used in this chapter. Also shown are the 
important small parts used within the printer. 
In order to perform a screen print, firstly the chosen screen designed for the bottommost 
layer (usually the conductive tracks e.g. silver/silver chloride) is screwed into the aluminium 
holding frame and this is placed into the printer. The chosen substrate is then loaded onto 
the vacuum sample holder, which has been lined with porous paper, and fed into the printer 
to align the screen design with the edges of the substrate. Once aligned a set of plastic guides 
is glued into place around the substrate edges to ensure near perfect reproduction of the 
alignment between each batch. Next the flood blade is placed into the machine, then the 
squeegee is wetted with the ink, secured in place, and the ink is loaded onto the screen. 
Finally the feed and print speeds are set, the squeegee pressure is selected and printing 
commences.  
When a print is performed, first the arms of the machine push the flood blade forward causing 
the ink to be spread evenly over the screen, then the squeegee is lowered to push against the 
sample holder and screen and pulled back over the substrate. This pressure forces the ink 
through the design on the screen which has pores to allow the ink through, thus leaving a thin 
layer of the ink on the substrate in the design chosen. Finally the squeegee is lifted off the 
screen and the flooding procedure is repeated ready for the next print. This is repeated until 
the desired number of prints have been performed, stopping the last flood on the final print 
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in order to allow the screen to be removed and cleaned. The general schematic for this is 
shown in Scheme 4.1. 
 
Scheme 4.1 The mechanical procedure for screen printing an electrode. The system floods, the squeegee is then lowered 
and pushes the ink through the screen mesh. Finally this repeats until the desired number of prints are complete. 
This whole procedure is repeated for each subsequent screen and layer, with the fiducial on 
the print (small crosses shown in the designs in Figure 4.3) used to line up each layer with 
the next screen correctly. 
4.2: Aims for the design of the multi-electrode array and remaining prototyping. 
The aim while on placement was to trial a variety of different carbon, silver/silver chloride 
and dielectric inks, determining an optimal set that would be most likely to survive the 
acetone/PCl5 treatment that had been used in the GCE modification procedure. This would 
allow us to not only speed up the modification procedure, over that of the previous set of 
SPCEs, but would also allow us to better relate the SPCE data to that obtained using the GCE. 
Finally, once the ink materials had been optimised, a new electrode design was to be 
developed with multiple active surfaces which would allow for repeated analyses using one 
electrode, and making future adaptation into a multi-target array possible. The ability to 
perform repeated analysis on one sensor being important for future employment as a 
biosensor.  
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Unfortunately the exact chemical formulation of each ink is not able to be discussed due to 
its commercial protection. However the product number of each ink is given so that it can be 
found in the Gwent product range easily in future. 
4.3: Testing the carbon ink materials. 
The first material to be tested while at GEM was the carbon ink that forms the basis of the 
SPCE. We wanted to determine which of the inks available would be most likely to survive the 
acetone/PCl5 treatment and still give readily interpretable and reproducible electrochemical 
responses. To do this, two of their inks, designed to be more solvent resistant through a cross-
linking polymer binder, were selected and printed as simple stick electrodes. The product 
codes for these carbon inks are given in Table 4.1 and the stick design is shown in Figure 4.2 
Table 4. 1 The product codes of the two thermoset cross linked inks used for increased chemical stability. 
Carbon ink 
C2100126_D6 : Thermoset (cross-linked) carbon/graphite ink 
C2050517_P1 : Thermoset (cross-linked) carbon/graphite ink 
 
 
Figure 4.2 The basic carbon stick electrode design used for determining the chemical stability of the carbon inks alone. 
Using these carbon stick based electrodes it was possible to perform a simple stability test by 
submerging an electrode produced using each ink in a solution of PCl5 dissolved in acetone, in 
a similar fashion to that of the GCE. After submerging for 30 minutes, and then allowing to 
dry, the sticks were visually inspected for any signs of damage such as peeling or cracking, 
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however no such damage was seen for either ink. Thus this procedure was repeated again 
using a new set of carbon sticks made of the two inks, some having resin and insulation tape 
to protect and define the electrode active surface and others used as they appear in Figure 
4.2. They were then analysed electrochemically. 
As a final experiment both carbon inks were used to produce a set of complete SPCEs using 
the design shown in Figure 4.3, these were also exposed to the chlorination solution then 
tested electrochemically using an external reference and counter rather than those contained 
within the electrode. The resulting observations for these tests are summarised in Table 4.2 
with an example of a successful and unsuccessful electrochemical measurement, determined 
by the presence of clear oxidation and reduction peaks of the reversible ferri/ferrocyanide 
analyte system, also shown in Figure 4.3. 
Table 4.2 A summary table of all the carbon ink compatibility tests towards the chlorination procedure. Those that 
appeared reasonably undamaged, and displayed the expected electrochemical oxidation and reduction peaks, are 
highlighted. 
Carbon ink Electrode type Acetone or 
PCl5/Acetone 
Submerged or 
droplets 
Electrochemistry 
successful? 
C2100126_D6 STICKS PCl5/Acetone Submerged No 
C2100126_D6 STICKS PCl5/Acetone Submerged No 
C2100126_D6 STICKS PCl5/Acetone Submerged No 
C2100126_D6 STICKS PCl5/Acetone Submerged No 
C2100126_D6 STICKS PCl5/Acetone Submerged No 
C2100126_D6 STICKS PCl5/Acetone Submerged No 
C2100126_D6 STICKS PCl5/Acetone Submerged Yes 
C2050517_P1 STICKS PCl5/Acetone Submerged No 
C2050517_P1 STICKS PCl5/Acetone Submerged Yes 
C2050517_P1 STICKS Acetone Submerged Yes 
C2100126_D6 FULL ELECTRODE PCl5/Acetone Droplets No 
C2100126_D6 FULL ELECTRODE PCl5/Acetone Submerged No 
C2050517_P1 FULL ELECTRODE PCl5/Acetone Droplets Yes 
C2050517_P1 FULL ELECTRODE PCl5/Acetone Submerged Yes 
C2050517_P1 FULL ELECTRODE PCl5/Acetone Droplets Yes 
C2050517_P1 FULL ELECTRODE PCl5/Acetone Droplets Yes 
C2050517_P1 FULL ELECTRODE PCl5/Acetone Droplets Yes 
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Figure 4.3 The 6 mm SPCE design and an example of a successful (blue) and unsuccessful (orange) CV electrochemical 
response. A successful CV showing clear oxidation and reduction peaks occurring as a result of the 5 mM ferri/ferrocyanide 
redox activity. 
From these preliminary stability tests it was concluded that the carbon ink C2050517_P1 was 
the best ink to use for the future electrodes. This ink survived the greatest number of 
exposure tests, giving a readily interpretable electrochemical response following said 
exposure, and from experience was also easier to print with than the C2100126_D6 ink. 
However, when using the full electrode prints, another important observation was that both 
the dielectric coating and silver/silver chloride reference and connections were heavily 
damaged. For those electrodes that were submerged in the chlorination solution it was noted 
that the PCl5/acetone solution turned cloudy when hydrolysed with water, further indicating 
that some material was leaching from the electrode during the chlorination procedure (shown 
in Figure 4.4). Therefore it was deemed necessary to test a series of silver and dielectric inks 
in order to enhance their stability also. 
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Figure 4.4 Images showing the 6 mm electrode design and how the exposure to the acetone/PCl5 solution results in damage 
to the silver and dielectric inks. The resulting cloudiness observed in the solution after electrode submergence and hydrolysis 
is also shown. 
4.4: Optimising the silver/silver chloride and dielectric inks. 
To further enhance the stability of the screen printed electrodes the best silver/silver chloride 
and dielectric inks that could be used with the PCl5/acetone chlorination mixture were 
investigated. Therefore the first modification to be tested was the use of a different 
silver/silver chloride ink as the standard ink C2130809_D5 was shown to be damaged upon 
exposure to this mixture. Therefore, as the cross-linked carbon ink had shown the best 
stability previously, a cross-linked silver/silver chloride ink C2131016_D1 was selected as the 
most likely to also be stable under the chlorination conditions. 
To test the stability of this new silver material another set of electrodes with the 2 mm 
electrode design (Figure 3.1) were printed using this new silver/silver chloride ink as the 
reference electrode and conductive track. For the working electrode the optimised carbon 
ink was used and finally the standard grey dielectric (D2070423_P5) was printed as the final 
layer. These electrodes were then tested by being submerged in the PCl5/acetone solution for 
30 minutes, after which they were inspected visually for any signs of damage or peeling of the 
silver layer. This was also repeated by submerging the electrodes upside down, submerging 
the connector pins at the top of the electrode and thus exposing the silver layer directly to 
the mixture without the protection of the dielectric. After exposure and subsequent drying, 
all silver surfaces were inspected visually, scratched to test the adhesion and then tested 
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electrochemically to ensure an electrochemical read-out was still obtainable. The exposed 
electrodes and example cyclic voltammogram obtained are given in Figure 4.5. 
 
Figure 4.5 Images showing the stability of the carbon and silver inks, but the dielectric is still damaged. It was possible 
however to generate a CV from the leftmost electrode, displaying the characteristic oxidation and reduction peaks of the 5 
mM ferri/ferrocyanide couple, which is displayed on the right. 
The key observations at this stage were that the silver layer, despite some minor 
discolouration, remained intact and did not peel from the substrate as it did previously. 
However, as has been seen with all designs to this point, the grey dielectric layer is still 
showing signs of leaching as it shows major discolouration and smearing, indicating the 
damage that the chlorination mixture is causing to this dielectric layer. Despite some of the 
electrodes proving successful even with this damage to the dielectric, some of them were not, 
and those that were (as seen) also had some misshapen areas in their voltammograms. This 
poor reproducibility would not be ideal for use in biosensor technology. Therefore the 
dielectric layer also had to be optimised; not only to ensure the electrodes would survive the 
chlorination procedure every time, but also to ensure the visual appearance of the electrode 
is negligibly affected. This last point being important from a commercial aspect as visual 
defects would not pass quality control inspections and the sensor would be rejected. 
Thus to determine the best dielectric material to be used throughout the future SPCEs, a 
number of different dielectric inks were selected, these are summarised in Table 4.3. 
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Table 4.3 The product codes, colours and GEM product description of the different dielectrics tested for stability. 
Product code Colour GEM description 
D2140114_D5 Blue Maximum resistance to solvents and 
their ingression 
D50706_P3 Blue Highest resistance to polar solvents 
D2130510_D2 White Cross linked material with good 
flexibility and high chemical 
resistance 
D50706_D2 Cream High resistance to polar solvents 
 
Of these the first two determined to be the most likely to withstand the chlorination 
treatment were the white and cream dielectric inks. The white ink being cross-linked, much 
like the carbon and silver, and so potentially having the greatest resistance, and the cream 
coloured ink having high polar solvent resistance according to GEMs product description. 
Therefore in order to test these two dielectric pastes a square of each was screen printed 
onto a Valox substrate and dried in a box oven. Once printed and dried a 100 µL droplet of 
acetone was placed onto the centre and edge of these squares and left at room temperature 
for approximately 30 minutes or until the acetone had dried. As with the silver and carbon 
inks these were then inspected visually to determine any peeling or signs of dissolution. Figure 
4.6 shows the results of this visual experiment. 
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Figure 4.6 Images of the cream and white dielectric pastes, showing the cream leaching but remaining attached to the 
substrate, the white however peels and cracks. The cream leaching results in electrode coverage when printed as a full 
electrode. 
Unfortunately, as can be seen in the pictures above, both dielectric inks showed visual signs 
of damage when exposed to the acetone solvent. The white (cross-linked) dielectric material 
became very dry, losing its glossy feel, and began to crack and peel particularly around the 
corners and edges. This indicated that it was losing both its structural integrity and its 
adhesion to the Valox substrate. When printed with the electrode shapes and submerged in 
acetone this effect was seen to a greater extent, with the entire exposed area coming away 
from the substrate within minutes. The cream dielectric, on the other hand, appeared to 
maintain its adhesion and shape, however there was significant leaching of the paste at the 
areas exposed to the acetone. This could be observed more clearly when the ink was used to 
produce a complete electrode, as the entire carbon surface became coated in a cream ‘haze’. 
This indicated that the use of the cream dielectric would result in substantial interference 
downstream in the modification process. 
When trialling the blue dielectrics however, much better results were obtained. The first trial 
used blue dielectric D2140114_D5 in square prints as before, this time having single and 
double layer prints due to the thinness of the paste. Using acetone droplet exposure as the 
initial stability test showed that in both cases the dielectric only showed mild discolouration 
around the exposed area with the double layer print having less of this effect. For D50706_P3 
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the dielectric shape from the 6 mm electrode design was used, with 1 and 2 layers and droplet 
exposure to the acetone, in order to show any effects on the finer details of the electrode 
shape. Again, especially when the print had been dried at a higher temperature, this dielectric 
also showed only minor discolouration, with the detailed shape still being present. Therefore 
in order to ascertain exactly which dielectric to use we moved forward to printing a full 6 mm 
SPCE using both dielectric pastes and then exposed them to the acetone/PCl5 mixture by 
submersion and via 10 µL droplets over time. The visual results of these tests are shown in 
Figure 4.7. 
 
Figure 4.7 The visual inspections of each blue dielectric tested, D2140114_D5 printed as squares and D50706_P3 as the 
electrode outline. D2140114_D5 printed as 2 layers shows little to no damage on droplet chlorination, D50706_P3 however 
leaches. 
By printing full electrodes using these dielectrics it became much more apparent which would 
be the most ideal material for the optimised electrodes. When exposed to the acetone/PCl5 
mixture, both by submersion and by droplet pipetting, the blue dielectric D50706_P3 showed 
the same leaching effect as the cream dielectric, covering areas of the carbon surface in a 
constituent of the paste which could not be easily removed. With the D2140114_D5 dielectric 
however, the dielectric remained reasonably intact for both exposure methods, with the 
droplet method showing negligible visual damage and the immersed method showing only 
small areas of peeling.  
Finally this dielectric was then used to print a set of electrodes using the 2 mm design, (as 
seen in Figure 4.7) which were exposed to the acetone/PCl5 mixture once more. These were 
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then tested visually and electrochemically (Figure 4.8) with both giving the expected shape. 
Therefore this dielectric was chosen as the most optimised material with which to print our 
future electrodes. The stability of this dielectric is ensured when printed with 2 layers and 
dried at 130 °C for 30 minutes after printing. 
 
Figure 4.8 The 6 mm and 2 mm electrodes printed using blue dielectric D2140114_D5 and chlorinated via pipetted droplets. 
The expected oxidation and reduction peaks for the 5 mM ferri/ferrocyanide redox couple, and limited surface damage can 
be seen. 
4.5: New design for multiple miRNA detection. 
Once the ink materials had been optimised to survive the harsh chlorination conditions, it was 
then possible to start designing our own custom electrode. Crucially we wanted this design 
to allow analysis repeats on one sensor. Also due to the ability of miRNA to have multiple 
targets in multiple biological pathways, each miRNA species expression level is relatable to 
multiple diseases.262 Therefore any potential diagnostic biosensor would require the ability to 
detect multiple miRNAs simultaneously. Thus we wanted a design that would also allow for 
this adaptation in future projects, 
With the assistance of GEM we were able to design a set of screens that allowed us to print 
an electrode with 3 carbon working electrodes and a shared carbon counter and silver/silver 
chloride reference. The working electrodes all had diameters of 3 mm, thus having the same 
diameter and active working area to the glassy carbon electrode used throughout Chapter 2, 
making any data obtained with this new design easier to relate back to that obtained with the 
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commercially available GCE standard. Figure 4.9 shows how the electrodes appear when 
printed with the new design, including how each individual electrode appears when cut out 
to be used. 
 
Figure 4.9 The design for the new 3 working electrode surfaces with shared counter and reference. There are 9 electrodes 
per substrate each with 3 surfaces for a total of 27 surfaces per substrate. 
By having multiple active surfaces on these electrodes it is possible to use them in different 
ways. Firstly, it is possible to attach the same sequence of DNA, complementary to a single 
miRNA target, to each working electrode to produce a set of data in triplicate. As the same 
sample of miRNA is analysed by each surface, this allows for rapid determination of the 
reliability of the data, as the electrochemical response should be the same for each surface. 
If there are any large discrepancies between the surfaces, it is likely that an error has occurred 
in their use. However, in future projects it may also possible that by attaching a different DNA 
sequence to each electrode surface it would be possible to detect up to 3 different miRNAs 
in one sample. This would mean that it is possible to simultaneously determine up and down 
regulation in relation to a non-changing control species, giving the sensor greater applicability 
in a diagnostic sense.   
As this design is a custom design and not a stock item from GEM it was necessary to develop 
a new connector for attaching the electrode to the potentiostat. The connector itself consists 
of a shortened, single row, printed circuit board (PCB) connector which has had colour coded 
wires soldered to the pins to indicate whether they are the location of the working (red), 
reference (blue) or counter (black) surfaces. Each of these wires terminates in a socket pin 
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and insulating shell for attachment to a crocodile clip. The electrodes are then able to be 
simply slid into place, making contact with the correct pin placement of the PCB connector 
for the respective surface. A multiplexer attachment on the potentiostat then acts as a switch 
to cycle between each surface during the potentiometric and EIS measurements. The 
completed connector and schematic of the multiplexer is shown in Figure 4.10. 
 
Figure 4.10 The completed PCB connector with example electrodes attached. This then attaches to the MUX 8 multiplexer 
which acts as an automated switch to switch between each surface or apply a single voltage to all surfaces. 
4.6: Optimising the deposition procedure 
Now that we have developed a new set of electrodes, with a new design and optimised 
materials, it was necessary to edit and optimise the modification procedure to better fit the 
new design. The first step to be tested and optimised for shortened reaction time is the 
deposition step, which, as the electrodes are now too wide to fit in the same vials that were 
used for the last design, can now be performed in two different fashions. In the first technique 
the ANSA compound can be pipetted onto each of the electrode surfaces separately, keeping 
the drops separate between each surface. By using this method it is possible to monitor the 
deposition step across each surface individually as a visual colour change occurs in the 
solution. The deposition itself takes place using cyclic voltammetry cycles in the same way as 
the GCE and previous SPCEs. This first deposition step, and the visual change across each 
surface, is shown in Figure 4.11. 
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Figure 4.11 Images of the screen printed electrode surfaces as the deposition step occurs. Each surface becomes 
sequentially deeper in colour due to the deposition occurring. Also shown is an example after 4 cycles. 
When performing these depositions a couple of important observations were made. The first 
is that for this first set of electrodes there is a minor shoulder peak at around 0.11 V which 
may pose a problem in the analysis of miRNA later if it is mistaken for a peak resulting from 
the miRNA presence. The second is that the main peaks of these cycles occur at around 0.6 – 
0.65 V, and as these peaks reduce in magnitude as the number of cycles increase, it is at this 
potential that the electrodeposition is likely to take place. Also, as performing the full 8 cycles 
required in previous experiments would require approximately 27 minutes for each surface 
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(1 hour 21 for the full electrode), it was deemed important that this deposition time should 
be shortened.  
Therefore an attempt was made to maintain the potential at 0.65 V for a period of time to 
perform the electrodeposition, using a single CV cycle afterwards to determine whether the 
deposition appeared to have taken place. Accordingly, for the next optimisation trial, the 
electrodes were prepared in the same fashion as above, with the ANSA solution separated 
over each surface, and then the voltage was held at 0.65 V for between 1 and 5 minutes 
before performing one CV cycle using the same ANSA solution. The result of this is shown in 
figure 4.12. 
 
Figure 4.12 The deposition CV curves obtained when holding the electrode at 0.65 V for 60-300 seconds in 60 second 
intervals, and three repeats at 4 minutes when ANSA applied as droplets. 
Performing the deposition in this fashion results in a single cycle voltammogram that shows 
peak currents at similar amplitudes as found after performing the repeated cycles. This is 
particularly the case after 4 minutes where the amplitude of the peak is at a level similar to 
that after 5 minutes and lower than the other time points. Therefore the experiment was 
repeated, this time holding the potential at 0.65 V for 4 minutes each time (also shown in 
figure 4.12). Again this shows very low peak currents, indicating that the deposition is taking 
place successfully, but it also does this in a reasonably repeatable fashion despite some noise 
in the voltammogram appearing at the higher positive potentials. 
Finally, and for simplicity, the same procedure as above was repeated, this time however 
covering the electrode completely in the ANSA solution, with each surface sharing the one 
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solution rather than being separated. This was done to ensure that this would not have a 
detrimental effect on the deposition, as maintaining the separation across the electrode 
surfaces can be difficult due to the close proximity of the droplets when applied to them. 
Consequently if the ANSA solution can be applied across electrode surfaces at once the 
pipetting would be easier and therefore quicker to perform. The result of this test is shown in 
Figure 4.13. 
 
Figure 4.13 The CV curves obtained over 2 electrodes following deposition of ANSA at 0.65V for 4 minutes via total electrode 
coverage method. 
Happily, as can be seen by the reasonably similar peak currents obtained between the CV 
curves shown above (with the exception of surface 6), this method does not have a 
detrimental effect. In fact it appears that this method results in as good, if not better, 
repeatability as using individual droplets. The droplet method resulted in different peak 
currents and gave a substantial amount of noise, whereas this is not seen when the whole 
electrode is covered. 
4.7: Optimising the chlorination procedure 
During the placement at Gwent, the inks used to produce these electrodes were optimised 
for stability in the acetone/PCl5 chlorination mixture. However, up until this point they have 
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not been fully tested using this new design. Therefore as a final optimisation test the 
electrode was modified by electrodeposition of the ANSA compound, and was then either 
submerged in the chlorination mixture or exposed to the solution via pipetted droplets over 
time. Examples of CV outputs of each of these are shown in Figure 4.14, along with a picture 
of how the electrodes appeared after droplet chlorination. 
 
Figure 4.14 The visual and electrochemical inspections of the electrodes following the droplet and submerged chlorination 
procedure. For the submerged electrodes there is minor peeling of the dielectric and poor electrochemical response. Cyclic 
voltammograms performed using 5 mM ferri/ferrocyanide redox couple. 
As can be seen from these images, the droplet chlorination is a much more reliable method 
for ensuring electrode stability. The electrodes also appear visually unaffected by the 
solution, with no cracking, peeling or discolouration, which is very important for the 
commercial applications of the modification procedure using these electrodes. The electrodes 
not being visually changed after the modification procedure would allow higher percentage 
of them to pass visual quality control tests if they were to be commercialised. Submerging the 
electrode affected both the electrochemistry, but also the same peeling around the working 
electrode was seen and the substrate was prone to bending. Therefore from this point the 
chlorination was performed using droplet exposure over time. 
4.8: First sensitivity tests  
Once the multi-surface electrodes had been shown to survive the deposition and chlorination 
steps of the modification procedure it was then possible to perform some initial sensitivity 
tests. These tests were performed in a similar fashion as the previous SPCEs and the initial 
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glassy carbon electrode tests from Chapter 2. The electrodes were modified with DNA 
complementary to a miR-21 target and then used to analyse solutions containing different 
concentrations of miR-21 in buffer between 10 nM and 10 fM. This was done by pipetting 300 
µL droplets of the sample to cover all electrode surfaces, and then heating the sample in a 
hybridisation oven. The change in coulometry response (Q) between the DNA containing 
electrode and the DNA/RNA hybridised electrode is then plotted against the corresponding 
concentration. The data is displayed in Figure 4.15 (raw data appendix 3 Table A3.1). 
 
Figure 4.15 An attempt at a calibration plot for the change in coulometric response (Q) vs. log10 [miR-21] (M) using the 
multiple surface SPCEs. A different concentration of miR-21 was pipetted to each surface. Performed in duplicate using 5 
mM K3[Fe(CN)6]/K4[Fe(CN)6] in 0.1 M KCl electrolyte at room temperature. 
Unfortunately no significant change was observed throughout this concentration range, and 
all responses were at a magnitude similar to the highest observed during the GCE calibration 
test. With the GCE (Figure 2.5) and SPCE data (Figures 3.9 and 3.12), despite some variance, 
there was an overall positive correlation with higher concentrations of miR-21 resulting in a 
greater change in response, this was not the case with this data. Although this is a problem, 
the fact that the presence of the miRNA is resulting in a change in response led to the 
conclusion that the sensor is functioning correctly at the surface, the lack of any correlation 
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between miRNA concentration and the resulting change in coulometric response has 
therefore been attributed to miRNA over concentration during analysis.  
Previously the electrodes had been submerged completely in a 1 mL solution of the target 
miRNA in a micro-centrifuge tube and heated via a thermo mixer heat block, with these 
electrodes however, as their dimensions do not allow for placement in a micro-centrifuge 
tube the solution was simply pipetted onto the surfaces directly. Hence, as the solution is 
spread over a larger area and heated in a hybridisation oven, it had evaporated by the time it 
was removed from said oven. Therefore it was inferred that the reason no change is observed 
using different concentrations is because as the buffer is evaporated the miRNA is becoming 
more concentrated, to the point of maximum response.  
In order to combat this evaporation a new vessel which could be used to incubate the 
electrodes with the sample during hybridisation was needed. This vessel had to be inert to 
biological and chemical materials and have a large enough gap to hold the electrode while 
also keeping the exposed area of the solution to a minimum to reduce the rate of evaporation. 
Therefore a Teflon block was constructed which had these features and could be used with 
up to 6 electrodes at any one time. The schematic design of this block and the finished item 
are shown in Figure 4.16. 
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Figure 4.16 The schematic design of the Teflon block wells from the top and in cross section. Also included are photographs 
of the top of the Teflon block and the side view including how the electrodes fit inside. 
The electrodes were placed in the Teflon block slots along with the buffer and heated in the 
hybridisation oven to simulate incubation with a solution of miRNA. After which the slots were 
inspected and it was observed that very little of the buffer had evaporated over the time 
period, thus it appears that the use of this block is capable of preventing the over 
concentration of miRNAs as desired. Therefore the sensitivity testing measurements were 
repeated once more, this time using the Teflon block to contain the electrodes during 
hybridisation with the target miRNA. The results are displayed in Figure 4.17 (raw data 
Appendix 3 Table A3.2). 
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Figure 4.17 A calibration plot showing the change in coulometric response (Q) vs. log10 [miR-21], obtained by incubation 
with samples in Teflon block slots. Each point is collected in triplicate using the three surfaces on each sensor. Performed 
using 5 mM K3[Fe(CN)6]/K4[Fe(CN)6] in 0.1 M KCl electrolyte at room temperature. 
Clearly the Teflon block is having a positive effect on the miR-21 concentration vs. charge 
change relationship readout of the biosensor, as there is now a correlation between the 
logged miR-21 concentrations and the change in coulometric response between the DNA 
containing electrode and the hybridised electrode. However the gradient of this relationship 
is very shallow and the error is still problematic, thus making clear distinctions between each 
concentration is difficult. The average of the data points collected for the final concentration 
breaks this correlation and loses linearity as well and therefore could be unreliable at this low 
concentration. These data are very recent however and before it can be used as a quantitative 
calibration plot it should be repeated multiple times to determine the reliability, with further 
optimisation being performed if the results prove to be unrepeatable. However, for the 
purposes of this research we moved on to determining whether a distinct difference can be 
obtained between patient and control urine samples. 
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4.9: Comparison between healthy control urine and patient samples 
As a final investigation of these electrode prototypes a comparative analysis between both 
healthy control urine and patient derived urine samples was required. If the sensors are to be 
adapted for future use in a diagnostic point of care environment then it is important that a 
significant difference can be observed between a healthy individual and an individual with 
DKN.  
Thus in order to test the sensors, a set of three miRNA targets were chosen, two of which 
have been shown by the host laboratory to show a difference in expression between a control 
group and nephropathy patients via RT-qPCR experiments. MiRNAs 191 and 126 have been 
investigated in patient samples and seen to vary in expression levels between controls and 
patients, miR-192 however has not yet been investigated but was also suggested as a 
potential miRNA sequence of interest for us to investigate electrochemically. A set of sensors 
were therefore modified with antisense DNA complementary to each miRNA of interest, each 
electrode detecting a different target in triplicate. Two control and two patient urine samples 
were then treated with proteinase K and spin filtration prior to being analysed by these 
electrochemical sensors. The resulting change in coulometric response, between the DNA 
containing electrodes and their subsequent hybrids, obtained for each sample and for each 
miRNA target is shown in Figure 4.18 (raw data Appendix 3 Table A3.3). 
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Figure 4.18 The change in coulometric response (Q) obtained for each miRNA target using 2 patient urine samples (blue) 
and 2 healthy control urine samples (orange) for 3 miRNA targets. A lower response indicates a lower concentration. 
Controls miR-191 and patients miR-126 performed in duplicate all others in triplicate, using 5 mM K3[Fe(CN)6]/K4[Fe(CN)6] in 
0.1 M KCl electrolyte at room temperature. 
This data, although only performed on a small number of samples, shows that the sensors are 
indeed detecting a change between the healthy samples and the patient samples.  For miR-
192 patient sample P12026 is of a similar response as control samples C11005 and C11021, 
with a possible slight up regulation, however with P12016 giving much smaller a response 
than the other patient sample, indicating a significant down regulation from patient to 
control. This significant difference between the two patient measurements appears to 
indicate the likely presence of an outlier, which, if P12026 is the outlier and after more repeats 
becomes more like P12016 would indicate that miR-192 is downregulated in patients. More 
samples in the future would therefore be required to determine whether miR-192 is of a 
similar concentration in both controls and patients or if there is indeed a down regulation.  
For miR-191, both patient samples give a smaller response than control sample C11005, thus 
indicating a down regulation from controls to patients. However the control sample C11021 
response for miR-191 is much lower than for the other 2 miRNAs and the other control, 
 152 
 
therefore it is possible this is also an outlier. Therefore it is also difficult to draw an accurate 
conclusion for this miRNA target as well, and analysing more samples in the future would help 
with this.  
Finally however, the data for miR-126 does appear to show an electrochemical response 
significantly lower than both controls, indicating a potential down regulation from control to 
patient, although a larger sample size is needed to confirm this. All of these combined 
differences in response indicate the potential of the sensor analysing patient and control 
samples, and possibly, as differences can be seen between each sample and for each miRNA 
species, differentiating between them. Nevertheless there is a long way to go before the 
sensor can be optimised for diagnostic use, and many more samples would be required to 
make the data statistically relevant. This is discussed further in Chapter 5. 
4.10: AFM imaging of new carbon ink 
As the carbon ink has been changed for this new electrode design it was necessary to perform 
the AFM measurements to analyse the topographical features of the new ink during the 
different modification steps. These AFM images were therefore performed again on an 
unmodified electrode consisting of this carbon ink, an ANSA modified electrode, an electrode 
chlorinated via PCl5 in acetone and finally an electrode that has been used to analyse a urine 
sample. The first of these images, the unmodified electrode surface, is shown in Figure 4.19. 
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Figure 4.19 AFM image of the new carbon ink that is unmodified. The yellow boxes are the zoom areas and the round circles 
are areas of further interest. Also given is the surface length and height of one of the larger flat artefacts. 
These images show that the surface is indeed different to the original carbon surface. The 
areas that are flat are not as triangular in nature and are not layered, they are in general 
around 100 nm high with the surrounding sections being around 20 nm high. This could 
indicate that the cross linking of the carbon ink is forming a more monolayer like graphitic 
surface. The presence of a binding polymer could be responsible for the rounded artefacts.  
The carbon ink used in Chapter 3 is much more triangular and layered than seen here, as 
would be expected from a graphitic ink. This ink does have areas that show this triangular 
shape, as seen in the areas in the white circles, and when roughness analysis is performed at 
the same scale for the previous ink and this ink it can be seen that not only is this ink smoother 
with an average roughness of 0.31 µm vs. 0.34 µm but the average height of the surface 
artefacts is also smaller at 0.99 µm compared to 1.26 µm. Therefore this ink is displaying a 
thinner average coverage compared to the previous ink. This data is shown in Figure 4.20. 
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Figure 4.20 The surface roughness data and average height data obtained for the previous ink from Chapter 3 (left) and the 
new ink used herein (right). 
However the remaining AFM images may help to elucidate whether the surface behaves the 
same throughout the rest of the modification steps as the previous ink did. Therefore a 
second surface was imaged, this time being modified electrochemically with the ANSA 
compound. These images are shown in Figure 4.21. 
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Figure 4.21 The AFM images of the electrode following deposition of the ANSA with the width and height of some of the 
artefacts indicated 
 
Figure 4.22The AFM images of the electrode following chlorination in a PCl5/acetone solution including the surface profile of 
some of the artefacts indicated. 
. 
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These images show that the flattened areas seen in Figure 4.19 are no longer as prevalent, 
instead there are many more smooth rounded artefacts as shown in the white circles. These 
rounded artefacts were also seen in the images from Chapter 3, thus indicating that this 
carbon ink is behaving in much the same way at this stage. The surface itself however has a 
roughness of 0.4 µm and average height of 1.15 µm indicating the presence of a new 
deposited layer, this increase also occurred with the previous ink at this stage (Figure 3.14). 
It is also possible to see slightly more triangular shapes across this surface, although not as 
well defined as in the previous ink, and much smaller in size, these triangular shapes are 
indicative of the graphitic nature of this cross linked ink as well. From the topographical 
information it can be seen that the surface changes in height smoothly from around 50 nm to 
400 nm with each artefact being around 0.3 µm wide. This smooth change in height would 
indicate the deposition of the ANSA onto crevices of differing heights, the shape of the profile 
curve also indicates that the deposition is giving rounded artefacts. 
The ink in these electrodes has been selected in order to survive treatment with PCl5 in 
acetone, thus performing an AFM of the surface following this modification was also possible 
and is shown in Figure 4.22. 
Unlike the previous carbon ink, which was unable to generate an ideal image of the electrode 
following PCl5/acetone treatment, and where it did showing high levels of swelling, this cross-
linked ink was able to be successfully imaged and shows only very small areas of poor 
definition. As far as the appearance of the image goes, the surface shows less defined 
triangular shapes as before, in fact the majority of the surface consists of sharper rounded 
artefacts again with a width of approximately 0.3 µm, in this case the stepwise changes in 
surface height 300 nm to 50 nm are much sharper, the exact variance at the peak height also 
being sharper.  
The sharpness of these artefacts display a change from the smoothness of the ANSA modified 
surface, indicating that the chlorination procedure has resulted in a change of the surface as 
would be expected by the substitution of the sulfonic acid for a sulfonyl chloride functional 
group. The appearance of these sharp edged artefacts at this stage could also indicate the 
partial removal of the top carbon surface, revealing the detail of the graphitic plates below. 
However from the roughness analysis the roughness is given as 0.46 µm with an average 
height of 1.79 µm. Therefore at this stage the height average height of the surface is 
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increasing which would not be expected if a layer of the carbon ink was being removed, 
therefore the sharpness is likely due to the functional group change.  
However, it should be noted that when a hexane/PCl5 mixture was used with the previous ink 
(Figure 3.15) there was actually a slight reduction in average height and roughness over the 
deposited electrode. The previous ink, when treated with an acetone/PCl5 mixture, resulted 
in a vast reduction in both roughness and height, assumed to be due to surface damage 
and/or swelling, this is not seen here. 
Finally the electrode was modified with DNA complementary for miR-21 and used to analyse 
a urine sample, the result being shown in Figure 4.23. 
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Figure 4.23 The AFM image of the electrode following hybridisation in a urine sample and a surface profile showing the 
height and width of the artefacts. The possible triangular graphite layers are also shown and the previous chlorinated 
surface is given in the top images for comparison. 
These final images show that the rounded artefacts are still present but are once again 
smoother in nature, also they appear to be forming across small triangular shapes (shown by 
the green dotted lines). These artefacts are approximately 0.3 µm in width as before, and thus 
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bigger than the 80-90 nm seen at this stage in the previous ink. However the change in height 
from approximately 20 nm to 250 nm is again much smoother indicating a change in the 
surface from that of the sulfonyl chloride. In fact, when the roughness analysis is performed 
the average roughness is 0.29 µm, with an average height of 1.18 µm. This, along with the 
similar width of the artefacts as seen in previous stages indicate that although the surface has 
changed as a result of incubation in urine it is not likely due to adsorption of large lipid or 
protein molecules (see Figure 3.19 for increased artefact length over these same stages). 
Once again suggesting that the electrochemical response obtained is due to the presence of 
miRNA not interferent macromolecules. The general appearance is also close to the miR-21 
and urine analyses seen in Figures 3.18 and 3.20 respectively. 
4.11: Conclusion 
Throughout this chapter the optimisation of SPCE inks and subsequent design and 
prototyping of a new multi-surfaced SPCE has been discussed. This includes work performed 
at GEM as part of an industrial placement, testing carbon, silver/silver chloride and dielectric 
inks for stability in a solution of PCl5 in acetone and then using these inks to produce the 
electrodes using the new 3 surface design. Once the ideal inks had been found the 
electrochemical deposition step of the modification procedure was shortened to reduce the 
time required to produce each sensor, and then the electrodes were used to generate a 
calibration plot.  
The first of these showed that no relationship between concentration and electrochemical 
response was obtained, which was deemed to be a result of the buffered miRNA solution 
evaporating when heated, resulting in a new Teflon block being produced to prevent the 
reduction of buffer volume during heating. Using this new block a new coulometry based 
calibration plot was obtained showing that there is indeed a negative correlation between 
miR-21 concentration and the resulting electrochemical response. This calibration plot could 
be repeated in future work to ensure its reproducibility and reliability.  
The electrodes were then used to analyse two patient and two control samples for miRNAs 
192, 191 and 126 in order to determine if the probe could detect a difference between the 
expression levels of these miRNAs depending on the health of the donor. Of these, 192 and 
191 were inconclusive, however 126 showed a down regulated expression level in the patient 
sample compared to the control. Despite this, the small sample size used so far cannot be 
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used as validation of the sensor and the use of a larger cohort will help elucidate these 
relationships.  
Finally AFM images were scanned of the new ink when unmodified, modified with ANSA, 
chlorinated with PCl5 in acetone and after analysis of a urine sample. These images showed 
distinct differences compared to the previous ink used in Chapter 3, and although the 
deposition stage showed similar surface change behaviour, and that in this case the 
chlorination treatment resulted in a readily analysable surface, it was more difficult to 
determine any surface artefact changes as a result of the hybridisation procedure from the 
rest of the surface artefacts after urine analysis.  
Despite the simple DNA probe based hybridisation based detection method used by us being 
similar to that employed by Cardoso et al., the sensitivity observed throughout the screen 
printed electrode chapters 3 and 4, was far removed from the aM sensitivities observed by 
Cardoso for gold screen printed electrodes.185 However our method does make potential 
commercialisation and patenting easier to achieve due to the modification technique 
employed. We have also explored the quantification of miRNA targets from urine in order to 
discriminate between healthy and diseased samples. At this time, our technique therefore 
shows greater promise over Cardosos’ methodology as a potential commercial biosensor 
following further optimisation. Our method is also a modification procedure that does not 
require the addition of potentially expensive gold nanoparticles or caliper proteins as has 
been employed by Labib et al.184 
Therefore the work done in this chapter forms a basis to show the potential of the sample, 
and provides a key starting point for any future work performed in the project, the 
possibilities of which is described in Chapter 5. 
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Chapter 5: Epilogue 
 
5.1: Appraisal and discussion 
Throughout the last 4 chapters of this research we have described a method to modify a series 
of glassy carbon and screen printed carbon electrodes for use in microRNA detection. Starting 
with a research standard glassy carbon electrode we were able to chemically manipulate the 
surface to contain a DNA strand complementary to a miR-21 target, and thus detect synthetic 
miR-21 in a buffered solution to a concentration of 20 fM. This same method was then used 
to detect a miR-16 target as well as determining the specificity using mismatched miRNA 
sequences before finally being applied to the detection of miR-21 in a set of 5 urine samples. 
The calculated concentration of miR-21 in these urine samples showed a similar expression 
level between each sample as was indicated by RT-qPCR analysis, however the absolute 
concentration appeared higher for the electrochemical analysis than the PCR analysis. A set 
of controls were therefore performed to ensure the response obtained was due to the miR-
21 concentration of the urine and not due to interferents. This data was then published in 
Sensors and Actuators B: Chemical (Appendix 4). 
In the subsequent results Chapters, 3 and 4, the modification method was adapted for use in 
disposable screen printed carbon electrodes, indicating their future potential as diagnostic 
products. Initially the screen printed electrodes had a single active surface and were not 
chemically stable enough to survive the acetone/PCl5 treatment, thus the chlorination solvent 
was modified to use a hexane solvent and an external reference and counter was used in 
place of those on the electrodes themselves. This allowed for the production of calibration 
plots for a set of 2 mm and 3 mm electrode designs. In Chapter 4 a new set of inks were 
investigated for their solvent stability in order to find a combination which would allow the 
use of the starting PCl5/acetone solution, after which they were used to produce a set of 
electrodes containing 3 active surfaces potentially allowing the detection of multiple miRs in 
one sample. In this case the electrodes were used to individually analyse 2 patient and 2 
control samples for one of 3 chosen miRNA sequences by using each electrode to analyse one 
sample in triplicate. The data obtained through this analysis indicated a possible down 
regulation of miR-126 in the patient samples compared to the controls, with the other miRNA 
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species being so far inconclusive, however the small sample size means this has not been 
validated. Thus this chapter forms the basis of this appraisal and acts as a key foundation for 
the discussion of future work. 
Despite the data given throughout this investigation showing great promise, there are areas 
that have been problematic and may require further development and/or repeat experiments 
before the data can be subject to further publication, and the sensors applicable for 
diagnostic use. The first example of a potential problem area is seen in the screen printed 
data in Chapter 3, the calibration curves obtained in this chapter show much greater variance 
than those obtained for the glassy carbon electrode which, in turn, made it difficult to obtain 
reliable data and on a number of occasions these electrodes stopped functioning correctly or 
resulted in outliers. This was particularly true following the hybridisation procedure where 
the use of resin was difficult to reproduce each time as the resin was applied manually using 
an applicator brush. Also, for the 3 mm single electrode design, the dielectric did not entirely 
surround the working surface, therefore the absolute surface area available may vary from 
one printed set of electrodes to the next, this may account for some of the variability using 
this design.  These problems largely guided the direction of the research for Chapter 4. 
In Chapter 4 we described how the screen printing materials were investigated for better 
solvent resistance, and then these materials were used to produce electrodes which were 
then used to analyse different concentrations of miR-21 solution in buffer. Initially meaningful 
data proved difficult to obtain as the first results showed no relationship between the change 
in coulometric response with varying miR-21 concentrations, however when a Teflon block 
was used to minimise the evaporation of the buffer a new set of data did show a negative 
correlation. These results did show high variability however, and the gradient of the 
correlation was very shallow which made it difficult to distinguish between each 
concentration by its electrochemical response. This data is very preliminary however, 
therefore it is clear that this data will require an extra set of carefully controlled and analysed 
repeats to ensure its reliability, further optimisation will then be needed to remove variability 
and maximise the correlation before it can be used to accurately quantify urinary miRNA 
concentrations. With this in mind a set of urine analyses was also performed to determine if 
there is a change in the expression of miRs 192, 191 and/or 126 when a healthy control 
sample is compared to that of a DKN patient, using 2 samples of each type. From this data a 
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clear down regulation was observed for the patient samples compared to the healthy control 
samples, however for the analysis of 192 and 191 the data proved inconclusive as at least one 
of the results prevented the observation of a specific pattern. In order to get a better 
distinction between healthy samples and patient samples a larger sample size would be 
required and would be the first experiments performed if more time was available. In order 
to fully display the potential of the sensors as diagnostic tools more work would also be 
required on detecting multiple miRNAs on one electrode, each of the 3 working surfaces 
detecting a different sequence, which has not yet been investigated due to time constraints. 
5.2: Future work 
This project has a great deal of potential for future avenues of research to further enhance 
the applicability of the sensors towards use as a diagnostic tool. These avenues revolve 
around making the modification procedure more reliable i.e. no longer having some 
electrodes producing outliers or unreadable response, as well as making the sensor patent 
protectable, increasing the sensitivity of the sensors and better demonstrating their ability to 
distinguish between healthy controls and patients when used to analyse urine samples. 
Should the project be taken forward, the following suggestions may prove useful in the 
development of the sensors. 
The first, and possibly most important suggestion, is to perform more repeats of the 
calibration experiments to get more reliable data on the relationship between the 
electrochemical response and the miR-21 concentration. Once the repeatability of the 
previously obtained data has been established, it may be necessary to further manipulate and 
optimise the technique to ensure that the variability between each sensor is reduced and the 
data obtained becomes more reliable. Once this has been done obtaining a better calibration 
plot will be possible and we will be able to more accurately determine the absolute 
concentration of miRNA in the control and patient urine samples. For even greater accuracy, 
producing a calibration plot for each miRNA of interest may also be of use. After obtaining 
these curves it will then be important to increase the sample size of the patient and control 
samples to get a better indication of how the expression of the chosen miRNA species varies 
between healthy individuals and DKN patients. The future success of the sensor as a potential 
diagnostic tool would rely on a distinct expression level differences between the patient and 
controls being measurable in the urine through other, more biologically standard, analytical 
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means such as RT-qPCR. These differences would also have to be statistically different so that 
any error rate does not deter from the result and will not result in a false positive/negative 
result, the use of ROC (receiver operating characteristic) curve, which in short illustrates the 
true positive and false positive rates according to a chosen threshold, would help to ensure 
this. If there is we would need to determine if it can also be detected electrochemically. Once 
this difference has been confirmed, analysing a greater sample size will be of high importance. 
After demonstrating the potential of the sensor using a larger patient/control sample size it 
will then be important to improve the novelty of the modification procedure to make it more 
easily patent protectable. In the process of doing this, it may even be possible to further 
optimise the technique to be sensitive to a lower concentration and/or decreasing the 
number of steps required to produce the sensor, thus removing the problematic chlorination 
step and speeding up the modification. One possible way of doing this would be to substitute 
the ANSA compound for carboxylic acid based analogues such as those shown in Figure 5.1. 
 
Figure 5.1 Two potential carboxylic acid based analogues of the ANSA compound. 
Using a carboxylic acid based derivative may allow for the avoidance of the chlorination step 
as, despite the carboxylic acid simply being deprotonated and resulting in the formation of 
the ammonium salt, by heating the reaction to drive off water production (>100 °C) or using 
a water soluble coupling reagent such as EDC (1-ethyl-3-(3-
dimethylaminopropyl)carbodiimide) it may be possible to push the reaction forward without 
needing to produce the acyl chloride.263 If this does prove possible, using the dual carboxylic 
acid containing analogue could strengthen the bonding of the DNA to the sensor by producing  
a napthalimide derivative (via middle structure, a similar functional group transformation is 
performed by Ringk et al.),264 or alternatively could allow the attachment of 2 DNA strands 
per monomer (via right structure), which in turn could increase the sensitivity of the resulting 
sensor. 
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Another suggestion to increase the sensitivity of the sensor would be to use PNA or LNA based 
antisense strands in place of the DNA strands used previously. As discussed in Chapter 1, PNA 
and LNA have the ability to form more stable duplexes with RNA than DNA does, due to the 
decreased electrostatic repulsion of PNA and the restricted degrees of conformational 
freedom for LNA.126 Using either of these could result in much greater binding affinity with 
the target miRs which could result in both greater sensitivity and greater selectivity than 
previously obtained.  
As a final potential modification to the sensor, it may be worth looking into the development 
of a bifunctional probe, as in a sensor that works by giving both an electrochemical reading 
and also a second analysable readout such as a fluorescence signal. If it was feasible to 
develop a sensor which could give two different forms of analytical responses, which when 
used together would reinforce the conclusions made from them individually, it would almost 
certainly help to increase the potential of the biosensor being applied as a diagnostic tool. 
Such an approach has been shown to be possible for the detection of circulating tumour cells 
so may be possible for oligonucleotide based detection also.265 Utilising the carboxylic acid 
ANSA derivatives described previously will also add in their described advantages. One 
example of how a dual mode probe may work is given in Figure 5.2. 
 
Figure 5.2 A diagram of how a potential bifunctional probe could function. 
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Although not shown in the above diagram, careful design of the fluorophore could result in a 
fluorophore that is both fluorescent and can act as a redox reporter, thus reducing the 
number of chemicals required to perform the analyses. 
Furthermore, once the modification procedure itself has been adapted, it may be useful to 
test the technique on more biological matrices such as blood or synovial fluid. These 
additional analyses would validate the scope of the biosensor for detecting miRNA in multiple 
biological matrices, and potentially allowing the detection of miRNA sequences with 
expression levels related to more diseases than just DKN. Then, once the biosensor shows 
promise in multiple diagnoses, the use of automated fluidics to handle the urine treatments 
and electrochemical reagents could result in a potential product that reduces the exposure 
of the user to any chemicals or biological matrices and ensures that each reading is performed 
in a perfectly repeatable manner. This would further enhance the sensors potential for 
application in clinical based trials. 
These suggestions barely scratch the surface of the potential of this project, and we predict 
that many more ideas will present themselves if the project is carried forward.  
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Chapter 6: Materials and methods 
 
The experimental procedures used throughout this project is described in the following 
section. For simplicity the experimental procedures are ordered in order of where they 
appear throughout the previous chapters. The DNA probe strands used throughout were 
supplied by Sigma-Aldrich and the synthetic miRNA strands by IDT, the RT-qPCR materials 
were supplied by Qiagen®, and the PNA strands were synthesised and purchased from 
Eurogentec®. 
Electrochemical analysis 
Analyses for following the initial modification procedure steps and generating the sensitivity 
data for miR-21 were performed using a PARSTAT-2283 potentiostat and Powersuite® 
software. All other analyses were performed using a PalmSens3® potentiostat and PSTrace 
4.7. EIS circuit fitting analysis was performed using EIS spectrum analyser, (the program is 
available online at http://www.abc.chemistry.bsu.by/vi/analyser/ ©Aliaksandr Bandarenka 
and Genady Ragoisha) and fitted using a Randles circuit and a Levenberg–Marquardt (damped 
least squares) minimisation algorithm. 
Electrochemical measurements were performed using 5 mM K3[Fe(CN)6]/ 5 mM K4[Fe(CN)6] 
(Sigma-Aldrich®) in 0.1 M KCl (Fisher scientific®) and consisted of i) CVs run between 0.6 V 
and −0.3 V at a scan rate of 100 mVs−1, ii) chronocoulometry/coulometry performed at 0.3 V 
for 0.1 s, 0.0 V for 2 s and 0.5 V for 2 s and iii) EIS run at a DC potential of 0.23 V between 
frequencies of 0.01 Hz to 10 kHz with an AC amplitude of 5 mV. 
Oligonucleotide sequences used throughout 
Table 6.1 The sequences of all oligonucleotides used throughout this investigation. 
Species Name Species Sequence 
Anti-miR-21 (DNA) 5’NH2-C6-TCA ACA TCA GTC TGA TAA GCT A 
hsa-miR-21-5p (RNA) 5’-UAG CUU AUC AGA CUG AUG UUG A 
Anti-miR-16 (DNA) 5’NH2-C6-CGC CAA TAT TTA CGT GCT GCT A 
hsa-miR-16-5p (RNA) 5’-UAG CAG CAC GUA AAU AUU GGC G 
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miR-21 1 mismatch 5’-UAG CUU AUC GGA CUG AUG UUG A 
miR-21 2 mismatches 5’-UAG CUU AUC GGA CUG AUG UUG C 
miR-21 3 mismatches 5’-AAG CUU AUC GGA CUG AUG UUG C 
Anti-miR-192 (DNA) 5’NH2-C6-GGC TGT CAA TTC ATA GGT CAG, 
hsa-miR-192-5p 5’-CUG ACC UAU GAA UUG ACA GCC 
Anti-miR-191 (DNA) 5’-NH2-C6-CAG CTG CTT TTG GGA TTC CGT TG 
hsa-miR-191-5p 5’-CAA CGG AAU CCC AAA AGC AGC UG 
Anti-miR-126 (DNA) 5’-NH2-C6-CGC ATT ATT ACT CAC GGT ACG A 
hsa-miR-126-3p 5’-UCG UAC CGU GAG UAA UAA UGC G 
 
6.1 Experimental procedures used throughout Chapter 2. 
 
Figure 6.1 The generalised scheme of the electrode modification procedure as previously shown in Figure 2.3. 
6.1.1 Glassy carbon electrode polishing procedure. 
A 3 mm diameter glassy carbon electrode (BASInc®) was polished to a ‘mirror like’ finish via 
sequential applications of 3 µm and 1 µm diamond polish, and then with a final polish using 
0.05 µm alumina, all supplied as part of a polishing kit (Alvatek®). Following manual polishing 
the electrode was sonicated for 90 s each in acetone, ethanol and water. During optimisation 
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of this polishing the efficiency was tested using cyclic voltammetry as described under the 
heading ‘electrochemical analysis’ with the result shown in Chapter 2.2. 
6.1.2 Electrode modification procedure 
This experimental procedure was also used to produce the data shown in Chapter 2.2. 
A glassy carbon electrode was cleaned to a ‘mirror like’ finish using the polishing procedure 
described previously (6.1.1). The electrode was submerged in a solution of 1-amino-2-
naphthol-4-sulfonic acid (Acros organics®, 12 mL, 10 mM, 28.7 mg) dissolved in phosphate 
buffer solution (PBS, 25 mM, pH 7.0), along with a silver/silver chloride reference electrode 
and platinum wire counter. This 3 electrode cell was used to perform a series of CV scans 
between 1.5 V and -0.5 V at a rate of 20 mVs-1 to induce electrodeposition of the sulfonic acid. 
This was performed until there was negligible difference between each cycle which occurred 
after a total of 8 cycles. The electrode was rinsed with deionised water for 30 s to remove any 
physisorbed sulfonic acid residue and shaken to dryness. The first time this was performed 
the electrode was analysed via CV using 5 mM K3[Fe(CN)6]/ 5 mM K4[Fe(CN)6] in 0.1 M KCl and 
compared to the clean electrode voltammogram in order to ensure the deposition had 
occurred.  
The deposition modified electrode was submerged in a solution of PCl5 (Alfa Aesar®, 16.7 mg, 
40 mM) in acetone (2 mL) for 30 min, with CV analysis performed the first time. A droplet of 
chemically synthesised amine labelled DNA anti-miR-21 (10 µL, 1 µM), dissolved in TMD buffer 
(50 mM Tris-HCl, 20 mM MgCl2, pH 8.0) and denatured for 2 min at 80 °C (calculated Tm 74.7 
°C) was pipetted onto the surface of the electrode.  The electrode was heated to dryness 
under vacuum at 80 °C for 90 min. This electrode was rinsed for 30 s using the TMD buffer 
and analysed via CV, chronocoulometry and EIS using 5 mM K3[Fe(CN)6]/ 5 mM K4[Fe(CN)6] in 
0.1 M KCl to give the DNA only response. Finally the DNA modified electrode was submerged 
in a 1.5mL microcentrifuge tube containing a solution of synthetic miR-21 target also 
dissolved in TMD buffer (1 mL, 0.1 nM) for 60 min at 50 °C with shaking in an Eppendorf 
Thermomixer, to induce a hybridisation event. Finally the hybridised probe was rinsed with 
TMD buffer for 30 s and once again analysed via CV, chronocoulometry and EIS 
measurements. The charge at the peak minimum in the chronocoulometry results at this 
stage were then subtracted from the charge peak minimum of the DNA only response to 
determine the coulometry change as a result of the hybridisation event.  
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6.1.3 Hybridisation timescale optimisation 
The anti-miR-21 biosensor was generated as previously described (6.1.2) and then in order to 
determine the most optimum hybridisation time the hybridisation procedure was performed 
for 40 min, 30 min and 10 min over separate experiments. The resulting change in coulometry 
response between the DNA containing probe and the resulting hybrid probe at each time was 
compared to that obtained after 60 min hybridisation. This showed that 30 min hybridisation 
time was enough to produce a similar response to that at 60 min and was thus chosen as the 
optimum time. The data being given in the appendices (Appendix 1 Figure A1.2) 
6.1.4 Sensitivity determination 
An anti-miR-21 containing electrode was generated as previously described (6.1.2) and 
hybridised with synthetic miR-21 over a range of concentrations between 10 nM and 10 fM. 
The electrode was cleaned after each concentration measurement and the whole procedure 
repeated in triplicate. The change in coulometric response and EIS charge transfer resistance 
between the DNA containing probe and the hybridised probe was then plotted against the 
respective concentrations to generate the calibration plot shown in Chapter 2.3. 
The limit of detection quoted for the coulometric plot was determined using 3 × standard 
deviation of the coulometry response obtained when a solution of buffer alone was used as 
the hybridisation target, again performed in triplicate (Appendix 1 Table A1.3). 
6.1.5 Selectivity determination 
The anti-miR-21 DNA containing electrode was generated as previously described (6.1.2). This 
was then hybridised with miRNA strands with different sequences containing 1 mismatch, 2 
mismatches, 3 mismatches and a final miR-16 sequence (10 nM). This was performed in 
triplicate by cleaning and re-modifying the probe for each analysis, the changes in coulometric 
and EIS responses were then compared to those obtained for the complementary miR-21 
target to determine the selectivity of the probe towards the complementary sequence. Again 
this is described in Chapter 2.3. 
To perform the miR-16 tests the electrode was modified to the sulfonyl chloride modification 
step as previously mentioned. This time however a droplet of amine tagged anti-miR-16 DNA 
oligonucleotide (10 µL, 1µM) and used as before to analyse a miR-16 target, (1 mL) in TMD 
buffer 
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6.1.6 Synthetic urine analyses 
The following experimental procedures form the basis of the data displayed in Chapter 2.4. 
The glassy carbon electrode was modified to attach the anti-miR-21 DNA oligonucleotide 
probe strand as described previously (6.1.2), however the matrix for the miR-21 hybridisation 
event was modified to simulate the constituents of human urine. Thus to test the effect of 
salt two solutions of miR-21 was prepared in TMD buffer (1 mL, 0.1 nM) and NaCl was added 
to each (3 mg and 10 mg respectively) to simulate potential low and high concentrations of 
salt that could be expected for urine. The solution was then analysed as described previously, 
with each sample being performed in triplicate. The resulting change in coulometry and EIS 
responses were plotted against those obtained for the miR-21 results with no salt additions. 
To simulate the urea content of urine the electrode was modified to contain the anti-miR-21 
DNA strand as previously described. The electrode was submerged in miR-21 (1 mL, 10 pM) 
in TMD buffered urea (9.3 g/L) and heated to 50 °C with shaking for 90 min in a Thermomixer. 
The resulting change in coulometric response was plotted with that obtained for the miR-21 
target in TMD buffer for comparison. 
For the simulation of proteinaceous urine the anti-miR-21 modified electrode was prepared 
as before and the miRNA solution matrix modified using BSA (Sigma®). Thus a solution of miR-
21 (1 mL, 0.1 nM) was prepared in TMD buffer as before, then BSA (3 mg) was added and the 
DNA modified electrode submerged in this mixture at 50 °C for 30 min with shaking. EIS 
analysis was then performed and the resulting Nyquist data compared to that of the miR-21 
target in buffer alone to determine the effect of the protein content on the response. As 
mentioned this results in a much more impeded response than expected. Therefore the 
hybridised electrode was submerged in a solution of proteinase K (1 mg/mL) dissolved in TMD 
buffer and CaCl2 (1 mg/mL) for 30 min at 50 °C with shaking. EIS analysis was then performed 
once again and the response again compared to that expected for a miR-21 solution of the 
same concentration in TMD buffer alone. 
6.1.7 Urine analysis 
Table 6.2 The healthy control urine samples used in the testing stages of Chapter 2. 
Urine Sample Registry Identifier 
1 C11007_02 
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2 C11008_02 
3 C13001_03 
4 C13002_03 
5 C13024_03 
 
The experimental procedure described here relates to the data shown in Chapter 2.5. 
The DNA modified electrode was generated via the method mentioned previously (6.1.2) to 
contain complementary strands for a miR-21 target. The first analysis of the urine sample was 
then performed by submerging the DNA bound electrode in a solution of urine sample 1 (500 
µL) and heated to 50 °C for 30 min with shaking in a Thermomixer. The sensor was then rinsed 
with TMD buffer and chronocoulometric analysis was then performed and the resulting data 
plotted against that of the DNA strand alone. As this proved unsuccessful, the electrode was 
then submerged in a solution of proteinase K (ThermoFisher®, 1 mg/mL) and CaCl2 (BDH®, 1 
mg/mL) in TMD buffer at 37 °C for 20 min, after which the electrode was rinsed with TMD and 
the chronocoulometric analysis repeated. This was then compared to the urine response pre-
proteinase K treatment and showed that protein ‘fouling’ was taking place. 
The modified urinary analysis methodology is described herein. Before each analysis the 
glassy carbon electrode was cleaned and modified to contain the anti-miR-21 DNA strand 
using the method mentioned previously. The urine sample to be used (490 µL) was then 
pipetted into a 1.5 mL eppendorf tube and proteinase K (10 µL, 20 mg/mL) dissolved in water 
was added along with CaCl2 (1 mg). The resulting mixture was then incubated at 50 °C for 10 
min with shaking in a thermo mixer to digest any proteins present in the urine sample. 
Following this the sample was added to a 10 kDa spin filter and centrifuged at 14,000 rcf 
(12,300 rpm) for 20 min at 20 °C. The DNA modified electrode was incubated in the filtrate 
for 50 °C for 30 min with shaking. Finally the electrode was rinsed with TMD buffer and 
chronocoulometry analysis performed, with the change in response between the hybridised 
electrode and the DNA only electrode used to calculate the concentration of miR-21 in the 
urine sample. The electrode was cleaned after each sample measurement and the full 
procedure performed in triplicate. 
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6.1.8 RT-qPCR based calibration 
To generate a calibration plot of qPCR based CT value vs. miR-21 concentration a serial 
dilution of synthetic miR-21 in TMD buffer underwent RT and qPCR steps. As such, solutions 
of miR-21 in TMD buffer were made up in 10 fold serial dilutions between 10 nM and 10 fM. 
Then an RT master mix was produced containing standardised amounts of RT materials per 
sample required (1.5 µL 10x RT mix, 0.1 µL RNase inhibitor, 0.5 µL 25x DNTP mix, 3 µL 5× miR-
21 specific primer, 1 µL multiscribe and 4.25 µL water per sample). An aliquot of this master 
mix (10 µL) was then added to an aliquot (5 µL) of miR-21 at each concentration in an 
Eppendorf RT strip. The aliquots were then placed in an RT thermocycler to induce 
transcription of cDNA complementary to the miR-21 target. Following the RT procedure each 
aliquot was diluted with water (30 µL). A Taqman PCR master mix was according to the 
number of samples required (10 µL Taqman master mix, 1 µL miR-21 primer assay number 
000397, and 5 µL water per sample). An aliquot of the master mix (16 µL) was then mixed 
with an aliquot of the cDNA mixture (4 µL) in each well of a 96 well PCR plate. These were 
then amplified using a Taqman assay pre-programmed procedure (heating to 50 °C and held 
for 2 minutes before being heated to 95 °C and held for a further 10 minutes, then 40 cycles 
of 15 seconds at 95 °C and cooling to 60 °C for 1 minute before reheating to 95 °C for 15 
seconds etc. with all heating/cooling stages being performed at 1.6 °C/s) on a ViiA 7 real time 
PCR system from Life Technologies Applied Biosystems. The CT values at a threshold of 
0.15182 were then plotted against the corresponding concentration to generate the RT-qPCR 
calibration plot for quantifying the concentration of miR-21 from the corresponding analysis 
from urinary extracts. 
6.1.9 RT-qPCR urine analysis 
To analyse the urine samples an extraction procedure was performed to isolate the RNA prior 
to the RT and qPCR steps. For each sample an aliquot (350 µL) was pipetted into a 1.5 mL 
eppendorf tube following which carrier RNA (MS2 RNA, 1.25 µL, 1 µg) was also added. Next 
Qiazol lysis reagent (Qiagen®, 750 µL) and cel-miR-39 housekeeping miR (1 µL, 0.5 pM) was 
added and the solution incubated at room temperature for 5 min to break down any proteins, 
cells and extracellular vesicles. Following this chloroform (Sigma ®) was also added (200 µL) 
and the whole mixture was vortexed briefly to mix before being allowed to incubate for 2-3 
min and then centrifuged for 15 min at 12,000 rcf and at 4 °C. After centrifugation 2 clear 
layers had formed in the mixture, the aqueous (upper) phase (600 µL) was transferred to 
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another eppendorf tube and absolute ethanol added with mixing (900 µL). An aliquot of the 
resulting mixture (750 µL) was pipetted into a mini centrifuge column, as part of the miRNeasy 
kit from Qiagen, and centrifuged at 12,000 rcf for 30 s, after which the filtrate was discarded. 
The remaining ethanol/RNA mixture (750 µL) was then added to the column and spun again 
at 12,000 rcf for 30 s, again discarding the filtrate. The isolated sample in the column was then 
washed with RWT buffer, again from the miRNeasy kit, (700 µL) and centrifuged at 12,000 rcf 
for 60 s, discarding the flow through filtrate. A second buffer, RPE, (500 µL) was then added 
to the column and spun at 12,000 rcf for 2 min after which the filtrate was discarded. The 
column was then centrifuged for a further 1 minute at 12,000 rcf to dry before being placed 
in a new 1.5 mL collection tube at which point 50 µL of RNase free water was added and 
centrifuged at 8,000 rcf for 1 minute to release and collect the isolated RNA. This was then 
stored at -80 °C for further use. 
Once isolated the RT and qPCR procedure mentioned previously was performed using these 
miRNA isolates, in place of the buffered synthetic miRNA, in exactly the same fashion. 
6.1.10 PNA based negative control 
The anti-miR-21 DNA bound electrode was generated as mentioned previously (6.1.2). A 
solution of miR-21 complementary PNA (50 µL, 10 nM, final concentration 1 nM) was added 
to an aliquot of urine sample 1 (450 µL), that had been treated with proteinase K and spin 
filtered via the procedure described (6.1.7). The electrode was then incubated in this solution 
for 30 min at 50 °C with shaking, it was then rinsed with TMD and chronocoulometry analysis 
performed and compared to the result obtained for the electrode with DNA alone. Finally an 
aliquot of this mixture (450 µL) was mixed with a solution of synthetic miR-21 (50 µL, 1 nM, 
final concentration 0.1nM) in TMD and the electrode incubated in this solution once again for 
30 min at 50 °C. The electrode was then rinsed with TMD and analysed via coulometry. 
6.1.11 PNA based positive control 
A glassy carbon electrode was modified to contain a DNA probe strand complementary to 
miR-16 as described earlier (6.1.5). Following this an aliquot of urine sample 1 that has been 
treated with proteinase K and spin filtered using the method described previously (6.1.7, 450 
µL) was mixed with a solution of PNA complementary to miR-21 (50 µL, 10 nM, 1 nM final 
concentration) in TMD. The electrode was then submerged in this solution and incubated at 
50 °C for 30 min prior to being rinsed with TMD buffer and analysed via coulometry. 
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6.1.12 RNase controls 
Again the electrode was modified to contain anti-miR-16 as described previously (6.1.5), after 
which an aliquot of urine sample 1 (490 µL) was mixed with RNase A (Sigma-Aldrich®, 1mg) 
and incubated for 20 min at 50 °C. Following this the same sample was treated with 
proteinase K and spin filtered using the same methodology mentioned previously (6.1.7) and 
the DNA modified electrode was then submerged in the resulting solution for 30 min at 50 °C, 
it was then rinsed with TMD buffer and chronocoulometry analysis performed. Finally an 
aliquot of the treated urine sample (450 µL) was mixed with synthetic miR-16 (50 µL, 0.1 nM, 
10 pM final concentration) and once again incubated at 50 °C for 30 min. The hybridised 
electrode was then once again rinsed with TMD and analysed via coulometry.  
6.1.13 Shelf life of the sensor 
This experimental procedure relates to the data in Chapter 2. 6 (Appendix 1 Figure A1.3 and 
A1.4 and Table A1.2). 
To determine the length of time the DNA modified electrode can be stored for while 
maintaining an acceptable level of sensitivity, a set of 3 glassy carbon electrodes were 
modified to contain anti-miR-21 and then stored for 24 hours at different temperatures 
before being used. The first set of 3 electrodes were modified to contain the anti-miR-21 DNA 
as earlier described and then immediately incubated with miR-21 (1 mL, 0.1 nM) for 30 min 
at 50 °C, they were then rinsed with TMD buffer and analysed via coulometry, with the change 
in response between the electrode with DNA alone and the hybridised electrode being 
plotted. The electrodes were then cleaned and modified to contain the anti-miR-21 DNA as 
before and were then stored for 24 hours at 4 °C, 25 °C, 30 °C, 40 °C and 50 °C with each 
respective experiment. The rate of decay over these temperatures was then assumed as 1st 
order and used to plot an Arrhenius plot with the potential storage time decided as the point 
when the response reaches 50% of the response obtained for the immediately used 
electrodes. 
6.1.14 Biosensor regeneration procedure 
The experimental procedure described here is used to obtain the data in Appendix 1 Figure 
A1.1 showing that, although not routinely performed throughout this project, it is possible to 
denature the DNA-RNA hybrid on the electrode and reobtain an electrochemical response of 
the same magnitude of the DNA alone response. 
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To perform this the hybridised electrode was submerged in a solution of TMD buffer (1 mL) 
and heated to 95 °C for 20 min to denature the DNA/RNA hybrid. Following this the electrode 
was transferred to a second solution of ice cold TMD buffer (1 mL) and cooled on ice for a 
further 10 min before being sonicated for 2 min in the TMD buffer and rinsed. Performing 
coulometric analysis on the electrode at this point shows the DNA only response has been 
regenerated. The electrode was then incubated with miR-21 (1 mL, 0.1 nM) in TMD buffer at 
50 °C for 30 min to re-hybridise before being rinsed with TMD buffer and analysed via 
coulometry. This coulometric response is reliable after 2 regenerations but begins to decline 
with subsequent regenerations. 
6.2 Experimental procedures of Chapter 3 
 
6.2.1 Initial testing of the full modification procedure 
The experimental procedure described here relates to the data shown in Chapter 3.2. 
A 2 mm electrode, of the kind described in Figure 3.1, was rinsed with deionised water and 
then attached to the working electrode cable via its silver/silver chloride connection and a 
crocodile clip. This was submerged in a solution of 1-amino-2-naphthol-4-sulfonic acid (15 mL, 
10 mM, 35.9 mg) along with a silver/silver chloride reference and a platinum wire counter. 
Electrodeposition then takes place by using 8 cycles (the first procedure uses 16 with 8 being 
chosen as the ideal number) of CV between 1.5 V and -0.5 V at a rate of 20 mVs-1 until a 
negligible change in the voltammograms was obtained. At this point the electrode was 
submerged in a solution of PCl5 (16.7 mg, 40 mM) in acetone (2 mL) for 30 min. Unfortunately, 
despite multiple attempts, visual damage and peeling of the electrode was noticed, and 
subsequent CV analyses further showed the loss of any analysable signal. 
6.2.2 Solvent compatibility testing 
In order to find a suitable solvent for the chlorination step, the PCl5 reagent (16.7 mg, 40 mM) 
was dissolved in the desired solvent (2 mL) and a screen printed electrode was then 
submerged in the mixture for 30 min. After this time, any solvents that had visually damaged 
the electrodes were not considered further, and any which failed to dissolve PCl5 were also 
removed. This left hexane as the most suitable solvent that was used in the future. 
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6.2.3 IR analysis 
After the deposition of the sulfonic acid had been completed, the active working surface of 
the electrode was compressed onto the sampling crystal of an ATR-FTIR and IR analysis 
performed. The resulting spectrum was compared to one obtained analysing an electrode 
surface that has not been modified, and one obtained using the sulfonic acid alone. 
As well as this, a selection of sulfonic acid modified electrodes were submerged in a solution 
of PCl5 (16.7 mg, 40 mM) in hexane (2 mL) for 18 hours, 4 hours, 2 hours and 1 hour. After 
which the surfaces were again analysed by IR spectroscopy and compared to one chlorinated 
using acetone as the solvent. This was done in order to try and determine the reaction time 
required for the hexane/PCl5 solution, however, as all spectra appeared very similar, 4 hours 
was chosen as the reaction time due to a combination visual, electrochemical, spectroscopic 
and (as described later) spectrometric analysis. 
6.2.4 Modification procedure using hexane solvent 
A 2 mm screen printed electrode was modified with 1-amino-2-naphthol-4-sulfonic acid as 
previously described (6.2.1), after which it was submerged in a solution of PCl5 (16.7 mg, 40 
mM) in hexane (2 mL) for 4 hours. After this the electrode was rinsed quickly with water (for 
this initial stability test only) and analysed via CV, with the resulting voltammogram compared 
to that obtained after chlorination of the glassy carbon electrode, in order to determine 
whether it had successfully survived the procedure.  
A second 2 mm screen printed electrode was then modified to the sulfonyl chloride stage, as 
described above, at which point a synthetic DNA oligonucleotide anti-miR-21 (10 µL, 1 µM) 
dissolved in TMD buffer was pipetted onto the electrode surface and the electrode allowed 
to dry overnight at room temperature. The electrode was then analysed via CV, coulometry 
and EIS measurements. Finally the electrode was submerged in a solution of synthetic miR-
21 (1 mL, 10 nM) dissolved in TMD buffer and incubated in a 1.5 mL eppendorf tube with 
shaking at 50 °C for 60 min in a Thermomixer. Unfortunately at this point the dielectric layer 
showed visual signs of water ingression and peeling, and the silver/silver connector showed 
discolouration, analysis via CV showed the extent of this damage which prevented useable 
analysis due to misshapen peaks. 
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6.2.5 Final modification procedure using hexane and applied nail hardening resin 
In order to combat the water ingression and potential damage of the silver connector a 
commercially available nail hardening resin from a local beauty store and insulation tape were 
employed to protect the electrode.  
A 2 mm screen printed electrode was modified to contain anti-miR-21 on its surface as 
described previously (6.2.4) and analysed via CV, coulometry and EIS. After this the electrode 
was rinsed with water and shaken to dryness, following which the nail hardening resin was 
cautiously applied to the area surrounding the active surface of the electrode. The electrode 
was then left to dry for 3 min before insulation tape was wrapped around the silver/silver 
chloride connector pin and the electrode was submerged in a solution of synthetic miR-21 (1 
mL, 10 nM) and incubated with shaking for 60 min at 50 °C in a Thermomixer. The hybridised 
electrode was then analysed via CV, coulometry and EIS measurements, the results of which 
were consistent with the electrode now surviving the miRNA incubation. 
6.2.6 Sensitivity determination of screen printed electrodes 
A set of 2 mm diameter and 3 mm diameter screen printed carbon electrodes were modified 
using the hexane, resin and tape edited modification procedure described previously (6.2.5). 
They were then incubated with serial dilutions of miR-21 solutions from 10 nM to 1 pM for 
the 2 mm electrodes and from 10 nM to 10 fM for the 3 mm electrodes with each 
hybridisation being performed in triplicate using 3 individual screen printed electrodes. The 
change in coulometry between the DNA containing electrodes and the hybridised electrodes 
was then plotted against the respective concentration. Thus generating a calibration curve 
for the 2 mm electrode (Chapter 3.2) and the 3 mm electrode (Chapter 3.3). 
6.2.7 AFM based surface imaging 
AFM imaging of the working electrode surface was performed by Matteo Lo Cicero of Cardiff 
University School of Chemistry, using tapping mode (TM-AFM) in air at 293 K using a 
Nanoscope V instrument (Veeco, USA) type multimode 8. PPP-NCHR PointProbe Plus® silicon-
SPM-sensor probes were used (NanosensorsTM, resonance frequency 33 kHz, force constant 
42 N/m, length 125 µm) operating at a frequency of 321.5 kHz to image the surfaces through 
Scan Asyst®-air mode. The data produced was processed and analysed by the author with 
WSxM software. 
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6.3 Experimental procedures of Chapter 4 
 
6.3.1 Testing the carbon ink 
The experimental procedure described here was used to collect the data in Chapter 4.3. 
To test the two selected inks (C2050517_P1, a cross linked and thixotropic carbon/graphite 
ink with a printed thickness of 12 µm, and C2100126_D6, a cross linked carbon/graphite ink 
of 25-36 µm printed thickness), a set of carbon sticks of each was produced using a DEK 2230 
screen printer, a nylon mesh and a Valox substrate, a description of how the printer works is 
given in Chapter 4.1. These were then submerged in PCl5 (16.7 mg, 40 mM) in acetone (2 mL) 
for 30 min and observed visually. This however only showed that no visible signs of damage 
were present.  
Then to determine whether the electrode could be electrochemically analysed following the 
acetone/PCl5 treatment a selection of the sticks and full screen printed electrodes were 
produced using both inks, and incubated in the solution of PCl5 (16.7 mg, 40 mM) in acetone 
(2 mL) for 30 min, some being protected with the nail resin and insulation tape and some not. 
Each electrode was then analysed using CV, coulometry and EIS in order to determine if the 
expected peak shapes were obtained. Of these the carbon ink C2050517_P1 showed the best 
stability. 
6.3.2 Testing the silver/silver chloride ink 
This experimental procedure was used to obtain the data in Chapter 4.4. 
Once the most ideal carbon had been determined the silver/silver chloride also needed to be 
tested. To do this a fully layered screen printed electrode was produced using the 
C2050517_P1 carbon ink as the working and counter electrodes, the silver/silver chloride 
reference and conductive tracks using 60:40 silver/silver chloride ink C2130809_D5 (20 µm 
printed thickness) and the grey coloured dielectric layer D2070423_P5. This electrode was 
then exposed to a solution of PCl5 (16.7 mg, 40 mM) in acetone (2 mL) either by complete 
submersion or via pipetting droplets (100 µL initially and another set using 10 µL every 60 s) 
onto it, focussing on the working electrode surface. Unfortunately the submersion technique 
showed complete peeling of the silver ink and minor leaching of the dielectric layer. 
Therefore another silver ink needed to be tested this time being the silver ink C2131016_D1 
(silver/silver chloride 70:30, cross linked ink). Then to test the stability of this silver the 
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electrode was submerged in a solution of PCl5 (16.7 mg, 40 mM) in acetone (2 mL) for 30 min 
and inspected visually. This showed that the silver no longer peeled from the substrate and 
subsequent CV, coulometry and EIS measurements showed the expected peak behaviour. 
6.3.3 Testing the dielectric inks. 
To test the stability of the available dielectric inks, a set of squares was printed with each of 
the dielectrics chosen (blue D2140114_D5, a water ingression resistant polymer dielectric, 
blue D50706_P3, a polymer dielectric with high resistance to polar solvents, white 
D2130510_D2, a cross-linked dielectric with high solvent resistance, and cream D50706_D2, 
a dielectric with high solvent resistance) and then a drop (100 µL) of acetone was placed onto 
the centre of the dielectric. The dielectrics which showed the least damage (blue) were then 
printed again as squares containing 2 layers of the dielectric. The exposure to the 
PCl5/acetone solution was then repeated showing that the dual layers enhanced the stability. 
Finally the two blue dielectrics were used in combination with the previously optimised 
carbon and silver/silver chloride inks to produce a set of full screen printed electrodes. One 
set was then submerged in the acetone/PCl5 solution for 30 min, and another had a droplet 
(10 µL) of the same solution added at a rate of 10 µL/min over 30 min, before being inspected 
visually and via CV, coulometry and EIS measurements. Dielectric D21140114_D5 gave a 
greater proportion of visibly undamaged electrodes via the droplet method. 
6.3.4 Optimising the deposition of sulfonic acid 
The experimental procedure described here relates to the data in Chapter 4.6. 
A set of electrodes consisting of 3 working electrode surfaces, one shared counter and one 
shared reference, printed using carbon ink C2050517_P1, silver/silver chloride ink 
C2131016_D1 and 2 layers of blue dielectric D2140114_D5 were sonicated in ethanol for 20 
s before being rinsed with water to remove any interferents. After this, the deposition of the 
1-amino-2-naphthol-4-sulfonic acid was performed using 3 individual procedures. 
In the first procedure, aliquots (50 µL) of the 1-amino-2-naphthol-4-sulfonic acid (14.4 mg, 6 
mL, 10 mM) dissolved in PBS were placed onto each of the working area surfaces and 4 CV 
cycles were performed between -0.5 V and 1.5 V at a scan rate of 20 mVs-1 to induce 
electrodeposition.  
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In the second procedure an aliquot (300 µL) of the 1-amino-2-naphthol-4-sulfonic acid (14.4 
mg, 6 mL, 10 mM) dissolved in PBS was pipetted over the three surfaces of the electrode. At 
which point the voltage was maintained at 0.65 V for 1 minute and then a standard CV was 
performed for 1 cycle between -0.5 V and 1.5 V at a scan rate of 20 mVs-1. This procedure was 
then repeated a number of times, each time increasing the number of min that the 0.65 V 
potential was maintained, over 2, 3, 4, 5 and 6 min. 4 minutes was then chosen as the ideal 
reaction time. 
In the third technique all 3 surfaces shared a full coverage of the 1-amino-2-naphthol-4-
sulfonic acid (14.4 mg, 6 mL, 10 mM) dissolved in PBS, via pipetting one large drop (300 µL) 
of the solution across all 3 of the electrode surfaces. After which point the surface is held at 
a voltage of 0.65 V for 4 min after which a CV cycle was performed between -0.5 V and 1.5 V 
at a scan rate of 20 mVs-1 to ensure the deposition had occurred. 
This third technique proved to give the most repeatable results. 
6.3.5 Optimising the chlorination 
This procedure is in reference to the data in Chapter 4.6. 
The final optimisation step revolved around the chlorination procedure. Thus to test this 2 
electrodes were produced using the 4 minute maintenance of 0.65 V procedure described 
above (6.3.4 technique 3). After this one of the electrodes was submerged in PCl5 (16.7 mg, 
40 mM) in acetone (2 mL) for 30 min and the other had the same concentration of 
PCl5/acetone mixture pipetted at a rate of 10 µL/min on each of the three active surfaces for 
a total of 30 min. Finally the electrode was rinsed with water and shaken to dryness before 
being analysed via CV, coulometry and EIS. Both visually and using the electrochemical 
measurements it could be seen that the droplet method resulted in the surfaces producing 
the desired peaks much more reliably than the submergence method. 
6.3.6 miR-21 sensitivity testing 
The experimental procedures described here relate to the results shown in Chapter 4.7. 
For initial sensitivity testing of the biosensor a set of electrodes were modified to the 
naphthalene sulfonyl chloride step as described in 6.3.5, at which point a droplet of anti-miR-
21 DNA (10 µL, 1 µM) was pipetted onto the each of the three working surfaces and allowed 
to dry at 80 °C for 90 mins in a fan hybridising oven. The electrode was then rinsed with TMD 
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buffer and analysed by CV, coulometry and EIS. After this a sample of miR-21 (300 µL, 10 nM) 
dissolved in TMD buffer was pipetted onto the electrode, covering all working surfaces and 
allowed to hybridise in a hybridising oven for 30 mins at 50 °C. This final step was repeated 
using one of a series of serial dilutions of miR-21 (10 nM to 100 fM) on each separate 
electrode. After hybridisation, each electrode was rinsed with TMD buffer and analysed via 
CV, coulometry and EIS. The resulting change in coulometry between the DNA only electrode 
and the hybridised electrode was then plotted for each concentration. Unfortunately this did 
not show any correlation. 
Therefore, for a second set of analyses, the Teflon well block described in Chapter 4.7 was 
used as the incubation vessel. The electrodes were produced to contain anti-miR-21 and 
analysed electrochemically as described in the procedure above, at which point the serial 
dilutions were once again prepared in TMD using a slightly larger volume (500 µL, 10 nM to 
100 fM) and each concentration pipetted into an individual well in the Teflon. An anti-miR-21 
containing electrode was then inserted into each well and allowed to incubate for 30 mins at 
50 °C in a hybridising oven. Each electrode was then rinsed with TMD buffer and analysed via 
CV, coulometry and EIS, with the change in coulometric response between the DNA 
containing electrode and the hybridised electrode being plotted for each concentration. This 
time the data showed a correlation shown in Figure 4.17. 
6.3.7 Optimised modification procedure for urine analysis 
Table 6.3 The healthy and DKD patient urine samples used for the testing in Chapter 4. 
Registry identifier Patient/Control 
C11005 Control 
C11021 Control 
P12016 Patient 
P12026 Patient 
 
A screen printed electrode containing 3 working surfaces and 1 shared counter and reference 
was sonicated in ethanol for 20 s and rinsed with water to clean of any interferents. An aliquot 
(300 µL) of the 1-amino-2-naphthol-4-sulfonic acid (14.4 mg, 6 mL, 10 mM) dissolved in PBS 
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was then pipetted over the surfaces of the electrode and a potential of 0.65 V applied for 4 
min to induce electrodeposition, a 1 cycle CV is then performed between -0.5 V and 1.5 V at 
a scan rate of 20 mVs-1. This was repeated for each working surface. The electrode was then 
rinsed with water and shaken to dryness, after which a solution of PCl5 (16.7 mg, 40 mM) 
dissolved in acetone (2 mL) was pipetted over each surface at a rate of 10 µL/min for 30 min. 
The electrode was then very briefly rinsed with acetone to remove the remaining 
PCl5/acetone mixture and shaken to dryness. A synthetic DNA oligonucleotide anti-192 (10 
µL, 1 µM), complementary to hsa-miR-192-5p  was then pipetted onto each electrode surface 
and dried for 80 °C for 90 min in a fan hybridising oven. After this the electrode was rinsed 
with TMD buffer and analysed via CV, EIS and coulometry. During this time the urine sample 
was treated with proteinase K and spin filtered using the same procedure mentioned 
previously (6.1.7). The electrode was then placed in a custom produced slot on a Teflon well 
block, and the well was filled with the treated urine sample. The block was then put in the fan 
hybridiser oven at 50 °C for 30 min. Finally the electrode was removed from the Teflon and 
rinsed with TMD before being analysed via CV coulometry and EIS. The resulting change in 
coulometric response was compared between each urine sample, with particular emphasis 
on the difference between patient and control samples. 
The above procedure was then repeated using anti-miR-191 and anti-miR-126 DNA to detect 
miRs hsa-miR-191-5p and hsa-miR-126-3p respectively. 
6.3.8 AFM imaging of new inks 
The working surface of these new electrodes were once again imaged by Matteo Lo Cicero 
when unmodified, modified with the sulfonic acid (ANSA), following chlorination in PCl5 in 
acetone and after incubation in the pre-treated urine. The analysis was performed as 
described in 6.2.7. 
 
 
 187 
 
References 
1 R. C. Lee, R. L. Feinbaum and V. Ambros, Cell, 1993, 75, 843–854. 
2 B. Wightman, I. Ha and G. Ruvkun, Cell, 1993, 75, 855–862. 
3 A. E. Pasquinelli, B. J. Reinhart, F. Slack, M. Q. Martindale, M. I. Kuroda, B. Maller, D. C. 
Hayward, E. E. Ball, B. Degnan, P. Müller, J. Spring, A. Srinivasan, M. Fishman, J. Finnerty, 
J. Corbo, M. Levine, P. Leahy, E. Davidson and G. Ruvkun, Nature, 2000, 408, 86–89. 
4 B. J. Reinhart, F. J. Slack, M. Basson, A. E. Pasquinelli, J. C. Bettinger, A. E. Rougvie, H. R. 
Horvitz and G. Ruvkun, Nature, 2000, 403, 901–906. 
5 S. Roush and F. J. Slack, Trends Cell Biol., 2008, 18, 505–516. 
6 B. Boyerinas, S.-M. Park, A. Hau, A. E. Murmann and M. E. Peter, Endocr. Relat. Cancer, 
2010, 17, F19-36. 
7 H. Dong, J. Lei, L. Ding, Y. Wen, H. Ju and X. Zhang, Chem. Rev., 2013, 113, 6207–6233. 
8 S. Griffiths-Jones, H. K. Saini, S. van Dongen and A. J. Enright, Nucleic Acids Res., 2008, 36, 
D154-158. 
9 miRBase, http://mirbase.org/, (accessed 9 September 2016). 
10 Y. Lee, M. Kim, J. Han, K.-H. Yeom, S. Lee, S. H. Baek and V. N. Kim, EMBO J., 2004, 23, 
4051–4060. 
11 K. Simpson, A. Wonnacott, D. J. Fraser and T. Bowen, Curr. Diab. Rep., 2016, 16, 35. 
12 J. Han, Y. Lee, K.-H. Yeom, J.-W. Nam, I. Heo, J.-K. Rhee, S. Y. Sohn, Y. Cho, B.-T. Zhang and 
V. N. Kim, Cell, 2006, 125, 887–901. 
13 R. I. Gregory, K.-P. Yan, G. Amuthan, T. Chendrimada, B. Doratotaj, N. Cooch and R. 
Shiekhattar, Nature, 2004, 432, 235–240. 
14 E. Lund, S. Güttinger, A. Calado, J. E. Dahlberg and U. Kutay, Science, 2004, 303, 95–98. 
15 J. Liu, M. A. Valencia-Sanchez, G. J. Hannon and R. Parker, Nat. Cell Biol., 2005, 7, 719–
723. 
16 D. S. Schwarz, Y. Tomari and P. D. Zamore, Curr. Biol. CB, 2004, 14, 787–791. 
17 G. L. Sen and H. M. Blau, Nat. Cell Biol., 2005, 7, 633–636. 
18 S. Yekta, I.-H. Shih and D. P. Bartel, Science, 2004, 304, 594–596. 
19 J. Brennecke, D. R. Hipfner, A. Stark, R. B. Russell and S. M. Cohen, Cell, 2003, 113, 25–36. 
20 C. Fernández-Hernando, Y. Suárez, K. J. Rayner and K. J. Moore, Curr. Opin. Lipidol., 2011, 
22, 86–92. 
21 L. Song and R. S. Tuan, Birth Defects Res. Part C Embryo Today Rev., 2006, 78, 140–149. 
22 R. A. Shivdasani, Blood, 2006, 108, 3646–3653. 
23 A. Siwaszek, M. Ukleja and A. Dziembowski, RNA Biol., 2014, 11, 1122–1136. 
24 F. M. Hamid and E. V. Makeyev, Bioessays, 2016, 38, 830–838. 
25 L. Shi, J. Chen, J. Yang, T. Pan, S. Zhang and Z. Wang, Brain Res., 2010, 1352, 255–264. 
26 Y. J. Kim, S. J. Hwang, Y. C. Bae and J. S. Jung, Stem Cells, 2009, 27, 3093–3102. 
27 L. E. B. Buscaglia and Y. Li, Chin. J. Cancer, 2011, 30, 371–380. 
28 D. Hanahan and R. A. Weinberg, Cell, 2011, 144, 646–674. 
29 M. E. Hatley, D. M. Patrick, M. R. Garcia, J. A. Richardson, R. Bassel-Duby, E. van Rooij and 
E. N. Olson, Cancer Cell, 2010, 18, 282–293. 
30 D. Frezzetti, M. De Menna, P. Zoppoli, C. Guerra, A. Ferraro, A. M. Bello, P. De Luca, C. 
Calabrese, A. Fusco, M. Ceccarelli, M. Zollo, M. Barbacid, R. Di Lauro and G. De Vita, 
Oncogene, 2011, 30, 275–286. 
31 M. A. Rivas, L. Venturutti, Y.-W. Huang, R. Schillaci, T. H.-M. Huang and P. V. Elizalde, 
Breast Cancer Res. BCR, 2012, 14, R77. 
32 R. I. Aqeilan, G. A. Calin and C. M. Croce, Cell Death Differ., 2010, 17, 215–220. 
 188 
 
33 Z. Hua, Q. Lv, W. Ye, C.-K. A. Wong, G. Cai, D. Gu, Y. Ji, C. Zhao, J. Wang, B. B. Yang and Y. 
Zhang, PLoS ONE, 2006, 1, e116. 
34 A. Chamorro-Jorganes, E. Araldi, L. O. F. Penalva, D. Sandhu, C. Fernández-Hernando and 
Y. Suárez, Arterioscler. Thromb. Vasc. Biol., 2011, 31, 2595–2606. 
35 A. Stark, J. Brennecke, N. Bushati, R. B. Russell and S. M. Cohen, Cell, 2005, 123, 1133–
1146. 
36 D. P. Bartel and C.-Z. Chen, Nat. Rev. Genet., 2004, 5, 396–400. 
37 K. K.-H. Farh, A. Grimson, C. Jan, B. P. Lewis, W. K. Johnston, L. P. Lim, C. B. Burge and D. 
P. Bartel, Science, 2005, 310, 1817–1821. 
38 F. Loayza-Puch, Y. Yoshida, T. Matsuzaki, C. Takahashi, H. Kitayama and M. Noda, 
Oncogene, 2010, 29, 2638–2648. 
39 X. Liang, Z. Xu, M. Yuan, Y. Zhang, B. Zhao, J. Wang, A. Zhang and G. Li, Int. J. Mol. Med., 
2016, 37, 967–975. 
40 J. Pothof, N. S. Verkaik, W. van IJcken, E. A. C. Wiemer, V. T. B. Ta, G. T. J. van der Horst, 
N. G. J. Jaspers, D. C. van Gent, J. H. J. Hoeijmakers and S. P. Persengiev, EMBO J., 2009, 
28, 2090–2099. 
41 A. Cimmino, G. A. Calin, M. Fabbri, M. V. Iorio, M. Ferracin, M. Shimizu, S. E. Wojcik, R. I. 
Aqeilan, S. Zupo, M. Dono, L. Rassenti, H. Alder, S. Volinia, C. Liu, T. J. Kipps, M. Negrini 
and C. M. Croce, Proc. Natl. Acad. Sci. U. S. A., 2005, 102, 13944–13949. 
42 V. Y. Shin, H. Jin, E. K. O. Ng, A. S. L. Cheng, W. W. S. Chong, C. Y. P. Wong, W. K. Leung, J. 
J. Y. Sung and K.-M. Chu, Carcinogenesis, 2011, 32, 240–245. 
43 S. Zafari, C. Backes, P. Leidinger, E. Meese and A. Keller, Genomics Proteomics 
Bioinformatics, 2015, 13, 159–168. 
44 K. G. Biden, L. A. Simms, M. Cummings, R. Buttenshaw, E. Schoch, J. Searle, G. Gobe, J. R. 
Jass, S. J. Meltzer, B. A. Leggett and J. Young, Oncogene, 1999, 18, 1245–1249. 
45 A. Pierce and J.-F. Pittet, Curr. Opin. Anaesthesiol., 2014, 27, 246–252. 
46 A. Akcay, Q. Nguyen, Z. He, K. Turkmen, D. Won Lee, A. A. Hernando, C. Altmann, A. Toker, 
A. Pacic, D. G. Ljubanovic, A. Jani, S. Faubel and C. L. Edelstein, J. Am. Soc. Nephrol. JASN, 
2011, 22, 2057–2067. 
47 G. A. Calin, C. D. Dumitru, M. Shimizu, R. Bichi, S. Zupo, E. Noch, H. Aldler, S. Rattan, M. 
Keating, K. Rai, L. Rassenti, T. Kipps, M. Negrini, F. Bullrich and C. M. Croce, Proc. Natl. 
Acad. Sci. U. S. A., 2002, 99, 15524–15529. 
48 E. van Rooij and S. Kauppinen, EMBO Mol. Med., 2014, 6, 851–864. 
49 Y. K. Ho, W. T. Xu and H. P. Too, PLOS ONE, 2013, 8, e72463. 
50 N. Ludwig, P. Leidinger, K. Becker, C. Backes, T. Fehlmann, C. Pallasch, S. Rheinheimer, B. 
Meder, C. Stähler, E. Meese and A. Keller, Nucleic Acids Res., 2016, gkw116. 
51 P. S. Mitchell, R. K. Parkin, E. M. Kroh, B. R. Fritz, S. K. Wyman, E. L. Pogosova-Agadjanyan, 
A. Peterson, J. Noteboom, K. C. O’Briant, A. Allen, D. W. Lin, N. Urban, C. W. Drescher, B. 
S. Knudsen, D. L. Stirewalt, R. Gentleman, R. L. Vessella, P. S. Nelson, D. B. Martin and M. 
Tewari, Proc. Natl. Acad. Sci., 2008, 105, 10513–10518. 
52 X. Chen, Y. Ba, L. Ma, X. Cai, Y. Yin, K. Wang, J. Guo, Y. Zhang, J. Chen, X. Guo, Q. Li, X. Li, 
W. Wang, Y. Zhang, J. Wang, X. Jiang, Y. Xiang, C. Xu, P. Zheng, J. Zhang, R. Li, H. Zhang, X. 
Shang, T. Gong, G. Ning, J. Wang, K. Zen, J. Zhang and C.-Y. Zhang, Cell Res., 2008, 18, 997–
1006. 
53 T. O. Yau, C. W. Wu, C.-M. Tang, Y. Chen, J. Fang, Y. Dong, Q. Liang, S. S. Man Ng, F. K. L. 
Chan, J. J. Y. Sung and J. Yu, Oncotarget, 2015, 7, 1559–1568. 
54 A. Gallo and I. Alevizos, Methods Mol. Biol., 2013, 1024, 183–190. 
 189 
 
55 C. Beltrami, A. Clayton, A. O. Phillips, D. J. Fraser and T. Bowen, Biochem. Soc. Trans., 2012, 
40, 875–879. 
56 J. Zhang, S. Li, L. Li, M. Li, C. Guo, J. Yao and S. Mi, Genomics Proteomics Bioinformatics, 
2015, 13, 17–24. 
57 C. Beltrami, A. Clayton, L. J. Newbury, P. Corish, R. H. Jenkins, A. O. Phillips, D. J. Fraser 
and T. Bowen, Non-Coding RNA, 2015, 1, 151–166. 
58 A. Gallo, M. Tandon, I. Alevizos and G. G. Illei, PLOS ONE, 2012, 7, e30679. 
59 M. K. McDonald, K. E. Capasso and S. K. Ajit, J. Vis. Exp. JoVE, 2013, e50294. 
60 C. Lässer, M. Eldh and J. Lötvall, JoVE J. Vis. Exp., 2012, e3037–e3037. 
61 T. Thum, C. Gross, J. Fiedler, T. Fischer, S. Kissler, M. Bussen, P. Galuppo, S. Just, W. 
Rottbauer, S. Frantz, M. Castoldi, J. Soutschek, V. Koteliansky, A. Rosenwald, M. A. Basson, 
J. D. Licht, J. T. R. Pena, S. H. Rouhanifard, M. U. Muckenthaler, T. Tuschl, G. R. Martin, J. 
Bauersachs and S. Engelhardt, Nature, 2008, 456, 980–984. 
62 Y.-H. Feng and C.-J. Tsao, Biomed. Rep., 2016, 5, 395–402. 
63 G. Wang, B. C.-H. Kwan, F. M.-M. Lai, K.-M. Chow, P. K.-T. Li and C.-C. Szeto, Am. J. 
Nephrol., 2012, 36, 412–418. 
64 S. Mukhadi, R. Hull, Z. Mbita and Z. Dlamini, Non-Coding RNA, 2015, 1, 192–221. 
65 K. M. Pauley, S. Cha and E. K. L. Chan, J. Autoimmun., 2009, 32, 189–194. 
66 N. Meola, V. A. Gennarino and S. Banfi, PathoGenetics, 2009, 2, 7. 
67 M. Rubio, Q. Bassat, X. Estivill and A. Mayor, Malar. J., 2016, 15, 167. 
68 C. Castro-Villegas, C. Pérez-Sánchez, A. Escudero, I. Filipescu, M. Verdu, P. Ruiz-Limón, M. 
A. Aguirre, Y. Jiménez-Gomez, P. Font, A. Rodriguez-Ariza, J. R. Peinado, E. Collantes-
Estévez, R. González-Conejero, C. Martinez, N. Barbarroja and C. López-Pedrera, Arthritis 
Res. Ther., , DOI:10.1186/s13075-015-0555-z. 
69 H. M. A. Elsayed, W. S. Khater, A. A. Ibrahim, M. S. E. Hamdy and N. A. Morshedy, Egypt. 
J. Med. Hum. Genet., 18, 173–179. 
70 H.-Y. Chien, C.-Y. Chen, Y.-H. Chiu, Y.-C. Lin and W.-C. Li, Int. J. Med. Sci., 2016, 13, 457–
465. 
71 E. Aguado-Fraile, E. Ramos, E. Conde, M. Rodríguez, L. Martín-Gómez, A. Lietor, Á. 
Candela, B. Ponte, F. Liaño and M. L. García-Bermejo, PloS One, 2015, 10, e0127175. 
72 W. Sui, Y. Dai, Y. Huang, H. Lan, Q. Yan and H. Huang, Transpl. Immunol., 2008, 19, 81–85. 
73 H. He, K. Jazdzewski, W. Li, S. Liyanarachchi, R. Nagy, S. Volinia, G. A. Calin, C.-G. Liu, K. 
Franssila, S. Suster, R. T. Kloos, C. M. Croce and A. de la Chapelle, Proc. Natl. Acad. Sci. U. 
S. A., 2005, 102, 19075–19080. 
74 F. Weber, R. E. Teresi, C. E. Broelsch, A. Frilling and C. Eng, J. Clin. Endocrinol. Metab., 
2006, 91, 3584–3591. 
75 A. Caporali, M. Meloni, C. Völlenkle, D. Bonci, G. B. Sala-Newby, R. Addis, G. Spinetti, S. 
Losa, R. Masson, A. H. Baker, R. Agami, C. le Sage, G. Condorelli, P. Madeddu, F. Martelli 
and C. Emanueli, Circulation, 2011, 123, 282–291. 
76 F. Wu, S. Zhang, T. Dassopoulos, M. L. Harris, T. M. Bayless, S. J. Meltzer, S. R. Brant and J. 
H. Kwon, Inflamm. Bowel Dis., 2010, 16, 1729–1738. 
77 C. N. Hayes and K. Chayama, Int. J. Mol. Sci., 2016, 17, 280. 
78 B.-X. Jin, Y.-H. Zhang, W.-J. Jin, X.-Y. Sun, G.-F. Qiao, Y.-Y. Wei, L.-B. Sun, W.-H. Zhang and 
N. Li, Sci. Rep., 2015, 5, 15026. 
79 S. Bala and G. Szabo, Int. J. Hepatol., 2012, 2012, e498232. 
 190 
 
80 D.-Z. Liu, Y. Tian, B. P. Ander, H. Xu, B. S. Stamova, X. Zhan, R. J. Turner, G. Jickling and F. 
R. Sharp, J. Cereb. Blood Flow Metab. Off. J. Int. Soc. Cereb. Blood Flow Metab., 2010, 30, 
92–101. 
81 S. S. Hébert, K. Horré, L. Nicolaï, A. S. Papadopoulou, W. Mandemakers, A. N. Silahtaroglu, 
S. Kauppinen, A. Delacourte and B. De Strooper, Proc. Natl. Acad. Sci. U. S. A., 2008, 105, 
6415–6420. 
82 J. Kim, K. Inoue, J. Ishii, W. B. Vanti, S. V. Voronov, E. Murchison, G. Hannon and A. 
Abeliovich, Science, 2007, 317, 1220–1224. 
83 N. J. Beveridge, P. A. Tooney, A. P. Carroll, E. Gardiner, N. Bowden, R. J. Scott, N. Tran, I. 
Dedova and M. J. Cairns, Hum. Mol. Genet., 2008, 17, 1156–1168. 
84 Current Situation Of The Kidney Disease | Kidney Research UK - Kidney Research UK - 
Kidney Research UK, https://www.kidneyresearchuk.org/health-
information/resources/kidney-disease-in-the-uk-today, (accessed 6 January 2017). 
85 26a2c68f-ed7c-4e57-bc01-e97526a86c04.pdf, 
http://www.britishrenal.org/BritishRenalSociety/files/26/26a2c68f-ed7c-4e57-bc01-
e97526a86c04.pdf, (accessed 6 January 2017). 
86 K112-00 1..14 - web_book_07-04-16.pdf, https://www.renalreg.org/wp-
content/uploads/2015/01/web_book_07-04-16.pdf, (accessed 6 January 2017). 
87 Diabetes Prevalence 2016 (November 2016) - Diabetes UK, 
https://www.diabetes.org.uk/Professionals/Position-statements-
reports/Statistics/Diabetes-prevalence-2016/, (accessed 6 January 2017). 
88 M. Lopez-Anton, T. Bowen and R. H. Jenkins, BioMed Res. Int., 2015, 2015, 929806. 
89 K. J. Siddle, L. Tailleux, M. Deschamps, Y.-H. E. Loh, C. Deluen, B. Gicquel, C. Antoniewski, 
L. B. Barreiro, L. Farinelli and L. Quintana-Murci, PLoS Genet., 2015, 11, e1005064. 
90 G. S. Tillotson and S. H. Zinner, Expert Rev. Anti Infect. Ther., 2017, 663–676. 
91 E. Várallyay, J. Burgyán and Z. Havelda, Nat. Protoc., 2008, 3, 190–196. 
92 D. W. Wegman and S. N. Krylov, Angew. Chem. Int. Ed., 2011, 50, 10335–10339. 
93 Z. Shi, J. J. Johnson and M. S. Stack, J. Oncol., 2012, 2012, e903581. 
94 S. F. Clarke and J. R. Foster, Br. J. Biomed. Sci., 2012, 69, 83–93. 
95 R. Sanders, K. J. Koval, T. DiPasquale, G. Schmelling, S. Stenzler and E. Ross, J. Bone Joint 
Surg. Am., 1993, 75, 326–330. 
96 M. Cox and D. L. Nelson, Lehninger Principles of Biochemistry, Palgrave Macmillan, New 
York, 4th Revised edition edition., 2008. 
97 L. E. H. Trainor, The Triplet Genetic Code: Key to Living Organisms, World Scientific, 2001. 
98 J. D. Watson and F. H. Crick, Nature, 1953, 171, 737–738. 
99 D. M. Perreault and E. V. Anslyn, Angew. Chem. Int. Ed., 1997, 36, 432–450. 
100 K. L. Dueholm, M. Egholm, C. Behrens, L. Christensen, H. F. Hansen, T. Vulpius, K. H. 
Petersen, R. H. Berg, P. E. Nielsen and O. Buchardt, J. Org. Chem., 1994, 59, 5767–5773. 
101 P. E. Nielsen, M. Egholm, R. H. Berg and O. Buchardt, Science, 1991, 254, 1497–1500. 
102 C. Avitabile, L. Moggio, L. D. D’Andrea, C. Pedone and A. Romanelli, Tetrahedron Lett., 
2010, 51, 3716–3718. 
103 D. Pokharel, S. Fueangfung, M. Zhang and S. Fang, Biopolymers, 2014, 102, 487–493. 
104 S. Ellipilli, S. Palvai and K. N. Ganesh, J. Org. Chem., 2016, 81, 6364–6373. 
105 J. Tse, Y. Wang, T. Zengeya, E. Rozners and A. Tan-Wilson, Anal. Biochem., 2015, 470, 34–
40. 
106 M. Moccia, M. F. A. Adamo and M. Saviano, Artif. DNA PNA XNA, 2016, 5, e11071716 1-
15. 
 191 
 
107 N. T. S. De Costa and J. M. Heemstra, PLoS ONE, 2013, 8, e58670. 
108 T. Akisawa, K. Yamada and F. Nagatsugi, Bioorg. Med. Chem. Lett., 2016, 26, 5902–5906. 
109 S. Ellipilli and K. N. Ganesh, J. Org. Chem., 2015, 80, 9185–9191. 
110 A. Kiviniemi, M. Murtola, P. Ingman and P. Virta, J. Org. Chem., 2013, 78, 5153–5159. 
111 M. Hollenstein and C. J. Leumann, Org. Lett., 2003, 5, 1987–1990. 
112 S. Siddiquee, K. Rovina and A. Azriah, Adv. Tech. Biol. Med., 2015, 3, 1–10. 
113 S. K. Singh, A. A. Koshkin, J. Wengel and P. Nielsen, Chem. Commun., 1998, 455–456. 
114 A. A. Koshkin, S. K. Singh, P. Nielsen, V. K. Rajwanshi, R. Kumar, M. Meldgaard, C. E. Olsen 
and J. Wengel, Tetrahedron, 1998, 54, 3607–3630. 
115 W. Saenger, Principles of Nucleic Acid Structure, Springer Science & Business Media, 2013. 
116 I. Faustino, A. Pérez and M. Orozco, Biophys. J., 2010, 99, 1876–1885. 
117 H. Doessing and B. Vester, Mol. Basel Switz., 2011, 16, 4511–4526. 
118 U. A. Ørom, S. Kauppinen and A. H. Lund, Gene, 2006, 372, 137–141. 
119 R. Nedaeinia, M. Sharifi, A. Avan, M. Kazemi, L. Rafiee, M. Ghayour-Mobarhan and R. 
Salehi, Cancer Gene Ther., 2016, 23, 246–253. 
120 Z. S. Dean, P. Elias, N. Jamilpour, U. Utzinger and P. K. Wong, Anal. Chem., 2016, 88, 8902–
8907. 
121 E. E. Swayze, A. M. Siwkowski, E. V. Wancewicz, M. T. Migawa, T. K. Wyrzykiewicz, G. 
Hung, B. P. Monia and C. F. Bennett, Nucleic Acids Res., 2007, 35, 687–700. 
122 P. P. Seth, A. Siwkowski, C. R. Allerson, G. Vasquez, S. Lee, T. P. Prakash, E. V. Wancewicz, 
D. Witchell and E. E. Swayze, J. Med. Chem., 2009, 52, 10–13. 
123 S. M. Abdur Rahman, S. Seki, S. Obika, H. Yoshikawa, K. Miyashita and T. Imanishi, J. Am. 
Chem. Soc., 2008, 130, 4886–4896. 
124 P. J. Hrdlicka, B. R. Babu, M. D. Sørensen and J. Wengel, Chem. Commun., 2004, 1478–
1479. 
125 P. Kumar, M. E. Østergaard, B. Baral, B. A. Anderson, D. C. Guenther, M. Kaura, D. J. Raible, 
P. K. Sharma and P. J. Hrdlicka, J. Org. Chem., 2014, 79, 5047–5061. 
126 C. Briones and M. Moreno, Anal. Bioanal. Chem., 2012, 402, 3071–3089. 
127 J. Lee, I.-S. Park, H. Kim, J.-S. Woo, B.-S. Choi and D.-H. Min, Biosens. Bioelectron., 2015, 
69, 167–173. 
128 J. K. Watts, Chem. Commun., 2013, 49, 5618–5620. 
129 D. Duan, K. Zheng, Y. Shen, R. Cao, L. Jiang, Z. Lu, X. Yan and J. Li, Nucleic Acids Res., 2011, 
39, e154–e154. 
130 M. C. Riedy, E. A. Timm and C. C. Stewart, BioTechniques, 1995, 18, 70–74, 76. 
131 M. K. Udvardi, T. Czechowski and W.-R. Scheible, Plant Cell, 2008, 20, 1736–1737. 
132 Y. Huang, W. Gong, H. Ren, J. Xiong, X. Gao and X. Sun, Gene, 2017, 626, 298–304. 
133 G. Klanert, V. Jadhav, V. Shanmukam, A. Diendorfer, M. Karbiener, M. Scheideler, J. H. 
Bort, J. Grillari, M. Hackl and N. Borth, J. Biotechnol., 2016, 235, 150–161. 
134 A. Brunet-Vega, C. Pericay, M. E. Quílez, M. J. Ramírez-Lázaro, X. Calvet and S. Lario, Anal. 
Biochem., 2015, 488, 28–35. 
135 R. He, X. Xie, L. Lv, Y. Huang, X. Xia, X. Chen and L. Zhang, Biochem. Biophys. Res. Commun., 
2017, 486, 342–348. 
136 C. Chen, D. A. Ridzon, A. J. Broomer, Z. Zhou, D. H. Lee, J. T. Nguyen, M. Barbisin, N. L. Xu, 
V. R. Mahuvakar, M. R. Andersen, K. Q. Lao, K. J. Livak and K. J. Guegler, Nucleic Acids Res., 
2005, 33, e179. 
137 M. F. Kramer, in Current Protocols in Molecular Biology, John Wiley & Sons, Inc., 2001. 
 192 
 
138 X. Min, M. Zhang, F. Huang, X. Lou and F. Xia, ACS Appl. Mater. Interfaces, 2016, 8, 8998–
9003. 
139 E. A. Hunt, A. M. Goulding and S. K. Deo, Anal. Biochem., 2009, 387, 1–12. 
140 H. Wang, R. A. Ach and B. Curry, RNA, 2007, 13, 151–159. 
141 L. A. Neely, S. Patel, J. Garver, M. Gallo, M. Hackett, S. McLaughlin, M. Nadel, J. Harris, S. 
Gullans and J. Rooke, Nat. Methods, 2006, 3, 41–46. 
142 X.-P. Wang, B.-C. Yin and B.-C. Ye, RSC Adv., 2013, 3, 8633–8636. 
143 X. Zhao, L. Xu, M. Sun, W. Ma, X. Wu, H. Kuang, L. Wang and C. Xu, Small, 2016, 12, 4662–
4668. 
144 Y. Li, J. Zhang, J. Zhao, L. Zhao, Y. Cheng and Z. Li, Analyst, 2016, 141, 1071–1076. 
145 Y. Tu, P. Wu, H. Zhang and C. Cai, Chem. Commun., 2012, 48, 10718–10720. 
146 S. Li, K. He, R. Liao, C. Chen, X. Chen and C. Cai, Talanta, 2017, 174, 679–683. 
147 Q. Xu, F. Ma, S. Huang, B. Tang and C. Zhang, Anal. Chem., 2017, 89, 7077–7083. 
148 C. Ma, E. S. Yeung, S. Qi and R. Han, Anal. Bioanal. Chem., 2012, 402, 2217–2220. 
149 K. Josefsen and H. Nielsen, Methods Mol. Biol., 2011, 703, 87–105. 
150 D. C. Rio, Cold Spring Harb. Protoc., 2014, 2014, pdb.prot080838. 
151 X. Su, H. F. Teh, X. Lieu and Z. Gao, Anal. Chem., 2007, 79, 7192–7197. 
152 C. M. Lederer and V. S. Shirley, Eds., Table of Isotopes, Wiley-Blackwell, New York, 7th 
Edition edition., 1979. 
153 A. Válóczi, C. Hornyik, N. Varga, J. Burgyán, S. Kauppinen and Z. Havelda, Nucleic Acids 
Res., 2004, 32, e175. 
154 G. S. Pall, C. Codony-Servat, J. Byrne, L. Ritchie and A. Hamilton, Nucleic Acids Res., 2007, 
35, e60. 
155 S. W. Kim, Z. Li, P. S. Moore, A. P. Monaghan, Y. Chang, M. Nichols and B. John, Nucleic 
Acids Res., 2010, 38, e98. 
156 S. H. Ramkissoon, L. A. Mainwaring, E. M. Sloand, N. S. Young and S. Kajigaya, Mol. Cell. 
Probes, 2006, 20, 1–4. 
157 Y. S. Choi, L. O. Edwards, A. DiBello and A. M. Jose, Nucleic Acids Res., 2017, 45, e87. 
158 C. Li, D. Wu, X. Hu, Y. Xiang, Y. Shu and G. Li, Anal. Chem., 2016, 88, 7583–7590. 
159 J. O. Bockris, Volume 1: Modern Electrochemistry: Ionics, Springer, New York, 2 edition., 
2013. 
160 L. Galvani, A. Volta, J. Zambelli and  donor D. Burndy Library, Aloysii Galvani De viribus 
electricitatis in motu musculari commentarius, Bononiae : Ex Typographia Instituti 
Scientiarium, 1791. 
161 E. Gileadi, Physical Electrochemistry: Fundamentals, Techniques and Applications, Wiley 
VCH, Weinheim, 2011. 
162 J. Wang, Analytical Electrochemistry, Wiley-Blackwell, Hoboken, N.J, 3rd Revised edition 
edition., 2006. 
163 C. H. Hamann, A. Hamnett and W. Vielstich, Electrochemistry, Wiley VCH, Weinheim, 2nd, 
Completely Revised and Updated Edition edition edn., 2007. 
164 P. R. Roberge, Corrosion Engineering: Principles and Practice, McGraw-Hill Education, 
New York, 2008. 
165 J. Kotz, P. Treichel and J. Townsend, Chemistry and Chemical Reactivity, Cengage Learning, 
2008. 
166 A. J. Bard and L. Faulkner, Electrochemical Methods: Fundamentals and Applications, John 
Wiley & Sons, New York, 2nd Revised edition edition., 2001. 
 193 
 
167 A. E. Kaifer and M. Gómez-Kaifer, Supramolecular Electrochemistry, Wiley VCH, 
Weinheim ; New York, 1999. 
168 D. A. Skoog, F. J. Holler and S. R. Crouch, Principles of Instrumental Analysis 6th edition, 
Thomson Brooks/Cole, 6th edition., 2007. 
169 Z. Gao and Y. H. Yu, Biosens. Bioelectron., 2007, 22, 933–940. 
170 Q. Wang, Y. Ding, F. Gao, S. Jiang, B. Zhang, J. Ni and F. Gao, Anal. Chim. Acta, 2013, 788, 
158–164. 
171 Z. Gao, H. Deng, W. Shen and Y. Ren, Anal. Chem., 2013, 85, 1624–1630. 
172 R. S. Nicholson, Anal. Chem., 1965, 37, 1351–1355. 
173 O. Makhotkina and P. A. Kilmartin, Anal. Chim. Acta, 2010, 668, 155–165. 
174 H. Yang, Y. Gu, Y. Deng and F. Shi, Chem. Commun., 2002, 0, 274–275. 
175 A. W. Bott and W. R. Heineman, Current Separations Vol.20 No.4, 
http://www.currentseparations.com/issues/20-4/index.html, (accessed 27 July 2017). 
176 G. Inzelt, in Electroanalytical Methods, Springer, Berlin, Heidelberg, 2005, pp. 137–148. 
177 Y. Zhou, M. Wang, X. Meng, H. Yin and S. Ai, RSC Adv., 2012, 2, 7140–7145. 
178 H. Yin, Y. Zhou, C. Chen, L. Zhu and S. Ai, The Analyst, 2012, 137, 1389–1395. 
179 H. Yin, Y. Zhou, H. Zhang, X. Meng and S. Ai, Biosens. Bioelectron., 2012, 33, 247–253. 
180 Y. Zhou, Z. Zhang, Z. Xu, H. Yin and S. Ai, New J. Chem., 2012, 36, 1985–1991. 
181 B. Yao, Y. Liu, M. Tabata, H. Zhu and Y. Miyahara, Chem. Commun., 2014, 50, 9704–9706. 
182 R. G. Compton, Electrode Potentials, Oxford University Press, U.S.A., Oxford ; New York, 
1996. 
183 A. C. Fisher, Electrode Dynamics, Oxford University Press, U.S.A., Oxford ; New York, 1996. 
184 M. Labib, N. Khan, S. M. Ghobadloo, J. Cheng, J. P. Pezacki and M. V. Berezovski, J. Am. 
Chem. Soc., 2013, 135, 3027–3038. 
185 A. R. Cardoso, F. T. C. Moreira, R. Fernandes and M. G. F. Sales, Biosens. Bioelectron., 2016, 
80, 621–630. 
186 F. M. Mirabella, Internal Reflection Spectroscopy: Theory and Applications, CRC Press, 
1992. 
187 B. C. Smith, Fundamentals of Fourier Transform Infrared Spectroscopy, Second Edition, 
CRC Press, 2011. 
188 B. C. Smith, Infrared Spectral Interpretation: A Systematic Approach, CRC Press, 1998. 
189 A. Burrows, A. Parsons, G. Price, G. Pilling and J. Holman, Chemistry3: Introducing 
inorganic, organic and physical chemistry, OUP Oxford, Oxford ; New York, 2009. 
190 C. J. Chen, Introduction to Scanning Tunneling Microscopy, Oxford University Press Inc, 
New York, 1993. 
191 G. Haugstad, Atomic Force Microscopy: Understanding Basic Modes and Advanced 
Applications, Wiley-Blackwell, Hoboken, N.J, 1st edition., 2012. 
192 N. J. DiNardo, Nanoscale Characterization of Surfaces and Interfaces, Wiley VCH, 
Weinheim, 1994. 
193 J. Goldstein, D. E. Newbury, D. C. Joy, C. E. Lyman, P. Echlin, E. Lifshin, L. Sawyer and J. R. 
Michael, Scanning Electron Microscopy and X-ray Microanalysis: Third Edition, Springer, 
New York, 3rd Corrected ed. 2003. Corr. 2nd printing 2007 edition., 2007. 
194 P. Eaton and P. West, Atomic Force Microscopy, Oxford University Press, 2010. 
195 Y. Sugimoto, M. Abe and S. Morita, in Imaging and Manipulation of Adsorbates Using 
Dynamic Force Microscopy, Springer, Cham, 2015, pp. 49–62. 
196 R. Barattin and N. Voyer, SpringerLink, 2011, 457–483. 
197 K. Haase and A. E. Pelling, J. R. Soc. Interface, , DOI:10.1098/rsif.2014.0970. 
 194 
 
198 A. L. Gray, Analyst, 1985, 110, 551–556. 
199 R. Thomas, Practical Guide to ICP-MS: A Tutorial for Beginners, Third Edition, CRC Press, 
2013. 
200 L. Dussubieux, M. Golitko and B. Gratuze, Recent Advances in Laser Ablation ICP-MS for 
Archaeology, Springer, 2016. 
201 B. Hattendorf, C. Latkoczy and D. Günther, Anal. Chem., 2003, 75, 341 A-347 A. 
202 D. Pozebon, G. L. Scheffler, V. L. Dressler and M. A. G. Nunes, J. Anal. At. Spectrom., 2014, 
29, 2204–2228. 
203 M. A. O. da Silva and M. A. Z. Arruda, Metallomics, 2012, 5, 62–67. 
204 I. Rodushkin and M. D. Axelsson, Sci. Total Environ., 2003, 305, 23–39. 
205 A. Mohamad Ghazi, S. Shuttleworth, S. J. Angulo and D. H. Pashley, J. Anal. At. Spectrom., 
2000, 15, 1335–1341. 
206 S. Panighello, A. Kavčič, K. Vogel-Mikuš, N. H. Tennent, A. Wallert, S. B. Hočevar and J. T. 
van Elteren, Microchem. J., 2016, 125, 105–115. 
207 R. Scarpelli, A. M. De Francesco, M. Gaeta, D. Cottica and L. Toniolo, Microchem. J., 2015, 
119, 93–101. 
208 H. A. Gasteiger, N. M. Markovic and P. N. J. Ross, J. Phys. Chem., , 
DOI:10.1021/j100020a063. 
209 H. Liu, Y. Zhang, Q. Ke, K. Hung Ho, Y. Hu and J. Wang, J. Mater. Chem. A, 2013, 1, 12962–
12970. 
210 Electrochemical Analysis of Proteins and Cells | Genxi Li | Springer, . 
211 D. M. Fouad and W. A. El-Said, J. Nanomater., 2016, 2016, e6194230. 
212 A. Ulman, Chem. Rev., 1996, 96, 1533–1554. 
213 L. D. Burke and P. F. Nugent, Gold Bull., 1997, 30, 43–53. 
214 L. Y. S. Lee and R. B. Lennox, Langmuir, 2007, 23, 292–296. 
215 Y. Zhao, R. Wang, Z. Han, C. Li, Y. Wang, B. Chi, J. Li and X. Wang, Electrochimica Acta, 
2015, 151, 544–551. 
216 M. Escudero-Escribano, C. Wildi, J. A. Mwanda and A. Cuesta, J. Solid State Electrochem., 
2016, 20, 1087–1094. 
217 JASDL » Analytical Electrochemistry, http://jasdl.asdlib.org/2009/06/analytical-
electrochemistry-the-basic-concepts/, (accessed 16 March 2017). 
218 N. Menegazzo, C. Jin, R. J. Narayan and B. Mizaikoff, Langmuir, 2007, 23, 6812–6818. 
219 Q.-L. Zhao, Z.-L. Zhang, L. Bao and D.-W. Pang, Electrochem. Commun., 2008, 10, 181–185. 
220 D. E. García-Rodríguez, L. H. Mendoza-Huizar, C. H. Rios-Reyes and M. A. Alatorre-Ordaz, 
Quím. Nova, 2012, 35, 699–704. 
221 M. Sankararao, S. Anandhakumar and J. Mathiyarasu, IJCT Vol226 Novemb. 2015. 
222 S. Ergun and V. H. Tiensuu, Nature, 1959, 183, 1668–1670. 
223 L. A. Pesin and E. M. Baitinger, Carbon, 2002, 40, 295–306. 
224 P. J. F. Harris, Philos. Mag., 2004, 84, 3159–3167. 
225 Y. Xue, X. Li, H. Li and W. Zhang, Nat. Commun., 2014, 5, 4348. 
226 N. Pourmand, M. Karhanek, H. H. J. Persson, C. D. Webb, T. H. Lee, A. Zahradníková and 
R. W. Davis, Proc. Natl. Acad. Sci., 2006, 103, 6466–6470. 
227 L. Zou, Y. Xu, P. Luo, S. Zhang and B. Ye, Analyst, 2011, 137, 414–419. 
228 K. M. Millan, A. J. Spurmanis and S. R. Mikkelsen, Electroanalysis, 1992, 4, 929–932. 
229 BASi® | Working Electrodes, 
https://www.basinc.com/manuals/LC_epsilon/Maintenance/Working/working#glassy, 
(accessed 10 February 2017). 
 195 
 
230 T. Mary Vergheese and S. Berchmans, Electrochimica Acta, 2006, 52, 567–574. 
231 M. Noel and P. N. Anantharaman, Analyst, 1985, 110, 1095–1103. 
232 F. Doğan, İ. Kaya and K. Temizkan, Polym. Int., 2015, 64, 1639–1648. 
233 J. Clayden, N. Greeves and S. Warren, Organic Chemistry, OUP Oxford, 2012. 
234 H. Lee, S. Han, C. S. Kwon and D. Lee, Protein Cell, 2016, 7, 100–113. 
235 Composition and Concentrative Properties of Human Urine, National Aeronautics and 
Space Administration, 1971. 
236 R. C. Campbell, P. Ruggenenti and G. Remuzzi, Curr. Diab. Rep., 2003, 3, 497–504. 
237 J. I. Park, H. Baek, B. R. Kim and H. H. Jung, PLOS ONE, 2017, 12, e0171106. 
238 E. V. Petrotchenko, J. J. Serpa, D. B. Hardie, M. Berjanskii, B. P. Suriyamongkol, D. S. 
Wishart and C. H. Borchers, Mol. Cell. Proteomics, 2012, 11, M111.013524. 
239 T. D. Schmittgen, E. J. Lee, J. Jiang, A. Sarkar, L. Yang, T. S. Elton and C. Chen, Methods San 
Diego Calif, 2008, 44, 31–38. 
240 J. Wang, L. Fang and D. Lopez, The Analyst, 1994, 119, 455–458. 
241 D. Zang, M. Yan, S. Ge, L. Ge and J. Yu, The Analyst, 2013, 138, 2704–2711. 
242 A. Avramescu, S. Andreescu, T. Noguer, C. Bala, D. Andreescu and J.-L. Marty, Anal. 
Bioanal. Chem., 2002, 374, 25–32. 
243 G. Carpini, F. Lucarelli, G. Marrazza and M. Mascini, Biosens. Bioelectron., 2004, 20, 167–
175. 
244 M. Li, Y.-T. Li, D.-W. Li and Y.-T. Long, Anal. Chim. Acta, 2012, 734, 31–44. 
245 B. R. Šljukić, R. O. Kadara and C. E. Banks, Anal. Methods, 2011, 3, 105–109. 
246 R. O. Kadara and I. E. Tothill, Anal. Chim. Acta, 2008, 623, 76–81. 
247 E. Suprun, G. Evtugyn, H. Budnikov, F. Ricci, D. Moscone and G. Palleschi, Anal. Bioanal. 
Chem., 2005, 383, 597–604. 
248 J. Wang, P. V. Pamidi and D. S. Park, Anal. Chem., 1996, 68, 2705–2708. 
249 S. Mu, X. Wang, Y.-T. Li, Y. Wang, D.-W. Li and Y.-T. Long, The Analyst, 2012, 137, 3220–
3223. 
250 S. Wang, N. Liu, C. Yang, W. Liu, J. Su, L. Li, C. Yang and Y. Gao, RSC Adv., 2015, 5, 85799–
85805. 
251 J. Suikkola, T. Björninen, M. Mosallaei, T. Kankkunen, P. Iso-Ketola, L. Ukkonen, J. Vanhala 
and M. Mäntysalo, Sci. Rep., 2016, 6, 25784. 
252 J. Liang, K. Tong and Q. Pei, Adv. Mater., 2016, 28, 5986–5996. 
253 R. D. Munje, S. Muthukumar and S. Prasad, Sens. Actuators B Chem., 2017, 238, 482–490. 
254 C. P. Bonafide, D. T. Jamison and E. E. Foglia, JAMA, 2017, 317, 353–354. 
255 C. Stadlbauer, C. Reiter, B. Patzak, G. Stingeder and T. Prohaska, Anal. Bioanal. Chem., 
2007, 388, 593–602. 
256 J. Shang, F. Xue and E. Ding, Chem. Commun., 2015, 51, 15811–15814. 
257 P. Wongkaew and S. Poosittisak, Int. J. Geomate, 2016, 11, 2356–2362. 
258 D. W. M. Arrigan, Electrochemical Strategies in Detection Science, Royal Society of 
Chemistry, 2015. 
259 C. G. Zoski, Handbook of Electrochemistry, Elsevier, 2006. 
260 P. N. Bartlett, Bioelectrochemistry: Fundamentals, Experimental Techniques and 
Applications, John Wiley & Sons, 2008. 
261 D. R. Gamota, P. Brazis, K. Kalyanasundaram and J. Zhang, Printed Organic and Molecular 
Electronics, Springer Science & Business Media, 2013. 
262 V. Jazbutyte and T. Thum, Curr. Drug Targets, 2010, 11, 926–935. 
263 H. S. Stoker, General, Organic, and Biological Chemistry, Cengage Learning, 2012. 
 196 
 
264 A. Ringk, W. S. Christian Roelofs, E. C. P. Smits, C. van der Marel, I. Salzmann, A. Neuhold, 
G. H. Gelinck, R. Resel, D. M. de Leeuw and P. Strohriegl, Org. Electron., 2013, 14, 1297–
1304. 
265 Y. Wu, P. Xue, K. M. Hui and Y. Kang, ChemElectroChem, 2014, 1, 722–727. 
 
  
 197 
 
Appendix 1: Chapter 2 additional data. 
Table A1.1 The raw data obtained for the coulometric response (C) of using an anti-miR-21 probe strand for target hsa-miR-
21-5p hybridisation at different concentrations. 
 Experiment number   Experiment number 
10-8 M 1 2 3 10-12 M 1 2 3 
DNA only -2.096E-04 -2.067E-04 -2.077E-04 DNA only -2.194E-04 -2.143E-04 -2.322E-04 
DNA/RNA -1.641E-04 -1.637E-04 -1.633E-04 DNA/RNA -1.983E-04 -1.991E-04 -2.139E-04 
Change 4.554E-05 4.304E-05 4.448E-05 Change 2.115E-05 1.520E-05 1.833E-05 
Average 4.435E-05 Average(µC) 44.353 Average 1.823E-05 Average(µC) 18.227 
S.D 1.025E-06 S.D (µC) 1.025 S.D 2.430E-06 S.D (µC) 2.430 
10-9 M 1 2 3 10-13 M 1 2 3 
DNA only -2.066E-04 -2.233E-04 -2.115E-04 DNA only -2.330E-04 -2.341E-04 -2.156E-04 
DNA/RNA -1.691E-04 -1.868E-04 -1.817E-04 DNA/RNA -2.159E-04 -2.176E-04 -2.047E-04 
Change 3.756E-05 3.644E-05 2.982E-05 Change 1.706E-05 1.647E-05 1.092E-05 
Average 3.461E-05 Average(µC) 34.607 Average 1.482E-05 Average(µC) 14.817 
S.D 3.415E-06 S.D (µC) 3.415 S.D 2.766E-06 S.D (µC) 2.766 
10-10 M 1 2 3 10-14 M 1 2 3 
DNA only -2.168E-04 -2.207E-04 -2.194E-04 DNA only -2.398E-04 -2.241E-04 -1.989E-04 
DNA/RNA -1.894E-04 -1.915E-04 -1.876E-04 DNA/RNA -2.241E-04 -2.249E-04 -1.943E-04 
Change 2.743E-05 2.925E-05 3.183E-05 Change 1.570E-05 -8.600E-07 4.580E-06 
Average 2.950E-05 Average(µC) 29.503 Average 6.473E-06 Average(µC) 6.473 
S.D 1.805E-06 S.D (µC) 1.805 S.D 6.892E-06 S.D (µC) 6.892 
10-11 M 1 2 3     
DNA only -2.292E-04 -2.342E-04 -2.268E-04     
DNA/RNA -2.064E-04 -2.070E-04 -2.084E-04     
Change 2.284E-05 2.725E-05 1.847E-05     
Average 2.285E-05 Average(µC) 22.853     
S.D 3.584E-06 S.D (µC) 3.584     
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Table A1.2 The raw data for the RCT (charge transfer) resistance response (Ω) of using an anti-miR-21 probe strand for 
target hsa-miR-21-5p hybridisation at different concentrations. 
 Experiment number  Experiment number 
10-8 M 1 2 3 10-12 M 1 2 3 
DNA only 794.9 791.8 883.8 DNA only 604.4 756.2 358.2 
DNA/RNA 2129.2 2079.5 2099.1 DNA/RNA 1024.0 1212.1 731.2 
Change 1334.3 1287.7 1215.3 Change 419.6 455.9 372.9 
Average 1279.1    Average 416.1    
S.D 48.9    S.D 34.0    
10-9 M 1 2 3 10-13 M 1 2 3 
DNA only 804.6 698.2 674.1 DNA only 439.2 494.9 810.2 
DNA/RNA 1897.2 1746.9 1727.4 DNA/RNA 811.3 761.7 1086.8 
Change 1092.6 1048.7 1053.3 Change 372.1 266.8 276.6 
Average 1064.8    Average 305.2    
S.D 19.7    S.D 47.5    
10-10 M 1 2 3 10-14 M 1 2 3 
DNA only 822.2 524.4 530.9 DNA only 455.7 518.3 746.2 
DNA/RNA 1380.8 1209.8 1249.6 DNA/RNA 729.1 574.5 1175.3 
Change 558.7 685.4 718.7 Change 273.4 56.2 429.1 
Average 654.3    Average 252.9    
S.D 69.0    S.D 152.9    
10-11 M 1 2 3     
DNA only 394.5 418.1 478.8     
DNA/RNA 904.9 902.4 879.9     
Change 510.4 484.3 401.1     
Average 465.3        
S.D 46.6        
 
Table A1.3 The coulometry data collected using a solution of TMD buffer as the hybridisation target for an anti-miR-21 
probe strand. Used in the calculation of limit of detection. 
Buffer Responses 1 2 3 4 
With DNA (C) -1.57E-04 -1.48E-04 -1.34E-04 -1.32E-04 
With hybrid (C) -1.48E-04 -1.34E-04 -1.32E-04 -1.39E-04 
Coulometry change (C)  9.49E-06 1.37E-05 1.92E-06 -6.62E-06 
Average coulometry change (µC) 4.62    
Standard deviation 7.74    
3x Standard deviation 23.22    
3x Standard deviation/ gradient 3.96    
Above with average added 8.58    
Limit of detection (M)  1.97E-14    
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Table A1.4 Coulometry response (C) raw data of using an anti-miR-21 probe strand for target hsa-miR-21-5p, along with 
mismatched sequences with 1, 2, and 3 mismatches and a hsa-miR-16-5p sequence, given for a 10 nM solution of each 
target. 
 Experiment number 
Complement   
Average  4.435E-05 Average (µC) 44.353 
S.D 1.025E-06 S.D (µC) 1.025 
1 Mismatch 1 2 3 
DNA alone -2.046E-04 -2.202E-04 -2.200E-04 
DNA/RNA -1.851E-04 -2.054E-04 -2.048E-04 
Change 1.956E-05 1.484E-05 1.516E-05 
Average 1.652E-05 Average (µC) 16.520 
S.D 2.154E-06 S.D (µC) 2.154 
2 Mismatches 1 2 3 
DNA alone -2.133E-04 -2.212E-04 -2.175E-04 
DNA/RNA -2.073E-04 -2.098E-04 -2.039E-04 
Change 6.080E-06 1.145E-05 1.353E-05 
Average 1.035E-05 Average (µC) 10.353 
S.D 3.139E-06 S.D (µC) 3.139 
3 Mismatches 1 2 3 
DNA alone -2.094E-04 -2.283E-04 -2.193E-04 
DNA/RNA -2.036E-04 -2.240E-04 -2.110E-04 
Change 5.890E-06 4.320E-06 8.340E-06 
Average 6.183E-06 Average (µC) 6.183 
S.D 1.654E-06 S.D (µC) 1.654 
miR-16 1 2 3 
DNA alone -1.995E-04 -2.237E-04 -2.048E-04 
DNA/RNA -1.920E-04 -2.182E-04 -2.043E-04 
Change 7.520E-06 5.430E-06 5.200E-07 
Average 4.490E-06 Average (µC) 4.490 
S.D 3.593E-06 S.D (µC) 3.593 
1mm Signal drop (%) 62.75   
2mm Signal drop (%) 76.66   
3mm signal drop(%) 86.06   
miR-16 signal drop(%) 89.88   
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Table A1.5 The raw data for the RCT (charge transfer) resistance response (Ω) using an anti-miR-21 probe strand for target 
hsa-miR-21-5p, along with mismatched sequences with 1, 2, and 3 mismatches and a hsa-miR-16-5p sequence, given for a 
10 nM solution of each target. 
 Experiment number 
Complement   
Average  1279.1     
STD 48.9    
1 Mismatch 1 2 3 
DNA alone 663.0 497.8 483.0 
DNA/RNA 1348.3 933.4 906.2 
Change 685.3 435.6 423.2 
Average 514.7     
S.D 120.7    
2 Mismatches 1 2 3 
DNA alone 537.4 520.9 413.5 
DNA/RNA 803.3 870.7 916.4 
Change 265.9 349.8 502.9 
Average 372.9     
S.D 98.1    
3 Mismatches 1 2 3 
DNA alone 534.5 332.4 399.6 
DNA/RNA 869.3 557.2 731.8 
Change 334.8 224.7 332.2 
Average 297.2     
S.D 51.3    
miR-16 1 2 3 
DNA alone 884.4 352.8 597.1 
DNA/RNA 1333.2 604.5 783.9 
Change 448.8 251.7 186.9 
Average 295.8     
S.D 111.4    
1mm Signal drop (%) 59.76   
2mm Signal drop (%) 70.85   
3mm signal drop(%) 76.76   
miR-16 signal 
drop(%) 76.87   
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Table A1.6 The raw data obtained for the coulometric response (C) of using an anti-miR-16 probe strand for target hsa-miR-
16-5p hybridisation at different concentrations. 
 Experiment number Experiment number  
10-8 M 1 2 3 10-12 M 1 2 3 
DNA only -2.010E-04 -2.321E-04 -2.074E-04 DNA only -2.342E-04 -1.801E-04 -1.877E-04 
DNA/RNA -1.688E-04 -1.878E-04 -1.625E-04 DNA/RNA -2.081E-04 -1.639E-04 -1.665E-04 
Change 3.220E-05 4.428E-05 4.484E-05 Change 2.611E-05 1.623E-05 2.116E-05 
Average 4.044E-05 Average(µC) 40.440 Average 2.116E-05 Average(µC) 21.165 
S.D 5.831E-06 S.D (µC) 5.831 S.D 4.035E-06 S.D (µC) 4.035 
10-9 M 1 2 3 10-13 M 1 2 3 
DNA only -2.470E-04 -2.239E-04 -1.652E-04 DNA only -2.179E-04 -2.308E-04 -2.228E-04 
DNA/RNA -2.204E-04 -1.841E-04 -1.218E-04 DNA/RNA -2.034E-04 -2.134E-04 -2.131E-04 
Change 2.662E-05 3.976E-05 4.335E-05 Change 1.451E-05 1.736E-05 9.690E-06 
Average 3.658E-05 Average(µC) 36.577 Average 1.385E-05 Average(µC) 13.853 
S.D 7.191E-06 S.D (µC) 7.191 S.D 3.166E-06 S.D (µC) 3.166 
10-10 M 1 2 3 10-14 M 1 2 3 
DNA only -2.011E-04 -2.113E-04 -1.988E-04 DNA only -2.308E-04 -2.427E-04 -1.963E-04 
DNA/RNA -1.704E-04 -1.785E-04 -1.705E-04 DNA/RNA -2.218E-04 -2.291E-04 -1.868E-04 
Change 3.071E-05 3.277E-05 2.827E-05 Change 8.980E-06 1.355E-05 9.507E-06 
Average 3.058E-05 Average(µC) 30.583 Average 1.068E-05 Average(µC) 10.679 
S.D 1.839E-06 S.D (µC) 1.839 S.D 2.042E-06 S.D (µC) 2.042 
10-11 M 1 2 3     
DNA only -2.300E-04 -2.162E-04 -2.236E-04     
DNA/RNA -2.077E-04 -1.916E-04 -1.999E-04     
Change 2.236E-05 2.456E-05 2.366E-05     
Average 2.353E-05 Average(µC) 23.527     
S.D 9.031E-07 S.D (µC) 0.903     
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Table A1.7 The raw data for the RCT (charge transfer) resistance response (Ω) of using an anti-miR-16 probe strand for 
target hsa-miR-16-5p hybridisation at different concentrations. 
 Experiment number  Experiment number 
10-8 M 1 2 3 10-12 M 1 2 3 
DNA only 950.6 814.3 1357.0 DNA only 745.7 944.7 724.2 
DNA/RNA 2023.3 1489.4 2472.2 DNA/RNA 1105.3 1491.8 1185.9 
Change 1072.8 675.1 1115.2 Change 359.6 547.1 461.7 
Average 954.4     Average 456.1     
S.D 198.2    S.D 76.6    
10-9 M 1 2 3 10-13 M 1 2 3 
DNA only 399.5 834.1 1672.8 DNA only 555.5 634.5 760.5 
DNA/RNA 1061.9 1669.4 3358.7 DNA/RNA 738.6 1084.1 1087.3 
Change 662.4 835.3 1685.9 Change 183.1 449.6 326.8 
Average 1061.2     Average 319.8     
S.D 447.3    S.D 108.9    
10-10 M 1 2 3 10-14 M 1 2 3 
DNA only 1080.4 957.8 1024.6 DNA only 364.0 604.5 532.5 
DNA/RNA 1985.6 1869.2 1587.6 DNA/RNA 549.6 1062.6 1001.7 
Change 905.2 911.4 563.0 Change 185.6 458.1 469.2 
Average 793.2     Average 371.0     
S.D 162.8    S.D 131.2    
10-11 M 1 2 3     
DNA only 664.2 813.0 965.6     
DNA/RNA 1225.3 1603.0 1348.0     
Change 561.1 790.0 382.4     
Average 577.8         
S.D 166.9        
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Table A1.8 Raw data for coulometry response (C) using an anti-miR-21 probe following hybridisation with target miR-21 in 
urine samples as specified in Table 6.2. 
 Experiment number     
Sample 1 1 2 3 Sample 5 1 2 3 
DNA only -1.996E-04 -1.990E-04 -1.808E-04 DNA only -1.691E-04 -1.751E-04 -1.756E-04 
DNA/RNA -1.901E-04 -1.724E-04 -1.543E-04 DNA/RNA -1.403E-04 -1.486E-04 -1.468E-04 
Change 9.484E-06 2.653E-05 2.651E-05 Change 2.879E-05 2.646E-05 2.880E-05 
Concentration -1.354E+01 -1.064E+01 -1.064E+01 Concentration -1.025E+01 -1.065E+01 -1.025E+01 
Average (µC) 20.839 Average 2.084E-05 Average (µC) 28.019 Average 2.802E-05 
S.D (µC) 8.030 S.D 8.030E-06 S.D (µC) 1.103 S.D 1.103E-06 
Average Conc 
(log10M) -11.607     
Average Conc 
(log10M) -10.385     
S.D Conc 1.367    S.D Conc 0.188    
Sample 2 1 2 3     
DNA only -1.785E-04 -1.675E-04 -1.813E-04     
DNA/RNA -1.408E-04 -1.308E-04 -1.558E-04     
Change 3.764E-05 3.678E-05 2.553E-05     
Concentration -8.747E+00 -8.894E+00 -1.081E+01     
Average (µC) 33.317 Average 3.332E-05     
S.D (µC) 5.517 S.D 5.517E-06     
Average Conc 
(log10M) -9.483         
S.D Conc 0.939        
Sample 3 1 2 3     
DNA only -1.730E-04 -1.804E-04 -1.748E-04     
DNA/RNA -1.467E-04 -1.474E-04 -1.531E-04     
Change 2.630E-05 3.296E-05 2.169E-05     
Concentration -1.068E+01 -9.543E+00 -1.146E+01     
Average (µC) 26.985 Average 2.698E-05     
S.D (µC) 4.630 S.D 4.630E-06     
Average Conc 
(log10M) -10.561         
S.D Conc 0.788        
Sample 4 1 2 3     
DNA only -1.785E-04 -1.897E-04 -1.932E-04     
DNA/RNA -1.423E-04 -1.579E-04 -1.676E-04     
Change 3.626E-05 3.178E-05 2.556E-05     
Concentration -8.983E+00 -9.745E+00 -1.080E+01     
Average (µC) 31.197 Average 3.120E-05     
S.D (µC) 4.387 S.D 4.387E-06     
Average Conc 
(log10M) -9.844         
S.D Conc 0.747        
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Table A1.9 The CT values obtained using known hsa-miR-21-5p concentrations in buffer. 
Log [miR-21] CT mean 
-8 8.078 
-9 12.047 
-10 17.067 
-11 20.981 
-12 25.139 
-13 29.623 
-14 33.297 
 
Table A1.10 PCR CT values for the urine samples specified in Table 6.2 and their extrapolated concentrations using buffered 
calibration plot. 
Sample CT mean Extrapolated log10 [miR-21] 
1 32.643 -13.768 
2 30.170 -13.185 
3 31.426 -13.481 
4 31.554 -13.511 
5 32.248 -13.675 
 
Table A1. 11 The PCR values obtained for buffered hsa-miR-21-5p solutions that have been extracted prior to RT-PCR, and 
the expected values. 
Log10[miR-21] CT mean Expected CT mean observed Observed log10[miR-21] 
-8 8.078 24.456 -11.840 
-10 17.067 28.711 -12.842 
-12 25.139 30.350 -13.228 
-14 33.297 36.835 -14.755 
-16 Not taken 36.063 -14.573 
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Figure A1.1 Data showing how the DNA/miRNA hybrid can be denatured and the anti-miR-21 probe re-used for detection of 
10-10 M hsa-miR-21-5p following multiple heat treatment cycles. 
 
 
Figure A1.2 Coulometry data obtained after hybridising the hsa-miR-21-5p miRNA target (10-10 M) with the anti-miR-21 
probe for different amounts of time. 
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Figure A1.3 Data showing how the coulometry response changes when the anti-miR-21 probe is stored for 24 hours at 
different temperatures to simulate aging before being hybridised with 0.1 nM of hsa-miR-21-5p. The Arrhenius plot is 
calculated from the rate of decay at each temperature compared to the point of no storage. 
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Figure A1.4 Data showing how the coulometry response changes when the anti-miR-21 probe is stored for 24 hours at 
different temperatures to simulate aging before being hybridised with 0.1 nM of hsa-miR-21-5p. Data plotted linearly for 
rate of change gradient.
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Table A1.12 The data used to plot the Arrhenius plot and calculated storage lifetimes to 50% response. 
 
Signal at 
time zero 
(µC) 17.59 
Storage 
time (h) 24.00        
T (°C) T (K) 
Rate 
(µC/h/K) 1/T ln rate 
Actual Signal 
at 24 h 
k first order 
(µC/h/K) ln (k first order) ln (k) from fit 
k calc 
(µC/h/K) 
t 90% first 
order from 
fit (h) 
t 50% first 
order from 
fit (h) 
4.00 277.15 0.08 3.61E-03 -2.51 15.64 4.89E-03 -5.32 -5.23 5.34E-03 19.74 129.88 
25.00 298.15 0.13 3.35E-03 -2.06 14.54 7.93E-03 -4.84 -4.59 1.01E-02 10.38 68.30 
30.00 303.15 0.23 3.30E-03 -1.46 12.00 1.59E-02 -4.14 -4.45 1.17E-02 9.03 59.38 
40.00 313.15 0.32 3.19E-03 -1.14 9.88 2.40E-02 -3.73 -4.18 1.52E-02 6.92 45.50 
50.00 323.15 0.19 3.09E-03 -1.65 12.97 1.27E-02 -4.37 -3.93 1.96E-02 5.39 35.44 
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Appendix 2: Chapter 3 additional data. 
 
Figure A2.1 A Nyquist diagram obtained at 0.23 V and between 0.01Hz and 10 kHz using the 2 mm SPCE, this does not 
display the impedance behaviour previously observed so was not easily analysed and thus not used for prototyping. 
Performed using 5 mM K3[Fe(CN)6]/K4[Fe(CN)6] in 0.1 M KCl electrolyte at room temperature  
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Figure A2.2 An example of the Warburg plot by plotting Zreal against 1/√Frequency (rad/s) obtained at 0.23 V and between 
0.01 Hz ant 10 kHz. The intercept of the linear section is used as the readout. Performed using 5 mM K3[Fe(CN)6]/K4[Fe(CN)6] 
in 0.1 M KCl electrolyte at room temperature  
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Figure A2.3 The calibration plot obtained following hybridisation of anti-miR-21 with its’ hsa-miR-21-5p target, at different 
concentrations, for the 2mm SPCE design using the Warburg plot intercepts. Performed using 5 mM K3[Fe(CN)6]/K4[Fe(CN)6] 
in 0.1 M KCl electrolyte at room temperature  
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Table A2. 1 The raw data obtained for the coulometric response (C) of using an anti-miR-21 probe strand for target hsa-
miR-21-5p hybridisation at different concentrations using a 2 mm SPCE. 
 Experiment number  Experiment number 
10-8 M 1 2 3 10-11 M 1 2 3 
DNA only -9.605E-05 -1.004E-04 -9.693E-05 DNA only -1.011E-04 -9.645E-05 -9.908E-05 
DNA/RNA -7.861E-05 -9.015E-05 -8.179E-05 DNA/RNA -9.484E-05 -9.301E-05 -9.869E-05 
Change 1.744E-05 1.021E-05 1.515E-05 Change 6.242E-06 3.445E-06 3.950E-07 
Average (µC) 13.828     Average (µC) 3.361     
S.D (µC) 3.016    S.D (µC) 2.388    
10-9 M 1 2 3 10-12 M 1 2 3 
DNA only -1.003E-04 -9.800E-05 -1.005E-04 DNA only -9.132E-05 -1.012E-04 -1.017E-04 
DNA/RNA -9.338E-05 -8.979E-05 -8.606E-05 DNA/RNA -9.002E-05 -1.005E-04 -1.009E-04 
Change 6.868E-06 8.207E-06 1.441E-05 Change 1.301E-06 7.500E-07 8.200E-07 
Average (µC) 9.828     Average (µC) 0.957     
S.D (µC) 3.285    S.D (µC) 0.245    
10-10 M 1 2 3     
DNA only -9.652E-05 -9.570E-05 -1.034E-04     
DNA/RNA -8.927E-05 -8.908E-05 -9.769E-05     
Change 7.243E-06 6.620E-06 5.685E-06     
Average (µC) 6.516         
S.D (µC) 0.640        
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Table A2. 2 The raw data obtained for the coulometric response (C) of using an anti-miR-21 probe strand for target hsa-
miR-21-5p hybridisation at different concentrations using a 3 mm SPCE. 
 Experiment number  Experiment number 
10-8 M 1 2 3 10-12 M 1 2 3 
DNA only -172.406 -217.288 -267.604 DNA only -246.873 -204.237 -193.162 
DNA/RNA -77.237 -156.146 -203.370 DNA/RNA -215.254 -174.604 -164.421 
Change 95.168 61.143 64.234 Change 31.619 29.633 28.740 
Average  73.515     Average  29.997     
S.D  15.363    S.D  1.203    
10-9 M 1 2 3 10-13 M 1 2 3 
DNA only -182.642 -204.860 -246.020 DNA only -249.340 -199.746 -172.872 
DNA/RNA -118.884 -136.030 -190.294 DNA/RNA -234.993 -190.324 -147.710 
Change 63.757 68.830 55.726 Change 14.347 9.421 25.161 
Average  62.771     Average  16.310     
S.D  5.395    S.D  6.574    
10-10 M 1 2 3 10-14 M 1 2 3 
DNA only -195.087 -181.123 -223.022 DNA only -206.268 - - 
DNA/RNA -147.773 -98.777 -183.709 DNA/RNA -193.375 - - 
Change 47.314 82.346 39.312 Change 12.892 - - 
Average  56.324     Average  12.892     
S.D  18.688    S.D  -    
10-11 M 1 2 3       
DNA only -233.887 -196.151 -247.088      
DNA/RNA -197.893 -167.827 -220.612      
Change 35.994 28.324 26.476      
Average  30.264         
S.D  4.121        
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Table A2.3 The full set of LA-ICPMS data obtained for each of the target elements. Each performed in triplicate and the average concentration given in the main text (ppm). Given as appears 
on ICP-MS SQ report. 
  P (ppm) N (ppm) 
  1 2 3 Average 1 2 3 average 
Blank 229.245 200.142 196.983 208.79 39819619.4 39852444.4 38905033.7 39525699.17 
ANSA 250.953 250.079 272.595 257.8757 37822344.4 37860323.4 37909336.1 37864001.31 
ANSCl (Ace) 119.828 109.209 110.15 113.0623 7463540.7 7330612.75 7149341.32 7314498.256 
ANSCl (hex) 4853.673 4804.94 4714.197 4790.937 36981367.5 36325585.6 36020754.5 36442569.2 
ANSm-DNA 5527.563 6131.69 6534.057 6064.437 1371752144 1729855932 1987933436 1696513837 
ANSm-DNA/miRNA 13371.55 9574.447 6545.92 9830.638 512539826 695589995 962937441 723689087.4 
ANSmDNA/mismatch 276.626 295.916 277.231 283.2577 72305419 73504292.9 73912969.5 73240893.81 
 C (ppm) Cl (ppm) S (ppm) 
 Electrode Stage 1 2 3 Average 1 2 3 average 1 2 3 average 
Blank 211721 236005.9 238059.1 228595.3143 6111.725 6454.016 5848.901 6138.214 269.497 269.497 362.428 300.474 
ANSA 253152.2 251746 260251.2 255049.8257 5720.552 5738.863 5592.197 5683.871 278.792 204.445 306.669 263.302 
ANSCl (Ace) 57527.48 57180.02 57053.06 57253.52033 1032.781 1020.559 1020.56 1024.633 - - - - 
ANSCl (hex) 277762.1 266972.2 259855.3 268196.537 5598.312 5531.064 5610.527 5579.968 315.962 250.913 278.79 281.8883 
ANSm-DNA 3823720 4465854 4686482 4325351.964 3404.047 4846.469 6454.197 4901.571 715.566 1040.825 1105.883 954.0913 
ANSm-DNA/miRNA 1351657 1931509 2770329 2017831.861 965.556 1368.902 2267.278 1533.912 585.461 594.755 789.911 656.709 
ANSm-
DNA/mismatch 2878723 3009945 2758928 2882532.189 2799.083 2823.537 2572.946 2731.855 278.794 390.306 353.134 340.7447 
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Appendix 3: Chapter 4 additional data 
Table A3.1 The first set of raw data obtained for the coulometric response (C) of using an anti-miR-21 probe strand for 
target hsa-miR-21-5p hybridisation at different concentrations using the 3 surfaced SPCE. 
 Experiment number  Experiment number 
10-8 M 1 2 10-11 M 1 2 
DNA only -132.727 -174.895 DNA only -126.611 -176.380 
DNA/RNA -47.131 -65.758 DNA/RNA -41.620 -60.186 
Change 85.596 109.137 Change 84.991 116.194 
Average  97.366   Average  100.593   
S.D  11.771   S.D  15.601   
10-9 M 1 2 10-12 M 1 2 
DNA only -150.151 -179.100 DNA only -137.934 -185.334 
DNA/RNA -65.135 -60.407 DNA/RNA -41.179 -69.806 
Change 85.016 118.693 Change 96.755 115.528 
Average  101.854   Average  106.142   
S.D  16.838   S.D  9.386   
10-10 M 1 2 10-13 M 1 2 
DNA only -147.197 -182.758 DNA only -141.043 -165.669 
DNA/RNA -52.852 -65.343 DNA/RNA -45.573 -60.098 
Change 94.344 117.415 Change 95.470 105.571 
Average  105.879   Average  100.520   
S.D  11.535   S.D  5.051   
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Table A3.2 The first set of raw data obtained for the coulometric response (C) of using an anti-miR-21 probe strand for 
target hsa-miR-21-5p hybridisation at different concentrations. Performed using the 3 surfaced SPCE and the Teflon wells. 
 
 Experiment number  Experiment number 
10-8 M 1 2 3 10-11 M 1 2 3 
DNA only -95.112 -119.932 -150.532 DNA only -97.840 -154.968 -144.661 
DNA/RNA -24.988 -28.059 -76.090 DNA/RNA -31.077 -114.450 -105.265 
Change 70.124 91.873 74.442 Change 66.763 40.518 39.396 
Average  78.813     Average  48.892     
S.D  9.401     S.D  12.645     
10-9 M 1 2 3 10-12 M 1 2 3 
DNA only -139.450 -97.840 -141.787 DNA only -162.750 -112.424 -102.448 
DNA/RNA -61.717 -35.435 -71.040 DNA/RNA -102.592 -76.720 -62.827 
Change 77.733 62.404 70.747 Change 60.158 35.704 39.621 
Average  70.295     Average  45.161     
S.D  6.266     S.D  10.724     
10-10 M 1 2 3 10-13 M 1 2 3 
DNA only -95.112 -96.156 -118.325 DNA only -127.084 -62.601 -113.039 
DNA/RNA -28.361 -30.616 -61.105 DNA/RNA -81.928 -26.009 -56.556 
Change 66.752 65.540 57.220 Change 45.156 36.592 56.483 
Average  63.170     Average  46.077     
S.D  4.237     S.D  8.146    
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Table A3. 3 The raw coulometry responses obtained for patient and control urine samples using a multiplexed electrode and 
Teflon wells. 
 Experiment number  Experiment number 
miR-192 C11005 miR-192 C11021 
DNA only -95.112 -119.932 -150.532 DNA only -97.840 -154.968 -144.661 
DNA/RNA -24.988 -28.059 -76.090 DNA/RNA -31.077 -114.450 -105.265 
Change 70.124 91.873 74.442 Change 66.763 40.518 39.396 
Average  78.813     Average  48.892     
S.D  9.401     S.D  12.645     
miR-191 C11005 miR-191 C11021 
DNA only -139.450 -97.840 -141.787 DNA only -162.750 -112.424 -102.448 
DNA/RNA -61.717 -35.435 -71.040 DNA/RNA -102.592 -76.720 -62.827 
Change 77.733 62.404 70.747 Change 60.158 35.704 39.621 
Average  70.295     Average  45.161     
S.D  6.266     S.D  10.724     
miR-126 C11005 miR-126 C11021 
DNA only -95.112 -96.156 -118.325 DNA only -127.084 -62.601 -113.039 
DNA/RNA -28.361 -30.616 -61.105 DNA/RNA -81.928 -26.009 -56.556 
Change 66.752 65.540 57.220 Change 45.156 36.592 56.483 
Average  63.170     Average  46.077     
S.D  4.237     S.D  8.146     
miR-192 P12016 miR-192 P12026 
DNA only -95.112 -119.932 -150.532 DNA only -97.840 -154.968 -144.661 
DNA/RNA -24.988 -28.059 -76.090 DNA/RNA -31.077 -114.450 -105.265 
Change 70.124 91.873 74.442 Change 66.763 40.518 39.396 
Average  78.813     Average  48.892     
S.D  9.401     S.D  12.645     
miR-191 P12016 miR-191 P12026 
DNA only -139.450 -97.840 -141.787 DNA only -162.750 -112.424 -102.448 
DNA/RNA -61.717 -35.435 -71.040 DNA/RNA -102.592 -76.720 -62.827 
Change 77.733 62.404 70.747 Change 60.158 35.704 39.621 
Average  70.295     Average  45.161     
S.D  6.266     S.D  10.724     
miR-126 P12016 miR-126 P12026 
DNA only -95.112 -96.156 -118.325 DNA only -127.084 -62.601 -113.039 
DNA/RNA -28.361 -30.616 -61.105 DNA/RNA -81.928 -26.009 -56.556 
Change 66.752 65.540 57.220 Change 45.156 36.592 56.483 
Average  63.170     Average  46.077     
S.D  4.237     S.D  8.146    
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Appendix 4: Sensors and Actuators B: Chemical publication. 
